# Title

 Animals and Animal Products. PART 113â€”STANDARD REQUIREMENTS


# ID

 CFR-2018-title9-vol1.Pt. 113


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(8.0, 'GBP')]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Constraints | ['at least', 'highest', 'maximum', 'within', 'less than', 'prior to', 'exceeds', 'minimum', 'after', 'more than', 'greater', 'greater than', 'less than or equal to', 'least', 'equal to', 'minimum of', 'before', 'exceed', 'no more than']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Duration    | ['15.0 day', '30.0 minute', '10.0 day', '72.0 hour', '35.0 day', '3.0 hour', '48.0 hour', '15.0 minute', '50.0 day', '120.0 day', '3.0 year', '15.0 month', '60.0 minute', '12.0 day', '5.0 day', '24.0 month', '5.0 year', '28 day', '11 day', '5.0 week', '15.0 second', '5 day', '28.0 hour', '13.0 day', '120.0 hour', '6.0 week', '25.0 minute', '3.0 week', '11.0 second', '90.0 minute', '4.0 week', '12.0 week', '4 week', '21.0 day', '24.0 hour', '180.0 day', '7.0 day', '1 day', '1.0 year', '2.0 day', '90.0 day', '6.0 month', '365.0 day', '35 day', '3.0 day', '8 week', '11.0 day', '8.0 day', '1.0 second', '18.0 day', '1.0 day', '28.0 day', '24 hour', '7.0 week', '4.0 hour', '6.0 day', '3 day', '17 day', '12.0 hour', '2.0 year', '2.0 week', '18.0 month', '4 day', '14 day', '10.0 minute', '1.0 hour', '30.0 day', '10.0 week', '20.0 day', '96.0 hour', '26.0 day', '23.0 day', '15 day', '6 week', '7 day', '21 day', '12.0 month', '8 day', '2.0 hour', '14.0 day']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Condition   | ['if not', 'when', 'unless', 'subject to', 'as soon as', 'until', 'provided that', 'if', 'where']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Entities    | ['Kinetic', 'United States', 'Release', 'Fecal', 'Normal', 'Equal', 'Tenosynovitis', 'Production', 'Serial', 'Eastern', 'Dried', 'Erysipelothrix', 'Mycobacterium', 'Western', 'Twenty', 'Source', 'Agglutination', 'Calves', 'Bulk', 'Severe', 'Phenol', 'New', 'Meslin, M.M', 'Sample', 'Clinical', 'Fifteen', 'Product', 'Salmonella', 'Pigs', 'Cell', 'Fluorescence', 'Lung', 'Examine', 'Kersey', 'Biological', 'Chickens', 'Clostridium', 'Kaplan, and H. Koprowski', 'Mouse', 'Eastern, Western, and Venezuelan', 'Filter', 'Observe', 'Porcine', 'Provided, That', 'Serials', 'Mix', 'Animal', 'Serum', 'Venezuelan', 'Strain', 'Failure', 'Test', 'That', 'Antibody', 'Additional', 'Policy', 'Virus', 'Throat', 'Ames, IA', 'Live', 'Smooth', 'Fixed', 'Agriculture', 'Rectal', 'Pn, C, and Dt', 'Example', 'Brucella', 'Blood', 'Balance', 'Chlamydia', 'Geneva, Switzerland', 'Incubation', 'Newcastle', 'Data', 'Sterile', 'Blank', 'Plate', 'Pasteurella', 'Swine', 'Parvovirus', 'Compliance', 'Microscopic', 'U.S. Department', 'Dog', 'Pullorum', 'Rabies', 'Guinea', 'Bovine', 'United States Pharmacopeia', 'Sheep', 'Productions', 'Culture', 'Provided', 'Vaccine', 'Final', 'Inject', 'Media', 'Liquid', 'Label', 'Thirty', 'Swiss', 'Fifty', 'Appropriate', 'IgG', 'Cat', 'Retain', 'Canine', 'Tuberculin', 'Chicken', 'Calf', 'Bacillus', 'Suitable', 'Nasal', 'Vero', 'Bacteria', 'Frozen', 'Divide', 'Unknown', 'Turkeys', 'Allowance', 'Mycoplasma', 'Reovirus', 'Such', 'Avian', 'Individual', 'Lyons'] |
| Date        | ['2018-10-03', '2018-03-04', '2018-03-05', '1980-01-01', '2018-01-10', '2018-10-01', '2018-10-14', '2018-07-14', '2018-05-10', '2018-10-15', '2004-07-14', '2018-07-10', '2018-01-25', '800-01-01', '2036-05-01', '2018-09-10', '2018-10-12', '2018-05-01', '2004-11-05', '2018-01-20', '2018-04-08', '2018-04-05']                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |


# Structured Analysis With Context

 


## Money

| Money        | Context                                                                                                                                                                                                                                                                                                                                         |
|:-------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (8.0, 'GBP') | (2) Each of at least eight rabbits of a strain acceptable to the Animal and Plant Health Inspection Service, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the recommended cattle dose.                                                                                                                 |
| (8.0, 'GBP') | (2) Each of at least eight rabbits of a strain acceptable to the Animal and Plant Health Inspection Service, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the recommended cattle dose: Provided, That, if the product is recommended only for sheep, half of the recommended sheep dose shall be used. |
| (8.0, 'GBP') | (2) Each of at least eight rabbits of a strain acceptable to APHIS, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any species indicated on the product label.                                                                                                          |
| (8.0, 'GBP') | (2) Each of at least eight rabbits of a strain acceptable to APHIS, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any species indicated on the product label.                                                                                                          |


## Constraints

| Constraints           | Context                                                                                                                                        |
|:----------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------|
| prior to              | procedures are developed, shall be revised and reissued prior to  application.                                                                 |
| after                 | for identification by the person making the selection after which they shall be packaged by the licensee                                       |
| minimum               | of such samples from each serial and the minimum quantity of product to be provided in each                                                    |
| after                 | sample may be returned to the serial inventory after  the serial is released.                                                                  |
| after                 | not eligible to be returned to serial inventory after  the serial is released.                                                                 |
| more than             | biologic eligible to be shipped that consists of more than  50 containers.                                                                     |
| more than             | serials or subserials eligible for shipment consisting of more than 50 containers, 10 samples from each serial or                              |
| at least              | section, the number of such samples shall be at least one and one-half times the number prescribed for                                         |
| minimum               | Master Seeds and Master Cell Stocks with a minimum individual volume of 1 ml shall be submitted                                                |
| more than             | in cell culture and intended for use in more than one species, an additional 2 samples are required                                            |
| at least              | (3) Thirty-six samples of  at least  1 ml each or six samples of                                                                               |
| at least              | (3) Thirty-six samples of  at least  1 ml each or six samples of                                                                               |
| at least              | (3) Thirty-six samples of  at least  1 ml each or six samples of                                                                               |
| at least              | (3) Thirty-six samples of  at least  1 ml each or six samples of                                                                               |
| at least              | with a virus, an additional four samples of at least  1 ml each are required.                                                                  |
| more than             | infected cell stocks are intended for use in more than one species, an additional two samples of at                                            |
| at least              | than one species, an additional two samples of at least 1 ml each are required for each additional                                             |
| highest               | of the Master Cell Stock + n ( highest  passage) cells.                                                                                        |
| before                | is required to rehydrate or dilute the product before  use.                                                                                    |
| after                 | temperature recommended on the labels for 6 months after  the expiration date stated on the labels.                                            |
| prior to              | (a) No biological product shall be released  prior to the completion of tests prescribed in a filed                                            |
| after                 | Plant Health Inspection Service, biological products tested there after shall be evaluated by such methods, and if                             |
| prior to              | or suggested in its labeling or proposed labeling prior to  the expiration date.                                                               |
| more than             | (a) When a biological product contains  more than one immunogenic fraction, the completed product shall be                                     |
| more than             | (b) When similar potency tests are required for  more than one fraction of a combination biological product, different                         |
| more than             | When the same safety test is required for more than one fraction, requirements are fulfilled by satisfactory results                           |
| minimum               | of the test, as compared with the required minimum potency, each serial and subserial shall either be                                          |
| exceed                | shows the count or titer to equal or exceed the required minimum, the serial or subserial is                                                   |
| minimum               | or titer to equal or exceed the required minimum , the serial or subserial is satisfactory without                                             |
| minimum               | or titer to be lower than the required minimum , the serial or subserial may be retested,                                                      |
| less than             | If the average is  less than the required minimum, the serial or subserial is                                                                  |
| minimum               | If the average is less than the required  minimum , the serial or subserial is unsatisfactory without                                          |
| equal to              | (3) If the average is  equal to or greater than the required minimum, the following                                                            |
| greater than          | (3) If the average is equal to or  greater than the required minimum, the following shall apply to                                             |
| minimum               | is equal to or greater than the required minimum , the following shall apply to live virus                                                     |
| greater               | obtained in the initial test is 10&#8201;0.7 or greater , the initial titer may be considered a                                                |
| less than             | the titer obtained in the initial test is less than 10&#8201;0.7, a new average shall be determined using                                      |
| minimum               | If the new average is below the required  minimum , the serial or subserial is unsatisfactory.                                                 |
| equal to              | (4) If the average is  equal to or greater than the required minimum, the following                                                            |
| greater than          | (4) If the average is equal to or  greater than the required minimum, the following shall apply to                                             |
| minimum               | is equal to or greater than the required minimum , the following shall apply to bacterial vaccines:                                            |
| at least              | the average count obtained in the retests is at least three times the count obtained in the initial                                            |
| less than             | the average count obtained in the retests is less than three times the count obtained in the initial                                           |
| minimum               | the new average count is below the required minimum , the serial or subserial is unsatisfactory.                                               |
| minimum               | test procedures, each serial that meets the required minimum potency shall be released to the firm for                                         |
| minimum               | test procedures, each serial that meets the required minimum potency shall be released to the firm for                                         |
| exceeds               | test (test 1) shows that potency equals or exceeds the required minimum potency, the serial is satisfactory                                    |
| minimum               | shows that potency equals or exceeds the required minimum  potency, the serial is satisfactory without additional testing.                     |
| exceeds               | and 3) shows that the potency equals or exceeds  the required minimum potency, the serial is satisfactory.                                     |
| minimum               | that the potency equals or exceeds the required minimum  potency, the serial is satisfactory.                                                  |
| less than             | an initial equivocal test shows that potency is less than the required minimum potency, disposition of the serial                              |
| minimum               | shows that potency is less than the required minimum potency, disposition of the serial will be based                                          |
| less than             | an initial equivocal test shows that potency is less than the required minimum potency, disposition of the serial                              |
| minimum               | shows that potency is less than the required minimum potency, disposition of the serial will be based                                          |
| less than             | initial test (test 1) shows that potency is less than the required minimum potency, the serial may be                                          |
| minimum               | shows that potency is less than the required minimum  potency, the serial may be retested a                                                    |
| minimum of            | minimum potency, the serial may be retested a minimum of two times (tests 2 and 3) but not                                                     |
| more than             | two times (tests 2 and 3) but not more than three times (tests 2, 3, and 4) with                                                               |
| exceeds               | show that potency of the serial equals or exceeds  the required minimum potency, the serial is satisfactory.                                   |
| minimum               | of the serial equals or exceeds the required minimum  potency, the serial is satisfactory.                                                     |
| less than             | 2 or 3) shows that the potency is less than  the required minimum potency, the serial is unsatisfactory.                                       |
| minimum               | that the potency is less than the required minimum  potency, the serial is unsatisfactory.                                                     |
| exceeds               | or 3) shows that the potency equals or exceeds the required minimum potency and the other retest                                               |
| minimum               | that the potency equals or exceeds the required minimum potency and the other retest (test 2 or                                                |
| exceeds               | that the potency of the serial equals or exceeds the required minimum potency, the serial is deemed                                            |
| minimum               | of the serial equals or exceeds the required minimum  potency, the serial is deemed satisfactory.                                              |
| equal to              | antigenic content shall have an initial dating period equal to the dating of the product or as supported                                       |
| prior to              | of product in a manner acceptable to APHIS. prior to                                                                                           |
| minimum               | extended by data acceptable to APHIS if the minimum potency of the Master Reference is determined to                                           |
| minimum               | extended by data acceptable to APHIS if the minimum potency of the Master Reference is determined to                                           |
| equal to              | it shall be allowed an initial dating period equal to the dating of the product or as supported                                                |
| prior to              | its immunogenicity using a Qualifying Serial of product. prior to                                                                              |
| at least              | (2) If  at least 80 percent of the controls do not show                                                                                        |
| at least              | actions taken: (i) The Administrator shall require that at least two additional serials prepared with the same Master                          |
| at least              | by Animal and Plant Health Inspection Service until at least two additional product licenses are issued for the                                |
| equal to              | liquid product shall be diluted to a volume equal to the contents of the sample times the concentration                                        |
| prior to              | contents of the sample times the concentration factor prior to  initiating potency tests.                                                      |
| equal to              | and have growth-promoting buffering, and oxygen tension-controlling properties equal to  or better than such media.                            |
| after                 | medium is held for 90 days or longer after being so tested, it shall be retested before                                                        |
| before                | after being so tested, it shall be retested before  use.                                                                                       |
| minimum               | the medium to support the growth of a minimum  number of micro-organisms.                                                                      |
| less than             | Provided, That, if each final container sample contains less than 2 ml, one-half of the contents shall be                                      |
| at least              | cells, or ingredients of animal origin are tested, at least a 20 ml test sample from each lot                                                  |
| less than             | of the turbid medium in amounts of not less than  1.0 ml.                                                                                      |
| prior to              | (3) Immediately  prior to starting the test, frozen liquid vaccine shall be                                                                    |
| at least              | final container into a corresponding individual vessel containing at least  120 ml of Soybean Casein Digest Medium.                            |
| greater               | required in &#167;&#8201;113.25(d) indicates the need for a greater  dilution of the product.                                                  |
| at least              | container sample into a corresponding individual vessel containing at least  40 ml of Soybean Casein Digest Medium.                            |
| greater               | required in &#167;&#8201;113.25(d) indicates the need for a greater  dilution of the product.                                                  |
| prior to              | (3) Immediately  prior to starting the test, frozen liquid vaccine shall be                                                                    |
| at least              | final container into a corresponding individual vessel containing at least  40 ml of Fluid Thioglycollate Medium.                              |
| greater               | required in &#167;&#8201;113.25(d) indicates the need for a greater  dilution of the product.                                                  |
| at least              | final container into a corresponding individual vessel containing at least  40 ml of Soybean Casein Digest Medium.                             |
| greater               | required in &#167;&#8201;113.25(d) indicates the need for a greater  dilution of the product.                                                  |
| less than             | Not  less than 4 ml of each lot of Master Seed                                                                                                 |
| prior to              | be rehydrated with Soybean Casein Digest Medium immediately prior to  starting the test.                                                       |
| at least              | Seed Virus into 10 individual vessels each containing at least  120 ml of Soybean Casein Digest Medium.                                        |
| at least              | Seed Virus into 10 individual vessels each containing at least  40 ml of Soybean Casein Digest Medium.                                         |
| less than             | Not  less than 4 ml of each lot of Master Seed                                                                                                 |
| prior to              | shall be rehydrated with sterile purified water immediately prior to  starting the test.                                                       |
| at least              | Seed Bacteria into 10 individual vessels each containing at least  40 ml of Fluid Thioglycollate Medium.                                       |
| at least              | Seed Bacteria into 10 individual vessels each containing at least  40 ml of Soybean Casein Digest Medium.                                      |
| prior to              | of penicillinase per ml of medium added just prior to  pouring the plates.                                                                     |
| prior to              | (3) Immediately  prior to starting the test, frozen liquid vaccine shall be                                                                    |
| equal to              | of 2 plates shall be inoculated with vaccine equal to 10 doses if the vaccine is recommended for                                               |
| exceeds               | If the average count at either incubation condition exceeds 1 colony per dose for vaccines recommended for                                     |
| exceeds               | the final test for a serial or subserial exceeds 1 colony per dose for vaccines recommended for                                                |
| prior to              | Immediately  prior to starting the test, frozen liquid vaccine shall be                                                                        |
| at least              | (1) If growth appears on  at least one of the plates in the positive control                                                                   |
| less than             | performed in an environment with a relative humidity less than  45 percent.                                                                    |
| less than             | dry at 60 &#177;3 &#176;C under vacuum at less than  2.5 kPa.                                                                                  |
| after                 | &#8220;A.&#8221; (iii) Return weighing bottles to the desiccator. after                                                                        |
| after                 | oven is equalized with the prevailing atmospheric pressure. after                                                                              |
| minimum of            | (4) After a  minimum of 3 hours of drying time, turn off the                                                                                   |
| minimum of            | (i) Allow a  minimum of 2 hours for the weighing bottle to cool                                                                                |
| less than or equal to | satisfactory if the percentage of residual moisture is less than or equal to  the manufacturer's specification.                                |
| before                | Samples shall be collected from the bulk suspension before  bacteriostatic or bactericidal agents have been added.                             |
| at least              | cultures shall be propagated at 35-37 &#176;C for at least  21 days.                                                                           |
| before                | intact cells and release the group specific antigen. before                                                                                    |
| prior to              | 1 ml of the extract of the tissue prior to the addition of antibiotics, diluent and stabilizer, shall                                          |
| at least              | atmosphere at a temperature of 35-37 &#176;C for at least  7 days.                                                                             |
| more than             | mL (the inoculation volume may be divided among more than one injection site), and the animals observed for                                    |
| prior to              | shall be collected from bulk suspensions of each prior to  mixing with the Newcastle Disease Vaccine.                                          |
| more than             | If the vaccine to be rehydrated contains  more than one virus fraction, the test shall be conducted                                            |
| after                 | the test shall be conducted with each fraction after neutralization of the other fraction(s), and/or dilution of                               |
| at least              | (c) Test procedure: (1) Rehydrate  at least two vials of the vaccine with the liquid                                                           |
| at least              | (2) Rehydrate  at least two vials of the vaccine with the same                                                                                 |
| more than             | virus(es) rehydrated with the product under test is more than 0.7 log10 below the titer of the vaccine                                         |
| at least              | the same source and hatch, shall be immunized at least  14 days prior to being put on test.                                                    |
| at least              | the same source and hatch, shall be immunized at least  14 days prior to being put on test.                                                    |
| prior to              | hatch, shall be immunized at least 14 days prior to  being put on test.                                                                        |
| at least              | Subcutaneous, intratracheal, eye-drop, and comb scarification (1 cm&#8201;2). at least                                                         |
| at least              | five birds shall be isolated as control birds. at least                                                                                        |
| after                 | of at least 20 fully susceptible chicken embryos. after                                                                                        |
| at least              | vaccine-serum mixture shall be inoculated into each of at least  20 fully susceptible chicken embryos.                                         |
| at least              | the first 24 hours shall be disregarded but at least 18 viable embryos shall survive 24 hours post-inoculation                                 |
| after                 | all embryos and CAM's from embryos which die after  the first day.                                                                             |
| at least              | (2) Each of  at least 10 susceptible cats shall be administered a sample                                                                       |
| before                | a serial of vaccine is tested for safety before  release.                                                                                      |
| at least              | (2) Each of  at least 10 susceptible dogs shall be administered a sample                                                                       |
| before                | a serial of vaccine is tested for safety before  release.                                                                                      |
| at least              | (a) Each of  at least 10 mice obtained from a source free of                                                                                   |
| more than             | show swelling in the injected footpad or if more than one becomes systemically abnormal, the material being tested                             |
| more than             | Not  more than  2 mg/ml of each antibiotic shall be used.                                                                                      |
| within                | each of the three passages, embryo deaths occurring within 48 hours of injection shall be disregarded, except                                  |
| more than             | of injection shall be disregarded, except that if more than three such deaths occur at any passage, that                                       |
| after                 | or more embryo deaths occur at any passage after 48 hours postinjection, the yolk sacs from each                                               |
| minimum               | (1) Inject each of two swine of the  minimum age for which the product is recommended with                                                     |
| minimum               | (1) Inject each of two sheep of the  minimum age for which the product is recommended with                                                     |
| at least              | One or more monolayers that are  at least  6 cm&#8201;2 and                                                                                    |
| at least              | One or more monolayers that are  at least  6 cm&#8201;2 and                                                                                    |
| at least              | One or more monolayers that are  at least  6 cm&#8201;2 and                                                                                    |
| at least              | One or more monolayers that are  at least  6 cm&#8201;2 and                                                                                    |
| before                | These suspensions may be mixed  before addition to the monolayer or they may be                                                                |
| at least              | (a) Monolayer cultures of cells (monolayers),  at least 7 days after the last subculturing, shall be                                           |
| after                 | cultures of cells (monolayers), at least 7 days after the last subculturing, shall be processed and stained                                    |
| at least              | of monolayers shall have a total area of at least  6 cm&#8201;2.                                                                               |
| before                | of the vessel in which they are grown) before 7 days after subculturing if fluorescence is enhanced                                            |
| after                 | in which they are grown) before 7 days after subculturing if fluorescence is enhanced by doing so,                                             |
| at least              | of the material under test is also fixed at least  seven days after subculturing.                                                              |
| after                 | in which they are grown) before 7 days after subculturing if fluorescence is enhanced by doing so,                                             |
| before                | Monolayers that are fixed  before 7 days after subculturing shall be stained at                                                                |
| after                 | Monolayers that are fixed before 7 days  after subculturing shall be stained at the same time                                                  |
| at least              | as the test monolayers and negative controls fixed at least  7 days after subculturing.                                                        |
| after                 | Monolayers that are fixed before 7 days  after subculturing shall be stained at the same time                                                  |
| more than             | testing for the listed extraneous viruses specified in more than one cell type, it need only be applied                                        |
| after                 | fluorescence attributable to the presence of extraneous viruses. after                                                                         |
| minimum               | the specific substances in the product below the minimum acceptable potency within the dating period when stored                               |
| within                | in the product below the minimum acceptable potency within the dating period when stored at the recommended                                    |
| at least              | The sample for testing shall consist of  at least 75 cm&#8201;2 of actively growing cells or the                                               |
| at least              | (c) A monolayer  at least 75 cm&#8201;2 from each batch of primary cells                                                                       |
| at least              | Monolayers of avian origin shall be maintained for at least  14 days and shall be subcultured                                                  |
| at least              | Monolayers of avian origin shall be maintained for at least  14 days and shall be subcultured                                                  |
| at least              | subculture shall result in a new monolayer of at least  75 cm&#8201;2.                                                                         |
| minimum               | The last subculture shall meet the  minimum  area requirement specified in &#167;&#167;&#8201;113.46 and 113.47.                               |
| at least              | not of avian origin shall be maintained for at least  28 days and shall be subcultured                                                         |
| at least              | not of avian origin shall be maintained for at least  28 days and shall be subcultured                                                         |
| at least              | subculture shall result in a new monolayer of at least  75 cm&#8201;2.                                                                         |
| minimum               | The last subculture shall meet the  minimum  area requirement specified in &#167;&#167;&#8201;113.46 and 113.47.                               |
| highest               | level and identity of the MCS and the highest passage level (MCS + n) intended for use                                                         |
| at least              | least four monolayers with a total area of at least  6 cm&#8201;2 shall be grown to                                                            |
| at least              | least four monolayers with a total area of at least  6 cm&#8201;2 shall be grown to                                                            |
| at least              | least four monolayers with a total area of at least  6 cm&#8201;2 shall be grown to                                                            |
| at least              | to the species of origin of the MCS. at least                                                                                                  |
| at least              | to the species of origin of the MCS. at least                                                                                                  |
| at least              | The sample for testing shall consist of  at least 75 cm&#8201;2 of actively growing cells or the                                               |
| at least              | (e) A monolayer  at least 75 cm&#8201;2 from each MCS shall be shown                                                                           |
| at least              | (1) The test monolayer shall be maintained for  at least 21 days using the medium (with additives) intended                                    |
| at least              | (2) Cells shall be subcultured  at least  two times during the maintenance period.                                                             |
| at least              | All but the last subculture shall result in  at least  one new monolayer of                                                                    |
| at least              | All but the last subculture shall result in  at least  one new monolayer of                                                                    |
| minimum               | The last subculture shall meet the  minimum area requirement specified in &#167;&#167;&#8201;113.46 and 113.47 and                             |
| at least              | period provided in paragraph (e) of this section, at least  one monolayer of                                                                   |
| at least              | period provided in paragraph (e) of this section, at least  one monolayer of                                                                   |
| greater than          | Centrifuge the disrupted cells at no  greater than 2,000 &#215; g for no more than 15                                                          |
| no more than          | at no greater than 2,000 &#215; g for no more than  15 minutes to remove cellular debris.                                                      |
| at least              | aliquots and dispense 1.0 ml onto each of at least  one monolayer (                                                                            |
| least                 | and dispense 1.0 ml onto each of at least  one monolayer (at                                                                                   |
| at least              | (iv) of this section shall be maintained for at least 14 days after inoculation with the aliquot of                                            |
| after                 | shall be maintained for at least 14 days after  inoculation with the aliquot of disrupted MCS.                                                 |
| at least              | Monolayers shall be subcultured  at least  once during the maintenance period.                                                                 |
| at least              | subculture shall result in a new monolayer of at least  75 cm&#8201;2.                                                                         |
| minimum               | The last subculture shall meet the  minimum  area requirement specified in &#167;&#167;&#8201;113.46 and 113.47.                               |
| minimum of            | A  minimum of 50 mitotic cells shall be examined at both                                                                                       |
| exceed                | number in the MCS + n shall not exceed plus or minus 15 percent of the modal                                                                   |
| exceeds               | If the modal number  exceeds the limits and/or the marker chromosomes do not                                                                   |
| at least              | tested as prescribed in this paragraph; (1) Monolayers at least 75 cm&#8201;2 of Vero (African green monkey kidney)                            |
| at least              | in the growth medium for the preparation of at least  75 cm&#8201;2 test monolayers.                                                           |
| at least              | in the growth medium for the preparation of at least  75 cm&#8201;2 test monolayers.                                                           |
| at least              | (3) The test monolayers shall be maintained for  at least  21 days.                                                                            |
| at least              | (4) Cells shall be subcultured  at least  two times during the maintenance period.                                                             |
| at least              | All but the last subculture shall result in  at least  one new monolayer of                                                                    |
| at least              | All but the last subculture shall result in  at least  one new monolayer of                                                                    |
| minimum               | The last subculture shall meet the  minimum  area requirements specified in &#167;&#167;&#8201;113.46 and 113.47.                              |
| less than             | (1) Not  less than 5.0 grams of trypsin shall be dissolved in                                                                                  |
| after                 | porcine cell line of proven equal PPV susceptibility. after                                                                                    |
| at least              | test and control monolayers shall be maintained for at least  14 days and subcultured                                                          |
| at least              | test and control monolayers shall be maintained for at least  14 days and subcultured                                                          |
| after                 | 14-day maintenance period, and 4 to 7 days after the last subculturing, monolayers shall be tested for                                         |
| at least              | of MSV shall be dispensed onto monolayers ( at least 75 cm&#8201;2 in area) of: (1) Vero (African                                              |
| least                 | (a) At  least a 1.0 ml aliquot per cell culture of                                                                                             |
| at least              | test shall be maintained as an uninoculated control. at least                                                                                  |
| at least              | (c) Each monolayer shall be maintained  at least  14 days.                                                                                     |
| at least              | (d) Cells shall be subcultured  at least  once during the maintenance period.                                                                  |
| at least              | All but the last subculture shall result in  at least  one new monolayer                                                                       |
| at least              | All but the last subculture shall result in  at least  one new monolayer                                                                       |
| minimum               | The last subculture shall meet the  minimum  area requirement specified in &#167;&#167;&#8201;113.46 and 113.47.                               |
| at least              | serial or first subserial of completed biological product. at least                                                                            |
| maximum               | The  maximum percent moisture in desiccated vaccines shall be stated                                                                           |
| minimum of            | bacterial count at release and expiration on a minimum of  10 consecutive released serials.                                                    |
| more than             | (ii) If the vaccine contains  more than  5 percent rough colonies or                                                                           |
| more than             | (ii) If the vaccine contains  more than  5 percent rough colonies or                                                                           |
| less than             | final container samples of freshly prepared vaccine contains less than 3.0 or more than 10.0 billion organisms per                             |
| more than             | freshly prepared vaccine contains less than 3.0 or more than 10.0 billion organisms per dose, the serial or                                    |
| less than             | the average count on the initial test is less than the minimum or greater than the maximum required                                            |
| minimum               | on the initial test is less than the minimum or greater than the maximum required in paragraph                                                 |
| greater than          | initial test is less than the minimum or greater than the maximum required in paragraph (b)(2) of this                                         |
| maximum               | less than the minimum or greater than the maximum required in paragraph (b)(2) of this section, the                                            |
| less than             | average count of the four vials retested is less than the required minimum or greater than the required                                        |
| minimum               | four vials retested is less than the required minimum or greater than the required maximum, the serial                                         |
| greater than          | retested is less than the required minimum or greater than the required maximum, the serial or subserial is                                    |
| maximum               | the required minimum or greater than the required maximum , the serial or subserial is unsatisfactory.                                         |
| within                | average count of the four vials retested is within the required limits described in paragraph (b)(2) of                                        |
| less than             | average count obtained in the initial test is less than one-third or more than three times the average                                         |
| more than             | the initial test is less than one-third or more than three times the average count obtained on the                                             |
| more than             | obtained in the initial test is one-third or more than the average retest count or three times or                                              |
| less than             | the average retest count or three times or less than the average retest count, a new average count                                             |
| less than             | If the new average is  less than the minimum or greater than the maximum required                                                              |
| minimum               | If the new average is less than the  minimum or greater than the maximum required in paragraph                                                 |
| greater than          | new average is less than the minimum or greater than the maximum required in paragraph (b)(2) of this                                          |
| maximum               | less than the minimum or greater than the maximum required in paragraph (b)(2) of this section, the                                            |
| within                | (4) If tested at any time  within the expiration period, each dose of rehydrated vaccine                                                       |
| at least              | period, each dose of rehydrated vaccine must contain at least  3.0 billion viable organisms per dose.                                          |
| at least              | samples of freshly prepared vaccine does not contain at least 10 billion viable organisms per milliliter, the serial                           |
| less than             | (3) If the initial bacterial count is  less than 10 billion organisms per milliliter, the serial or                                            |
| less than             | average count of the four vials retested is less than the required minimum, the serial or subserial is                                         |
| minimum               | four vials retested is less than the required minimum , the serial or subserial is unsatisfactory.                                             |
| within                | (4) If tested at any time  within the expiration period, each milliliter of rehydrated vaccine                                                 |
| at least              | each milliliter of rehydrated vaccine does not contain at least 5 billion viable organisms per milliliter, the serial                          |
| highest               | mean spore count of vaccine produced from the highest passage of the Master Seed shall be established                                          |
| before                | passage of the Master Seed shall be established before  the immunogenicity test is conducted.                                                  |
| less than             | and controls shall each be challenged with not less than 4,500 guinea pig LD50 of a virulent suspension                                        |
| at least              | (4) If  at least 10 of the 12 controls do not die                                                                                              |
| within                | 12 controls do not die from Bacillus anthracis within the 10-day postchallenge observation period the test is                                  |
| at least              | (5) If  at least 27 of 30 of the vaccinates do not                                                                                             |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a spore count sufficiently greater than that of the vaccine used in the immunogenicity                               |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| at least              | and subserial shall have a spore count of at least twice that used in the immunogenicity test but                                              |
| less than             | that used in the immunogenicity test but not less than  2,000,000 spores per dose.                                                             |
| highest               | colony forming units from vaccine produced from the highest passage of the Master Seed shall be established                                    |
| before                | passage of the Master Seed shall be established before  the immunogenicity test is conducted.                                                  |
| prior to              | be examined and their average body temperature determined prior to  challenge.                                                                 |
| at least              | (5) If  at least 80 percent of the controls do not show                                                                                        |
| at least              | (5) If  at least 80 percent of the controls do not show                                                                                        |
| after                 | (6) To demonstrate immunity  after challenge, the vaccinates shall remain free of clinical                                                     |
| exceed                | clinical signs and the body temperature shall not exceed  104.6 &#176;F on 2 or more consecutive days.                                         |
| at least              | If  at least 90 percent of the vaccinates do not remain                                                                                        |
| before                | An Outline of Production change shall be made before authority for use of a new Master Seed                                                    |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| highest               | colony forming units from vaccine produced from the highest passage of the Master Seed shall be established                                    |
| before                | passage of the Master Seed shall be established before  the immunogenicity test is conducted.                                                  |
| prior to              | be examined and their average body temperature determined prior to  challenge.                                                                 |
| before                | An Outline of Production change must be made before authority for use of a new lot of                                                          |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| at least              | serial and subserial shall have a bacterial count at least two times greater than that used in the                                             |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| highest               | colony forming units from vaccine produced from the highest passage of the Master Seed shall be established                                    |
| before                | passage of the Master Seed shall be established before  the immunogenicity test is conducted.                                                  |
| prior to              | be examined and their average body temperature determined prior to  challenge.                                                                 |
| before                | An Outline of Production change must be made before authority for use of a new lot of                                                          |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| at least              | serial and subserial shall have a bacterial count at least two times greater than that used in the                                             |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| highest               | colony forming units from vaccine produced from the highest passage of Master Seed shall be established before                                 |
| before                | highest passage of Master Seed shall be established before  the immunogenicity test is conducted.                                              |
| less than             | (3) Not  less than 14 days after vaccination, each of 20 vaccinates                                                                            |
| after                 | (3) Not less than 14 days  after vaccination, each of 20 vaccinates and each of                                                                |
| at least              | If  at least 16 of 20 of the vaccinates do not                                                                                                 |
| more than             | If the vaccine is recommended for  more than one species, only one species needs to be                                                         |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| at least              | serial and subserial shall have a bacterial count at least two times greater than that used in the                                             |
| greater than          | and subserial shall have a bacterial count sufficiently greater than that of the vaccine used in the immunogenicity                            |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed shall be established                                           |
| before                | passage of the Master Seed shall be established before  the immunogenicity test is conducted.                                                  |
| after                 | (3) Fourteen or more days  after the final dose of vaccine, the vaccinates and                                                                 |
| minimum of            | controls shall each be challenged intranasally with a minimum of 10,000 yolk sac LD50 of virulent feline pneumonitis                           |
| less than             | (i) If  less than 8 of 10 controls show clinical signs of                                                                                      |
| before                | An Outline of Production change must be made before authority for use of a new lot of                                                          |
| greater than          | and each subserial shall have a titer sufficiently greater than the titer of vaccine used in the immunogenicity                                |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | and each subserial shall have a titer sufficiently greater than the titer of vaccine used in the immunogenicity                                |
| less than             | that used in such immunogenicity test but not less than  2.5 ID50 per dose.                                                                    |
| exceed                | of biological products containing clostridial antigens must not exceed  1.85 grams per liter (g/L).                                            |
| exceed                | other than those containing clostridial antigens, must not exceed  0.74 grams per liter (g/L).                                                 |
| more than             | saline so that each 0.25 ml contains not more than 1/800th of the dose recommended on the label                                                |
| at least              | Inject each of  at least 10 but not more than 12 young adult                                                                                   |
| more than             | Inject each of at least 10 but not  more than 12 young adult hamsters, each weighing 50 to                                                     |
| at least              | Retain  at least 10 but not more than 12 additional hamsters                                                                                   |
| more than             | Retain at least 10 but not  more than 12 additional hamsters from the same group as                                                            |
| more than             | saline so that each 0.25 ml contains not more than 1/80th of the dose recommended on the label                                                 |
| at least              | Inject each of  at least 10 but not more than 12 young adult                                                                                   |
| more than             | Inject each of at least 10 but not  more than 12 young adult hamsters, each weighing 50 to                                                     |
| at least              | Retain  at least 10 but not more than 12 additional hamsters                                                                                   |
| more than             | Retain at least 10 but not  more than 12 additional hamsters from the same group as                                                            |
| more than             | saline so that each 0.25 ml contains not more than 1/80th of the dose recommended on the label                                                 |
| at least              | Inject each of  at least 10 but not more than 12 young adult                                                                                   |
| more than             | Inject each of at least 10 but not  more than 12 young adult hamsters, each weighing 50 to                                                     |
| at least              | Retain  at least 10 but not more than 12 additional hamsters                                                                                   |
| more than             | Retain at least 10 but not  more than 12 additional hamsters from the same group as                                                            |
| more than             | saline so that each 0.25 ml contains not more than 1/800th of the dose recommended on the label                                                |
| at least              | Inject each of  at least 10 but not more than 12 young adult                                                                                   |
| more than             | Inject each of at least 10 but not  more than 12 young adult hamsters, each weighing 50 to                                                     |
| at least              | Retain  at least 10 but not more than 12 additional hamsters                                                                                   |
| more than             | Retain at least 10 but not  more than 12 additional hamsters from the same group as                                                            |
| at least              | (1) Each of  at least 8 but not more than 10 guinea pigs,                                                                                      |
| more than             | (1) Each of at least 8 but not  more than 10 guinea pigs, each weighing 300 to 500                                                             |
| after                 | dose shall be injected 21 to 23 days after  the first dose.                                                                                    |
| at least              | (3) For a valid test,  at least 80 percent of the controls shall die within                                                                    |
| within                | least 80 percent of the controls shall die within  the 3 day post-challenge observation period.                                                |
| at least              | (1) Each of  at least 8 but not more than 10 guinea pigs,                                                                                      |
| more than             | (1) Each of at least 8 but not  more than 10 guinea pigs, each weighing 300 to 500                                                             |
| after                 | dose shall be injected 21 to 23 days after  the first dose.                                                                                    |
| at least              | (3) For a valid test,  at least 80 percent of the controls shall die within                                                                    |
| within                | least 80 percent of the controls shall die within  the 3 day post-challenge observation period.                                                |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| at least              | (2) Each of  at least eight rabbits of a strain acceptable to the                                                                              |
| more than             | 4-8 pounds, shall be injected subcutaneously with not more than  half of the recommended cattle dose.                                          |
| less than             | A second dose shall be given not  less than 20 days nor more than 23 days after                                                                |
| more than             | be given not less than 20 days nor more than  23 days after the first dose.                                                                    |
| after                 | than 20 days nor more than 23 days after  the first dose.                                                                                      |
| after                 | (3) Fourteen to seventeen days  after the second dose, all surviving rabbits shall be                                                          |
| at least              | are required to make an acceptable serum pool. at least                                                                                        |
| less than             | (iii) If  less than seven rabbits are available, the test is invalid                                                                           |
| less than             | (ii) If  less than 80 percent of the mice inoculated with the                                                                                  |
| less than             | Toxin die, the serum is considered to contain less than  0.50 International Units per ml.                                                      |
| less than             | pooled serum from seven or more rabbits contains less than 0.5 International Unit per ml, the serial is                                        |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| at least              | (2) Each of  at least eight rabbits of a strain acceptable to the                                                                              |
| more than             | 4-8 pounds, shall be injected subcutaneously with not more than half of the recommended cattle dose: Provided, That,                           |
| less than             | A second dose shall be given not  less than 20 days nor more than 23 days after                                                                |
| more than             | be given not less than 20 days nor more than  23 days after the first dose.                                                                    |
| after                 | than 20 days nor more than 23 days after  the first dose.                                                                                      |
| after                 | (3) Fourteen to seventeen days  after the second dose, all surviving rabbits shall be                                                          |
| at least              | are required to make an acceptable serum pool. at least                                                                                        |
| less than             | (iii) If  less than seven rabbits are available, the test is a                                                                                 |
| less than             | (ii) If  less than 80 percent of the mice inoculated with the                                                                                  |
| less than             | Toxin die, the serum is considered to contain less than  1.0 International Units per ml.                                                       |
| less than             | pooled serum from seven or more rabbits contains less than 1.0 International Unit per ml, the serial is                                        |
| at least              | and approximately the same age shall be used. at least                                                                                         |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| at least              | (2) Each of  at least eight rabbits of a strain acceptable to APHIS,                                                                           |
| more than             | 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any                                   |
| less than             | A second equivalent dose shall be given not  less than 20 days nor more than 23 days after                                                     |
| more than             | be given not less than 20 days nor more than  23 days after the first does.                                                                    |
| after                 | than 20 days nor more than 23 days after  the first does.                                                                                      |
| after                 | (3) Fourteen to seventeen days  after the second dose, all surviving rabbits shall be                                                          |
| at least              | are required to make an acceptable serum pool. at least                                                                                        |
| less than             | (iii) If  less than seven rabbits are available, the test is a                                                                                 |
| less than             | (ii) If  less than 80 percent of the mice inoculated with mixture                                                                              |
| less than             | Toxin die, the serum is considered to contain less than  10 International Units per ml.                                                        |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| at least              | (2) Each of  at least eight rabbits of a strain acceptable to APHIS,                                                                           |
| more than             | 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any                                   |
| less than             | A second equivalent dose shall be given not  less than 20 days nor more than 23 days after                                                     |
| more than             | be given not less than 20 days nor more than  23 days after the first dose.                                                                    |
| after                 | than 20 days nor more than 23 days after  the first dose.                                                                                      |
| after                 | (3) Fourteen to seventeen days  after the second dose, all surviving rabbits shall be                                                          |
| at least              | are required to make an acceptable serum pool. at least                                                                                        |
| less than             | (iii) If  less than seven rabbits are available, the test is a                                                                                 |
| less than             | (ii) If  less than 80 percent of the mice inoculated with mixture                                                                              |
| less than             | Toxin die, the serum is considered to contain less than 2 International Units per ml, and the serial                                           |
| more than             | the same herd may be used as seed. more than                                                                                                   |
| at least              | (iv) Identification of microorganism(s),  at least  to genus.                                                                                  |
| exceed                | expiration date of the autogenous biologic shall not exceed  18 months from the date of harvest.                                               |
| after                 | (ii) Serials which are satisfactory  after the third day of observation of purity test                                                         |
| at least              | follows: Bacteria, fungi, and mycoplasma shall be identified at least  to genus and species.                                                   |
| at least              | Viruses shall be identified  at least  to family.                                                                                              |
| before                | identification shall be completed to strain and/or serotype before  such microorganism may be used for production.                             |
| at least              | in the filed outline of production or shall at least be standardized to contain an antigenic mass for                                          |
| after                 | (1) Six weeks  after injection, all surviving guinea pigs shall be bled                                                                        |
| less than             | bled and equal portions of serum, but not less than  0.5 ml from each, shall be pooled.                                                        |
| at least              | test, the pool shall contain the serum from at least  eight animals.                                                                           |
| at least              | the antitoxin titer of the serum pool is at least  2.0 A.U.                                                                                    |
| less than             | the antitoxin titer of the serum pool is less than  2.0 A.U.                                                                                   |
| less than             | For serials in which the serum pool contains less than  2.0 A.U.                                                                               |
| at least              | If  at least 80 percent of the individual serums have an                                                                                       |
| at least              | If  at least 80 percent of the individual serums have an                                                                                       |
| less than             | If  less than 80 percent of the individual serums have an                                                                                      |
| at least              | the individual serums have an antitoxin titer of at least  2.0 A.U.                                                                            |
| at least              | If the average of the two pools is  at least  2.0 A.U.                                                                                         |
| less than             | If the average of the two pools is  less than  2.0 A.U.                                                                                        |
| less than             | pooled serums from the eight rabbits shall contain less than  0.2 alpha antitoxin units per ml.                                                |
| more than             | rabbit shall be given a series of not more than three intramuscular injections at 7 day intervals (1.0                                         |
| at least              | Turkeys  at least 6 weeks old obtained from the same source                                                                                    |
| more than             | Each of not  more than 21 turkeys shall be vaccinated with the dose                                                                            |
| after                 | A second dose shall be given  after 3 weeks and the turkeys observed for an                                                                    |
| more than             | Each of not  more than  11 turkeys shall be held as controls.                                                                                  |
| less than             | Not  less than 14 days after the second dose, each of                                                                                          |
| after                 | Not less than 14 days  after the second dose, each of 20 vaccinates, and                                                                       |
| at least              | Chickens,  at least 12 weeks of age, obtained from the same                                                                                    |
| more than             | Each of not  more than 21 chickens shall be injected with the dose                                                                             |
| after                 | A second dose shall be injected  after 3 weeks and the chickens observed for an                                                                |
| more than             | Each of not  more than  11 chickens shall be held as controls.                                                                                 |
| less than             | Not  less than 14 days after the second injection, each of                                                                                     |
| after                 | Not less than 14 days  after the second injection, each of 20 vaccinates, and                                                                  |
| minimum of            | unvaccinated controls shall be challenged intramuscularly with a minimum of 250 colony-forming units of virulent Pasteurella multocida, Strain |
| at least              | Turkeys,  at least 6 weeks of age, obtained from the same                                                                                      |
| more than             | Each of not  more than 21 turkeys shall be injected with the dose                                                                              |
| after                 | A second dose shall be injected  after 3 weeks and the turkeys observed for an                                                                 |
| more than             | Each of not  more than  11 turkeys shall be held as controls.                                                                                  |
| less than             | Not  less than 14 days after the second injection, each of                                                                                     |
| after                 | Not less than 14 days  after the second injection, each of 20 vaccinates, and                                                                  |
| minimum of            | unvaccinated controls shall be challenged intramuscularly with a minimum of 150 colony-forming units of virulent Pasteurella multocida, Strain |
| least                 | A mouse dose shall be 1/10 of the  least  dose recommended on the label for swine.                                                             |
| less than             | Such swine dose shall not be  less than  1 ml.                                                                                                 |
| at least              | threefold dilutions shall be made for each Unknown. at least                                                                                   |
| at least              | each dilution of an Unknown, a group of at least 20 mice, each weighing 16 to 22 grams,                                                        |
| after                 | shall be challenged subcutaneously 14 to 21 days after  being injected.                                                                        |
| at least              | A dose containing  at least 100 mouse LD50 of a suitable culture of                                                                            |
| at least              | less than 100 percent of the mice injected. at least                                                                                           |
| more than             | least two dilutions of the Standard shall protect more than 0 percent and two dilutions shall protect less                                     |
| less than             | than 0 percent and two dilutions shall protect less than  100 percent of the mice injected.                                                    |
| more than             | The lowest dilution of the Standard shall protect  more than  50 percent of the mice.                                                          |
| highest               | The  highest dilution of the Standard shall protect less than                                                                                  |
| less than             | The highest dilution of the Standard shall protect  less than  50 percent of the mice.                                                         |
| less than             | (7) If the RP of the Unknown is less than  0.6, the serial being tested is unsatisfactory.                                                     |
| exceed                | be calculated because the lowest dilution does not exceed 50 percent protection, that serial may be retested                                   |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| highest               | a valid test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is                                   |
| exceeds               | test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is satisfactory without                      |
| less than             | (10) If the RP is  less than 0.6, the serial may be retested by conducting                                                                     |
| less than             | If the average RP is  less than  0.6, the serial is unsatisfactory without further testing.                                                    |
| equal to              | the average RP obtained in the retests is equal to or greater than 0.6, the following shall apply:                                             |
| greater than          | obtained in the retests is equal to or greater than 0.6, the following shall apply: (i) If the                                                 |
| less than             | obtained in the original test is one-third or less than the average RP obtained in the retests, the                                            |
| more than             | RP value obtained in the original test is more than one-third the average RP obtained in the retests,                                          |
| less than             | If the new average is  less than  0.6, the serial is unsatisfactory.                                                                           |
| least                 | A mouse dose shall be 1/20 of the  least dose recommended on the label for other animals                                                       |
| less than             | label for other animals which shall not be less than  2 ml.                                                                                    |
| at least              | tenfold dilutions shall be made for each Unknown. at least                                                                                     |
| at least              | each dilution of an Unknown, a group of at least 20 mice, each weighing 16-22 grams, shall be                                                  |
| after                 | per group shall be challenged intraperitoneally 7-10 days after the second vaccination with a 0.25 ml dose                                     |
| at least              | less than 100 percent of the mice injected. at least                                                                                           |
| more than             | least two dilutions of the Standard shall protect more than 0 percent and two dilutions shall protect less                                     |
| less than             | than 0 percent and two dilutions shall protect less than  100 percent of the mice injected.                                                    |
| more than             | The lowest dilution of the Standard shall protect  more than  50 percent of the mice.                                                          |
| highest               | The  highest dilution of the Standard shall protect less than                                                                                  |
| less than             | The highest dilution of the Standard shall protect  less than  50 percent of the mice.                                                         |
| less than             | (7) If the RP of the Unknown is less than  0.30, the serial being tested is unsatisfactory.                                                    |
| exceed                | be calculated because the lowest dilution does not exceed 50 percent protection, that serial may be retested                                   |
| exceeds               | total number of mice protected by the Standard exceeds the total number of mice protected by the                                               |
| highest               | a valid test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is                                   |
| exceeds               | test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is satisfactory without                      |
| less than             | (10) If the RP is  less than the minimum required in paragraph (c)(7) of this                                                                  |
| minimum               | (10) If the RP is less than the  minimum required in paragraph (c)(7) of this section, the                                                     |
| less than             | If the average RP is  less than  the required minimum, the serial is unsatisfactory.                                                           |
| minimum               | the average RP is less than the required minimum , the serial is unsatisfactory.                                                               |
| equal to              | the average RP obtained in the retests is equal to or greater than the required minimum, the following                                         |
| greater than          | obtained in the retests is equal to or greater than the required minimum, the following shall apply: (i)                                       |
| minimum               | is equal to or greater than the required minimum , the following shall apply: (i) If the                                                       |
| less than             | obtained in the original test is one-third or less than the average RP obtained in the retests, the                                            |
| more than             | RP value obtained in the original test is more than one-third the average RP obtained in the retests,                                          |
| less than             | If the new average is  less than the minimum required in paragraph (c)(7) of this                                                              |
| minimum               | If the new average is less than the  minimum required in paragraph (c)(7) of this section, the                                                 |
| least                 | A mouse dose shall be 1/20 of the  least dose recommended on the label for other animals                                                       |
| less than             | label for other animals which shall not be less than  2 ml.                                                                                    |
| at least              | fivefold dilutions shall be made for each Unknown. at least                                                                                    |
| at least              | each dilution of each Unknown, a group of at least 20 mice, each weighing 16-22 grams, shall be                                                |
| after                 | per group shall be challenged intraperitoneally 10-12 days after the second vaccination with a 0.2 ml dose                                     |
| at least              | less than 100 percent of the mice injected. at least                                                                                           |
| more than             | least two dilutions of the Standard shall protect more than 0 percent and two dilutions shall protect less                                     |
| less than             | than 0 percent and two dilutions shall protect less than  100 percent of the mice injected.                                                    |
| more than             | The lowest dilution of the Standard shall protect  more than  50 percent of the mice.                                                          |
| highest               | The  highest dilution of the Standard shall protect less than                                                                                  |
| less than             | The highest dilution of the Standard shall protect  less than  50 percent of the mice.                                                         |
| less than             | (7) If the RP of the Unknown is less than  0.50, the serial being tested is unsatisfactory.                                                    |
| exceed                | be calculated because the lowest dilution does not exceed 50 percent protection, that serial may be retested                                   |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| highest               | a valid test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is                                   |
| exceeds               | test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is satisfactory without                      |
| less than             | (10) If the RP is  less than the minimum required in paragraph (c)(7) of this                                                                  |
| minimum               | (10) If the RP is less than the  minimum required in paragraph (c)(7) of this section, the                                                     |
| less than             | If the average RP is  less than  the required minimum, the serial is unsatisfactory.                                                           |
| minimum               | the average RP is less than the required minimum , the serial is unsatisfactory.                                                               |
| equal to              | the average RP obtained in the retests is equal to or greater than the required minimum, the following                                         |
| greater than          | obtained in the retests is equal to or greater than  the required minimum, the following shall apply:                                          |
| minimum               | is equal to or greater than the required minimum , the following shall apply:                                                                  |
| less than             | obtained in the original test is one-third or less than the average RP obtained in the retests, the                                            |
| more than             | RP value obtained in the original test is more than one-third the average RP obtained in the retests,                                          |
| less than             | If the new average is  less than the minimum required in paragraph (c)(7) of this                                                              |
| minimum               | If the new average is less than the  minimum required in paragraph (c)(7) of this section, the                                                 |
| least                 | A mouse dose shall be 1/20 of the  least dose recommended on the label for other animals                                                       |
| less than             | label for other animals which shall not be less than  2 ml.                                                                                    |
| at least              | fivefold dilution shall be made for each Unknown. at least                                                                                     |
| at least              | each dilution of an Unknown, a group of at least 20 mice, each weighing 16 to 22 grams,                                                        |
| after                 | shall be challenged intraperitoneally 7 to 10 days after the second vaccination with a 0.25 ml dose                                            |
| at least              | less than 100 percent of the mice injected. at least                                                                                           |
| more than             | least two dilutions of the Standard shall protect more than 0 percent and two dilutions shall protect less                                     |
| less than             | than 0 percent and two dilutions shall protect less than  100 percent of the mice injected.                                                    |
| more than             | The lowest dilution of the Standard shall protect  more than  50 percent of the mice.                                                          |
| highest               | The  highest dilution of the Standard shall protect less than                                                                                  |
| less than             | The highest dilution of the Standard shall protect  less than  50 percent of the mice.                                                         |
| less than             | (7) If the RP of the Unknown is less than  0.50, the serial being tested is unsatisfactory.                                                    |
| exceed                | be calculated because the lowest dilution does not exceed 50 percent protection, that serial may be retested                                   |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| highest               | a valid test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is                                   |
| exceeds               | test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is satisfactory without                      |
| less than             | (10) If the RP is  less than the minimum required in paragraph (c)(7) of this                                                                  |
| minimum               | (10) If the RP is less than the  minimum required in paragraph (c)(7) of this section, the                                                     |
| less than             | If the average RP is  less than  the required minimum, the serial is unsatisfactory.                                                           |
| minimum               | the average RP is less than the required minimum , the serial is unsatisfactory.                                                               |
| equal to              | the average RP obtained in the retests is equal to or greater than the required minimum, the following                                         |
| greater than          | obtained in the retests is equal to or greater than the required minimum, the following shall apply: (i)                                       |
| minimum               | is equal to or greater than the required minimum , the following shall apply: (i) If the                                                       |
| less than             | obtained in the original test is one-third or less than the average RP obtained in the retests, the                                            |
| more than             | RP value obtained in the original test is more than one-third the average RP obtained in the retests,                                          |
| less than             | If the new average is  less than the minimum required in paragraph (c)(7) of this                                                              |
| minimum               | If the new average is less than the  minimum required in paragraph (c)(7) of this section, the                                                 |
| least                 | A mouse dose shall be 1/20 of the  least dose recommended on the label for other animals                                                       |
| less than             | label for other animals which shall not be less than  2 ml.                                                                                    |
| at least              | tenfold dilutions shall be made for each Unknown. at least                                                                                     |
| at least              | each dilution of an Unknown, a group of at least 20 mice, each weighing 16 to 22 grams,                                                        |
| after                 | shall be challenged intraperitoneally 7 to 10 days after the second vaccination with a 0.25 ml dose                                            |
| at least              | less than 100 percent of the mice injected. at least                                                                                           |
| more than             | least two dilutions of the Standard shall protect more than 0 percent and two dilutions shall protect less                                     |
| less than             | than 0 percent and two dilutions shall protect less than  100 percent of the mice injected.                                                    |
| more than             | The lowest dilution of the Standard shall protect  more than  50 percent of the mice.                                                          |
| highest               | The  highest dilution of the Standard shall protect less than                                                                                  |
| less than             | The highest dilution of the Standard shall protect  less than  50 percent of the mice.                                                         |
| less than             | (7) If the RP of the Unknown is less than  0.30, the serial being tested is unsatisfactory.                                                    |
| exceed                | be calculated because the lowest dilution does not exceed 50 percent protection, that serial may be retested                                   |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| exceeds               | provided by the lowest dilution of the Standard exceeds the protection provided by the lowest dilution of                                      |
| highest               | a valid test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is                                   |
| exceeds               | test cannot be calculated because the highest dilution exceeds 50 percent protection, the Unknown is satisfactory without                      |
| less than             | (10) If the RP is  less than the minimum required in paragraph (c)(7) of this                                                                  |
| minimum               | (10) If the RP is less than the  minimum required in paragraph (c)(7) of this section, the                                                     |
| less than             | If the average RP is  less than  the required minimum, the serial is unsatisfactory.                                                           |
| minimum               | the average RP is less than the required minimum , the serial is unsatisfactory.                                                               |
| equal to              | the average RP obtained in the retests is equal to or greater than the required minimum, the following                                         |
| greater than          | obtained in the retests is equal to or greater than the required minimum, the following shall apply: (i)                                       |
| minimum               | is equal to or greater than the required minimum , the following shall apply: (i) If the                                                       |
| less than             | obtained in the original test is one-third or less than the average RP obtained in the retests, the                                            |
| more than             | RP value obtained in the original test is more than one-third the average RP obtained in the retests,                                          |
| less than             | If the new average is  less than the minimum required in paragraph (c)(7) of this                                                              |
| minimum               | If the new average is less than the  minimum required in paragraph (c)(7) of this section, the                                                 |
| prior to              | be tested for mycoplasma as prescribed in &#167;&#8201;113.28, prior to  adding the killing agent.                                             |
| exceed                | agent, the residual free formaldehyde content must not exceed 0.74 grams per liter (g/L) as determined using                                   |
| prior to              | of this section shall be observed each day prior to  challenge.                                                                                |
| at least              | virus and observed each day for 12 days. at least                                                                                              |
| after                 | At least 2 weeks  after the last inoculation, the five vaccinates and the                                                                      |
| at least              | A serial is satisfactory if  at least 80 percent of the vaccinates remain free of                                                              |
| at least              | A serial is satisfactory if  at least 80 percent of the vaccinates remain free of                                                              |
| at least              | If  at least 80 percent of the vaccinates remain free of                                                                                       |
| less than             | do not shed virus in the feces, while less than 80 percent of the controls develop clinical signs                                              |
| at least              | If  at least 80 percent of the vaccinates remain free of                                                                                       |
| at least              | the label and kept isolated under observation for at least  14 days.                                                                           |
| after                 | the vaccinates observed each day for 14 days. after                                                                                            |
| at least              | (2) After  at least  14 days post-vaccination, the vaccinates and                                                                              |
| at least              | (2) After  at least  14 days post-vaccination, the vaccinates and                                                                              |
| at least              | (3) If  at least 90 percent of the controls do not show                                                                                        |
| at least              | If  at least 90 percent of the vaccinates do not remain                                                                                        |
| at least              | The vaccine shall be a tissue extract representing at least 10 percent weight to volume suspension of wart                                     |
| at least              | (1) Each of  at least ten 6 to 12 hour old chickens shall                                                                                      |
| after                 | (2) Fourteen to 21 days  after the second injection, serum samples from each vaccinate                                                         |
| greater               | serum samples show a titer of 1:4 or greater for any fraction, the test is a No                                                                |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than  1:40 for the Eastern type fraction,                                                     |
| less than             | the vaccinate serum samples show a titer of less than 1:40 for the Eastern type fraction or the                                                |
| less than             | the vaccinate serum samples show a titer of less than 1:40 for the Eastern type fraction or the                                                |
| at least              | For a valid test,  at least 80 percent of the embryos shall survive for                                                                        |
| at least              | not repeated, the serial shall be declared unsatisfactory. at least                                                                            |
| at least              | is not repeated, the serial shall be unsatisfactory. at least                                                                                  |
| at least              | hatch shall be kept in isolation as controls. at least                                                                                         |
| at least              | the chickens observed each day for 21 days. at least                                                                                           |
| at least              | (2) If  at least 80 percent of the controls do not show                                                                                        |
| at least              | (3) If  at least 80 percent of the vaccinates do not remain                                                                                    |
| highest               | immunogenicity of vaccine prepared with virus at the highest passage from the Master Seed shall be established                                 |
| before                | filed with Animal and Plant Health Inspection Service before  initiation of the tests.                                                         |
| after                 | titer must be established as soon as possible after  harvest by at least five separate virus titrations.                                       |
| at least              | established as soon as possible after harvest by at least  five separate virus titrations.                                                     |
| at least              | host animal potency test must be established by at least five replicate potency tests conducted in accordance with                             |
| minimum               | Techniques in Rabies,&#8221; Fourth Edition (1996), are the minimum standards for achieving compliance with this section and                   |
| no more than          | be used in the immunogenicity test shall be no more than the amount which, on the basis of The                                                 |
| minimum               | For Potency, has been diluted to the proposed minimum  acceptable potency value.&#8201;1                                                       |
| minimum               | administered a dose of vaccine at the proposed minimum potency level and by the method specified in                                            |
| after                 | Animal and Plant Health Inspection Service 1 year after vaccinations, except as provided in (b)(4) of this                                     |
| at least              | tests shall be death due to rabies in at least  80 percent of the controls while                                                               |
| at least              | tests shall be death due to rabies in at least  80 percent of the controls while                                                               |
| at least              | challenged at the same time as the vaccinates. at least                                                                                        |
| at least              | well for a period of 90 days, and at least 80 percent of the controls must die of                                                              |
| before                | An Outline of Production change shall be made before authority for use a new lot of Master                                                     |
| more than             | (c) If  more than 1 year duration of immunity is to be                                                                                         |
| at least              | The test animals shall be monitored serologically  at least  every 180 days.                                                                   |
| at least              | Where mouse brains are used in production,  at least five mice which have not been injected with                                               |
| at least              | The relative potency of each serial must be  at least equal to that used in an approved host                                                   |
| equal to              | potency of each serial must be at least equal to that used in an approved host animal immunogenicity                                           |
| highest               | used for this test shall be at the highest passage from the Master Seed and prepared at                                                        |
| minimum               | from the Master Seed and prepared at the minimum  preinactivation titer specified in the Outline of Production.                                |
| after                 | are recommended, the second dose shall be given after  the interval recommended on the label.                                                  |
| after                 | (iii) Fourteen or more days  after the final dose of vaccine, the vaccinates and                                                               |
| highest               | used for this test shall be at the highest passage from the Master Seed and prepared at                                                        |
| minimum               | from the Master Seed and prepared at the minimum  preinactivation titer specified in the Outline of Production.                                |
| at least              | route recommended on the label and observe for at least  21 days.                                                                              |
| at least              | Retain  at least 10 additional chickens from the same source and                                                                               |
| at least              | If  at least 80 percent of the controls do not have                                                                                            |
| highest               | used for this test shall be at the highest passage from the Master Seed and at the                                                             |
| minimum               | passage from the Master Seed and at the minimum  preinactivation titer provided in the Outline of Production.                                  |
| after                 | (iv) Fourteen days or more  after the last vaccination, blood samples shall be drawn                                                           |
| at least              | If  at least four of the five vaccinates in a valid                                                                                            |
| greater               | developed 50 percent endpoint titers of 1:8 or greater , the serial is unsatisfactory, except as provided                                      |
| highest               | used for this test shall be at the highest passage from the Master Seed and at the                                                             |
| minimum               | passage from the Master Seed and at the minimum  preinactivation titer provided in the Outline of Production.                                  |
| after                 | (iv) Fourteen or more days  after the last vaccination, blood samples shall be drawn                                                           |
| at least              | If  at least four of the five vaccinates in a valid                                                                                            |
| more than             | If  more than one of the vaccinates shows a temperature of                                                                                     |
| more than             | If  more than one of the vaccinates shows a temperature of                                                                                     |
| at least              | than poultry shall be tested for safety in at least one species for which the vaccine is intended                                              |
| at least              | each serial or first subserial of biological product. at least                                                                                 |
| at least              | For positive identification,  at least 100 ID50 of vaccine virus shall be neutralized                                                          |
| maximum               | (1) The  maximum moisture content in desiccated vaccines must be stated                                                                        |
| within                | reaction with hyperemia which resolves progressively and disappears within 2 weeks, may be characterized as a typical                          |
| at least              | susceptible mink shall be used as test animals. at least                                                                                       |
| less than             | in a varying serum-constant virus neutralization test with less than  500 ID50 of canine distemper virus.                                      |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | with a predetermined quantity of vaccine virus and at least 5 additional mink shall be held as unvaccinated                                    |
| at least              | with a predetermined quantity of vaccine virus and at least 5 additional mink shall be held as unvaccinated                                    |
| at least              | virus and observed each day for 21 days. at least                                                                                              |
| at least              | (i) If  at least 80 percent of the controls do not die                                                                                         |
| at least              | (ii) If  at least 19 of 20, 27 of 30, or 36                                                                                                    |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| highest               | mean titer of the vaccine produced from the highest passage from the Master Seed shall be established                                          |
| before                | passage from the Master Seed shall be established before  the immunogenicity test is conducted.                                                |
| at least              | the 60 to 300 TCID50 of bluetongue virus. at least                                                                                             |
| at least              | (i) If  at least four of the five controls do not show                                                                                         |
| at least              | (ii) If  at least 19 of the 20 vaccinates tested as prescribed                                                                                 |
| more than             | 1:4 final serum dilution or higher, or if more than one of the vaccinates shows a temperature rise                                             |
| more than             | 1:4 final serum dilution or higher, or if more than one of the vaccinates shows a temperature rise                                             |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| prior to              | an average of three or more counts taken prior to  injection, the Master Seed Virus is unsatisfactory.                                         |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | (i) If  at least 80 percent of the controls do not show                                                                                        |
| less than             | mm, or the white cell count drops to less than 25 percent of the normal level established by                                                   |
| prior to              | an average of three or more counts taken prior to  challenge.                                                                                  |
| at least              | (ii) If  at least 19 of the 20 vaccinates do not survive                                                                                       |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test but not less than  10&#8201;2.5 TCID50 per dose.                                                         |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| less than             | (ii) Not  less than 14 days postinjection, the vaccinates and the controls                                                                     |
| at least              | (A) If  at least four of the five controls do not show                                                                                         |
| at least              | (B) If  at least 19 of the 20 vaccinates do not survive                                                                                        |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| less than             | (ii) Not  less than 14 days postinjection, the vaccinates and the controls                                                                     |
| at least              | (A) If  at least 6 of 10 controls do not show clinical                                                                                         |
| before                | An Outline of Production change shall be made before authorization for use of a new lot of                                                     |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test(s) but not less than  10&#8201;2.5 TCID50 dose.                                                          |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | Service and observed each day for 21 days. at least                                                                                            |
| at least              | (i) If  at least four of the five controls do not die                                                                                          |
| at least              | (ii) If  at least 19 of the 20 vaccinates do not survive                                                                                       |
| before                | An Outline of Production change shall be made before authorization for use of a new lot of                                                     |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                        |
| less than             | that used in such immunogenicity test but not less than  10&#8201;2.5 TCID50 per dose.                                                         |
| at least              | on the demonstration of a serological response of at least  that magnitude following vaccination of serologically negative horses.             |
| at least              | equine encephalomyelitis, shall be used as test animals. at least                                                                              |
| highest               | mean titer of the vaccine produced from the highest passage of the Master Seed shall be established                                            |
| before                | established using a method acceptable to Veterinary Services before  the immunogenicity test is conducted.                                     |
| at least              | In a valid test, if  at least 19 of 20 vaccinates do not have antibody                                                                         |
| at least              | In a valid test, if  at least 19 of 20 vaccinates do not have antibody                                                                         |
| at least              | In a valid test, if  at least 19 of 20 vaccinates do not have antibody                                                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine used in the                                          |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine used in the                                          |
| less than             | that used in the immunogenicity test, but not less than  10&#8201;2.5 TCID50 per dose.                                                         |
| less than             | a varying serum constant virus neutralization test with less than 500 TCID50 of bovine parainfluenza3 virus; and (ii)                          |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | shall be given acceptable challenge PI3 virus titrating at least 10&#8201;7.0 TCID50 per ml and the animals observed                           |
| at least              | Each day for  at least the first 10 days post-challenge, nasal specimens for                                                                   |
| at least              | days post-challenge, and all animals shall be bled at least once 14 to 28 days post-challenge for serum                                        |
| at least              | virus isolations attempts shall be by culture and at least one subculture in PI3 susceptible cells for a                                       |
| at least              | virus isolations attempts shall be by culture and at least one subculture in PI3 susceptible cells for a                                       |
| at least              | (ii) Two to four weeks post-vaccination,  at least 19 of the 20 vaccinates shall have PI3                                                      |
| at least              | (ii) Two to four weeks post-vaccination,  at least 19 of the 20 vaccinates shall have PI3                                                      |
| greater               | reveal serum neutralization antibody titers of 1:32 or greater  based upon final dilution.                                                     |
| no more than          | alternates shall be allowed for the vaccinates and no more than  two for the controls.                                                         |
| no more than          | alternates shall be allowed for the vaccinates and no more than  two for the controls.                                                         |
| greater               | five vaccinates which develop antibody of 1:32 or greater by day 6 &#177;2 days post-vaccination or up                                         |
| greater               | five vaccinates which develop antibody of 1:32 or greater by day 6 &#177;2 days post-vaccination or up                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID50 per dose.                                                          |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | for virus-neutralization tests from each of the vaccinates. at least                                                                           |
| at least              | (5) If  at least four of the five controls do not show                                                                                         |
| less than             | (6) If  less than 19 of the post-injection serum samples tested as                                                                             |
| more than             | of the 1:2 final serum dilution, or if more than one of the vaccinates show a temperature of                                                   |
| more than             | of the 1:2 final serum dilution, or if more than one of the vaccinates show a temperature of                                                   |
| before                | An outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID50 per dose.                                                          |
| less than             | in a varying serum-constant virus neutralization test with less than  500 TCID50 of bovine virus diarrhea virus.                               |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | for virus-neutralization tests from each of the vaccinates. at least                                                                           |
| less than             | The test virus shall be  less than  500 TCID50 of bovine virus diarrhea virus.                                                                 |
| at least              | for all vaccinates and controls shall be established at least  3 days just before challenge.                                                   |
| before                | shall be established at least 3 days just before  challenge.                                                                                   |
| at least              | If leukopenia does not develop in  at least four of the five controls as compared with                                                         |
| less than             | (5) If  less than 19 of the post-injection serum samples, tested as                                                                            |
| more than             | all tubes of the 1:8 dilution; or if more than one of the vaccinates exhibits respiratory or other                                             |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID 50 per dose.                                                         |
| at least              | (i) Obtain  at least 10 unvaccinated animals, negative at 1:2 final serum                                                                      |
| more than             | rabies virus by injection of suckling mice (not more than  7 days of age).                                                                     |
| at least              | Seed Virus shall be tested for safety in at least 10 unvaccinated serologically negative animals of each domestic                              |
| highest               | immunogenicity of vaccine prepared with virus at the highest passage of the Master Seed shall be established                                   |
| before                | filed with Animal and Plant Health Inspection Service before  initiation of the tests.                                                         |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| no more than          | be used in the immunogenicity test shall be no more than the amount of rehydrated vaccine which, on the                                        |
| minimum               | previous titrations, has been diluted to the proposed minimum  acceptable virus titer.                                                         |
| minimum               | with a dose of vaccine at the proposed minimum virus titer as specified in the filed Outline                                                   |
| after                 | Animal and Plant Health Inspection Service 1 year after vaccination, except as provided in paragraphs (b)(4), (b)(5),                          |
| at least              | tests shall be death due to rabies in at least  80 percent of controls while                                                                   |
| at least              | tests shall be death due to rabies in at least  80 percent of controls while                                                                   |
| at least              | challenged at the same time as the vaccinates. at least                                                                                        |
| at least              | well for a period of 90 days, and at least 80 percent of the controls must die of                                                              |
| before                | An outline of Production change shall be made before authority for use of a new lot of                                                         |
| more than             | (c) If  more than 1 year duration of immunity is to be                                                                                         |
| at least              | The test animals shall be monitored serologically  at least  every 180 days.                                                                   |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| equal to              | serial and subserial shall have a virus titer equal to or greater than that used in the immunogenicity                                         |
| greater than          | shall have a virus titer equal to or greater than  that used in the immunogenicity test.                                                       |
| at least              | 10 mice for each dilution shall be used. at least                                                                                              |
| at least              | 10 mice shall be used for each dilution. at least                                                                                              |
| less than             | (1) Twenty-five dogs,  less than 12 weeks of age and free of measles                                                                           |
| less than             | in a varying serum-constant virus neutralization test with less than  500 ID50 of measles virus.                                               |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| less than             | dilution in varying serum-constant virus neutralization test using less than  500 ID50 of canine distemper virus.                              |
| at least              | uniform dose of aerosolized virulent canine distemper virus. at least                                                                          |
| at least              | (i) If  at least 4 of the 5 controls do not die                                                                                                |
| at least              | (i) If  at least 4 of the 5 controls do not die                                                                                                |
| at least              | (ii) If  at least 19 of the 20 vaccinates do not survive                                                                                       |
| after                 | higher and a weight loss exceeding 15 percent after day 8 postchallenge, the Master Seed Virus is                                              |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of the vaccine virus used in                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of the vaccine virus used in                                       |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 ID50 per dose.                                                            |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| after                 | (3) Twenty-one or more days  after the final dose of vaccine, the vaccinates and                                                               |
| minimum of            | controls shall each be challenged intranasally with a minimum of 100,000 TCID50 or plaque forming units of virulent                            |
| less than             | (i) If  less than 8 of 10 controls show clinical signs of                                                                                      |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID50 or plaque forming units per dose.                                  |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| after                 | (3) Twenty-one or more days  after the final dose of vaccine, the vaccinates and                                                               |
| minimum of            | controls shall each be challenged intranasally with a minimum of 100,000 TCID50 or plaque forming units of virulent                            |
| less than             | (i) If  less than 8 of 10 controls show clinical signs of                                                                                      |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID50 or plaque forming units per dose.                                  |
| highest               | geometric mean titer of vaccine produced at the highest passage from the Master Seed shall be established                                      |
| before                | passage from the Master Seed shall be established before  the immunogenicity test is conducted.                                                |
| after                 | (3) Three to 4 weeks  after the final dose of vaccine, all dogs shall                                                                          |
| at least              | be collected from each dog each day for at least  10 consecutive days postchallenge.                                                           |
| at least              | culture in canine parainfluenza virus susceptible cells for at least  7 days.                                                                  |
| more than             | (ii) If  more than one vaccinate shows febrile response, respiratory or other                                                                  |
| less than             | signs of canine parainfluenza virus infection; or, if less than 19 of 20 vaccinates show serum neutralization titers                           |
| greater               | vaccinates show serum neutralization titers of 1:4 or greater ; or, if there is not a significant                                              |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| at least              | serial and subserial shall have a virus titer at least 10&#8201;0.7 greater than that used in the immunogenicity                               |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in the immunogenicity test but not less than  10&#8201;2.5 TCID50 per dose.                                                          |
| within                | If a significant increase in virulence is seen  within  five backpassages, the Master Seed is unsatisfactory.                                  |
| highest               | mean titer of the vaccine produced at the highest passage from the Master Seed shall be established                                            |
| before                | passage from the Master Seed shall be established before  the immunogenicity test is conducted.                                                |
| after                 | (3) Fourteen days or more  after the final dose of vaccine the vaccinates and                                                                  |
| at least              | be taken from each dog each day for at least 10 days postchallenge and the presence or absence                                                 |
| at least              | If  at least  80 percent of the controls do not show                                                                                           |
| at least              | If  at least  80 percent of the controls do not show                                                                                           |
| at least              | (ii) If  at least 19 of the 20 vaccinates do not survive                                                                                       |
| more than             | do not survive the observation period without showing more than one criterion of infection described in paragraph (c)(3)(i),                   |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine used in the immunogenicity                              |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine used in the immunogenicity                              |
| less than             | that used in the immunogenicity test, but not less than  10&#8201;2.5 ID50 per dose.                                                           |
| highest               | mean titer of the vaccine produced at the highest passage from the Master Seed shall be established                                            |
| before                | passage from the Master Seed shall be established before  the immunogenicity test is conducted.                                                |
| at least              | (i) If  at least four of the five controls do not develop                                                                                      |
| at least              | (ii) If  at least 19 of the 20 vaccinates in a valid                                                                                           |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine used in the                                          |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| at least              | serial and subserial shall have a virus titer at least 10.&#8201;0.7 greater than that used in the immunogenicity                              |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine used in the                                          |
| less than             | that used in the immunogenicity test, but not less than  10&#8201;2.5 TCID50 per dose.                                                         |
| highest               | mean titer of the vaccine produced from the highest passage of the Master Seed Virus shall be                                                  |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | conducted as follows: (i) For each dilution, inoculate at least 10 embryos, 5 or 6 days old, in                                                |
| exceed                | At least three appropriate (not to  exceed tenfold) dilutions shall be used and the test                                                       |
| at least              | conducted as follows: (i) For each dilution, inoculate at least 10 embryos, 5 or 6 days old, in                                                |
| at least              | To be a valid test,  at least  75 percent of the uninoculated eggs shall hatch.                                                                |
| after                 | (iii) On the third day  after normal hatching time, count all unhatched eggs and                                                               |
| at least              | (iv) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                                |
| at least              | (iv) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                                |
| at least              | virus and observed each day for 21 days. at least                                                                                              |
| at least              | (4) If  at least 80 percent of the controls do not show                                                                                        |
| at least              | If  at least 19 of 20, or 27 of 30, or                                                                                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | &#167;&#8201;113.300 and the requirements prescribed in this paragraph. after                                                                  |
| at least              | and be observed each day for 21 days. at least                                                                                                 |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test but not less than  10&#8201;.5 EID50 per dose.                                                           |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | conducted as follows: (i) For each dilution, inoculate at least five embryos, 9 to 11 days old, on                                             |
| exceed                | At least three appropriate (not to  exceed tenfold) dilutions shall be used and the test                                                       |
| at least              | conducted as follows: (i) For each dilution, inoculate at least five embryos, 9 to 11 days old, on                                             |
| at least              | conducted as follows: (i) For each dilution, inoculate at least five embryos, 9 to 11 days old, on                                             |
| at least              | To be a valid test,  at least four embryos in each dilution shall remain viable                                                                |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | (4) If  at least 90 percent of the controls do not develop                                                                                     |
| at least              | If  at least 19 of 20, or 27 of 30, or                                                                                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | &#167;&#8201;113.300 except paragraph (c), and in this paragraph. after                                                                        |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test but not less than  10&#8201;2.0 EID50 per dose.                                                          |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity tests are conducted.                                                  |
| at least              | be used and the test conducted as follows; at least                                                                                            |
| exceed                | At least three approved (not to  exceed tenfold) dilutions shall be used and the test                                                          |
| at least              | (i) For each dilution, inject  at least five embryos, 9 to 11 days old, in                                                                     |
| at least              | the first 24 hours shall be disregarded, but at least four viable embyros in each dilution shall survive                                       |
| after                 | examine the surviving embryos for evidence of infection. after                                                                                 |
| at least              | (ii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                                |
| at least              | (ii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                                |
| at least              | and Plant Health Inspection Service and shall titer at least  10&#8201;4.0 EID50 per ml.                                                       |
| at least              | For each chicken swab,  at least five chicken embryos 9 to 11 days old                                                                         |
| at least              | that, if a swab is not represented by at least four embryos, the test of that swab is                                                          |
| less than             | If  less than 20 percent of the embryos which survive the                                                                                      |
| less than             | (iii) If  less than 90 percent of the controls are positive for                                                                                |
| less than             | (iv) If  less than 90 percent of the vaccinates are negative for                                                                               |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | in the virus identity tests prescribed in &#167;&#8201;113.300(c). after                                                                       |
| more than             | this paragraph, except that, if the vaccine contains more than one virus type, bulk samples taken from each                                    |
| prior to              | virus type, bulk samples taken from each type prior to mixing shall be used in the virus identity                                              |
| prior to              | fraction of combined Newcastle-Bronchitis Vaccines shall be neutralized prior to  titration of the bronchitis virus fraction.                  |
| after                 | to allow for serum dilution of the vaccine. after                                                                                              |
| prior to              | sample of bulk harvested material shall be collected prior to  mixing with the other virus type(s).                                            |
| less than             | Each sample shall contain not  less than the minimum virus titer stated in the filed                                                           |
| minimum               | Each sample shall contain not less than the  minimum virus titer stated in the filed Outline of                                                |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test but not less than  10&#8201;2.0 EID50 per dose.                                                          |
| at least              | tested for safety as follows: (1) Each of at least ten 3 to 4 week old susceptible chickens                                                    |
| more than             | (2) If  more than 20 percent of the chickens die during the                                                                                    |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | conducted as follows: (i) For each dilution, inject at least five embryos, 9 to 11 days old, on                                                |
| exceed                | At least three appropriate (not to  exceed tenfold) dilutions shall be used for vaccine of                                                     |
| at least              | conducted as follows: (i) For each dilution, inject at least five embryos, 9 to 11 days old, on                                                |
| at least              | To be a valid test,  at least four embryos in each dilution shall remain viable                                                                |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | (5) If  at least 80 percent of the controls do not die                                                                                         |
| at least              | If  at least 19 of 20, 27 of 30, or 36                                                                                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | &#167;&#8201;113.300 and the requirements prescribed in this paragraph. after                                                                  |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test but not less than 10&#8201;2.5 EID50 per dose for chicken embryo origin                                  |
| highest               | titer of the dried vaccine produced from the highest passage of the Master Seed Virus shall be                                                 |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | conducted as follows: (i) For each dilution, inject at least five embryos, 9 to 11 days old, in                                                |
| exceed                | At least three appropriate (not to  exceed tenfold) dilutions shall be used and the test                                                       |
| at least              | conducted as follows: (i) For each dilution, inject at least five embryos, 9 to 11 days old, in                                                |
| at least              | conducted as follows: (i) For each dilution, inject at least five embryos, 9 to 11 days old, in                                                |
| at least              | To be a valid test,  at least four embryos in each dilution shall remain viable                                                                |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | (iii) A satisfactory titration shall have  at least one dilution with between 50 and 100 percent                                               |
| at least              | vaccinates and controls shall be challenged intramuscularly with at least 10&#8201;4.0 EID50 of virus per chicken and observed                 |
| at least              | (4) If  at least 90 percent of the controls do not develop                                                                                     |
| at least              | If  at least 19 of 20, or 27 of 30, or                                                                                                         |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | &#167;&#8201;113.34, and the requirements prescribed in this paragraph. after                                                                  |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | shall have a virus titer per dose sufficiently greater than the titer of vaccine virus used in the                                             |
| less than             | that used in the immunogenicity test but not less than  10&#8201;5.5 EID50 per dose.                                                           |
| at least              | of vaccine, by the route recommended for vaccination. at least                                                                                 |
| at least              | will cause gross lesions of Marek's disease in at least 80 per cent of the chickens within 50                                                  |
| at least              | will cause gross lesions of Marek's disease in at least 80 per cent of the chickens within 50                                                  |
| within                | at least 80 per cent of the chickens within  50 days.                                                                                          |
| at least              | group shall survive to 5 days of age. at least                                                                                                 |
| at least              | If  at least 80 percent of this group do not develop                                                                                           |
| less than             | If  less than 30 of the chickens in group 3 survive                                                                                            |
| less than             | If  less than 30 chickens in groups 1 and 4 survive                                                                                            |
| highest               | production shall be tested for immunogenicity at the highest passage level allowed for the product, and the                                    |
| minimum of            | A  minimum of 35 test subjects shall be inoculated with the                                                                                    |
| minimum of            | A  minimum of 35 nonvaccinated test subjects shall be held as                                                                                  |
| minimum of            | A  minimum of 25 nonvaccinated test subjects shall be held as                                                                                  |
| minimum of            | 3 virus as the Marek's disease fraction, a minimum of 35 chicks shall be vaccinated at 1 day                                                   |
| at least              | chickens in groups 1, 2, and 4, and at least 20 chickens in group 3, shall survive to                                                          |
| at least              | chickens in groups 1, 2, and 4, and at least 20 chickens in group 3, shall survive to                                                          |
| before                | All chickens dying  before the end of the 7 week observation period                                                                            |
| at least              | (4) For a valid test,  at least 80 percent of the chickens in group 2                                                                          |
| greater than          | shall develop grossly observable lesions, and (when included) greater than 20 percent of the chickens in group 4                               |
| at least              | For a valid test to be considered satisfactory, at least 80 percent of the chickens in group 1                                                 |
| at least              | 10 chicken doses of virus (vaccine concentrated 10X). at least                                                                                 |
| at least              | (i) If  at least 20 chickens do not survive the observation period,                                                                            |
| less than             | (iii) If  less than 20 chicks survive the observation period and there                                                                         |
| more than             | For vaccines composed of  more than one Marek's disease virus serotype, each fraction shall                                                    |
| before                | be incubated at 37 &#176;C for 3 days before  preparation for use in the potency test.                                                         |
| prior to              | 0 &#176;C to 4 &#176;C for 2 hours prior to  use in the potency test.                                                                          |
| at least              | have a virus titer per dose which is at least 3 times greater than the number of plaque                                                        |
| greater than          | per dose which is at least 3 times greater than the number of plaque forming units (pfu) used                                                  |
| less than             | in paragraph (c) of this section, but not less than  1000 pfu per dose.                                                                        |
| within                | pretest incubation of desiccated products) at any time within the expiration period, each serotype contained in the                            |
| at least              | have a virus titer per dose which is at least 2 times the number of pfu used in                                                                |
| less than             | pfu used in the immunogenicity test, but not less than  750 pfu per dose.                                                                      |
| at least              | postvaccination, each of five controls shall be administered at least 10&#8201;2.0 EID50 of a virulent bursal disease virus                    |
| more than             | attributable to the Master Seed Virus occur in more than two of the vaccinates, the test shall be                                              |
| more than             | If  more than two of the vaccinates have such lesions, the                                                                                     |
| less than             | that, if any of the negative controls or less than four of the positive controls have such lesions,                                            |
| minimum               | chickens (vaccinates) shall be vaccinated with approximately one minimum protective dose of vaccine virus as determined in                     |
| at least              | the same source and hatch shall be administered at least 10&#8201;2.0 EID50 of a virulent bursal disease virus                                 |
| less than             | that, if any of the negative controls or less than 8 of the positive controls have such lesions,                                               |
| highest               | mean titer of the vaccine produced from the highest passage of the Master Seed Virus shall be                                                  |
| before                | of the Master Seed Virus shall be established before  the immunogenicity test is conducted.                                                    |
| at least              | acceptable to Animal and Plant Health Inspection Service. at least                                                                             |
| exceed                | At least three appropriate (not to  exceed tenfold) dilutions shall be used to conduct the                                                     |
| less than             | 28 to 35 days of age but not less than 14 days postvaccination, each vaccinate and each control                                                |
| at least              | (ii) If  at least 19 of 20, or 27 of 30, or                                                                                                    |
| less than             | Master Seed Virus is unsatisfactory, except that, if less than 90 percent of the controls have such lesions,                                   |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| after                 | &#167;&#8201;113.300 and the requirements prescribed in this paragraph. after                                                                  |
| more than             | If unfavorable reactions occur in  more than one of the controls or if unfavorable reactions                                                   |
| more than             | If unfavorable reactions occur in  more than one of the controls or if unfavorable reactions                                                   |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| within                | to assure that when tested at any time within the expiration period, each serial and subserial shall                                           |
| greater than          | each subserial shall have a virus titer sufficiently greater than the titer of vaccine virus used in the                                       |
| less than             | that used in such immunogenicity test, but not less than  10&#8201;2.0 titration units (PFU or ID50's) per dose.                               |
| at least              | leukosis virus contamination as follows: (i) Each of at least 10 3-week-old or older lymphoid leukosis free chickens                           |
| equal to              | injected intra-muscularly with an amount of Master Seed equal to  100 label doses of vaccine.                                                  |
| at least              | or more with subgroup B lymphoid leukosis virus. at least                                                                                      |
| within                | the vaccinates shall be tested separately, but serums within  each control group may be pooled.                                                |
| less than             | (i) For vaccines intended for use in chickens less than 14 days of age, Master Seed equal to                                                   |
| equal to              | less than 14 days of age, Master Seed equal to 10 label doses shall be administered subcutaneously to                                          |
| equal to              | 14 days of age or older, Master Seed equal to 10 label doses shall be administered subcutaneously to                                           |
| highest               | mean titer of the vaccine produced at the highest passage from the Master Seed shall be established                                            |
| before                | acceptable to Animal and Plant Health Inspection Service before  the immunogenicity test is conducted.                                         |
| at least              | If  at least 90 percent of the controls do not develop                                                                                         |
| at least              | If  at least 19 of 20, 27 of 30, or 36                                                                                                         |
| within                | from these signs, disregarding transient swelling which subsides within  5 days postchallenge, the Master Seed is unsatisfactory.              |
| before                | An Outline of Production change shall be made before authority for use of a new lot of                                                         |
| more than             | If unfavorable reactions occur in  more than two vaccinates which are not attributable to the                                                  |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine virus used in                                        |
| within                | to assure that, when tested at any time within the expiration period, each serial and subserial shall                                          |
| greater than          | and subserial shall have a virus titer sufficiently greater than the titer of the vaccine virus used in                                        |
| less than             | that used in the immunogenicity test, but not less than  10&#8201;2.0 titration units (PFU or ID&#8201;50) per dose.                           |
| less than             | pigs shall be considered sensitized for testing not less than  30 days nor more than 120 days post-injection.                                  |
| more than             | for testing not less than 30 days nor more than  120 days post-injection.                                                                      |
| at least              | guinea pigs shall be prepared for sensitivity testing at least  4 hours prior to the injection of tuberculin.                                  |
| prior to              | prepared for sensitivity testing at least 4 hours prior to  the injection of tuberculin.                                                       |
| after                 | of the tuberculins shall be determined 24 hours after  injected by measuring the area of erythema.                                             |
| prior to              | been standardized with a pH 7.0 buffer just prior to  use.                                                                                     |
| at least              | (2) A total of  at least  12 serums shall be used.                                                                                             |
| at least              | This shall include  at least  three definitely positive,                                                                                       |
| at least              | This shall include  at least  three definitely positive,                                                                                       |
| at least              | This shall include  at least  three definitely positive,                                                                                       |
| at least              | comparative sensitivity between test and reference plate antigens. at least                                                                    |
| more than             | the six or more negative serums and not more than one unsatisfactory test among the six or more                                                |
| at least              | event of an unsatisfactory test using positive serums, at least three additional definitely positive and three additional weakly               |
| more than             | If not  more than one unsatisfactory test is obtained with the additional                                                                      |
| prior to              | been standardized with a pH 4.0 buffer just prior to  use.                                                                                     |
| after                 | level is specified for Pullorum Tube Antigen but after dilution as recommended for use, it shall have                                          |
| prior to              | has been standardized with a pH buffer just prior to  use.                                                                                     |
| at least              | do not have the same agglutination reactions with at least four of the five positive serums used, the                                          |
| at least              | The sensitized animals and controls shall be prepared at least 4 hours prior to injection of PPD tuberculin                                    |
| prior to              | controls shall be prepared at least 4 hours prior to injection of PPD tuberculin by clipping the hair                                          |
| at least              | specificity index of the reference PPD tuberculin is at least  400 square millimeters.                                                         |
| after                 | An inconclusive serial is satisfactory  after the second stage test, if its specificity index                                                  |
| less than             | more, and unsatisfactory if its specificity index is less than  400 square millimeters.                                                        |
| before                | individually subjected to applicable tests for infectious diseases. before                                                                     |
| before                | anemia (EIA) at a laboratory approved by APHIS. before                                                                                         |
| equal to              | Horses with standard agglutination titers  equal to or greater than 1:100 may be tested by                                                     |
| greater than          | Horses with standard agglutination titers equal to or  greater than 1:100 may be tested by the Rivanol or                                      |
| after                 | Nonreactors to the supplemental tests shall be retested  after  30 days.                                                                       |
| before                | applicable Milk Ordinances or similar laws or regulations. before                                                                              |
| equal to              | Cattle with standard agglutination titers  equal to or greater than 1:100 may be tested by                                                     |
| greater than          | Cattle with standard agglutination titers equal to or  greater than 1:100 may be tested by the Rivanol or                                      |
| after                 | Nonreactors to the supplemental tests shall be retested  after  30 days.                                                                       |
| less than             | until a negative herd test is obtained not less than  28 days following removal of the positive animal(s).                                     |
| at least              | procedure may be substituted if demonstrated to be at least as effective by data acceptable to APHIS and                                       |
| at least              | derivatives of any origin may be treated with at least 2.5 megarads of ionizing radiation, with a maximum                                      |
| maximum               | least 2.5 megarads of ionizing radiation, with a maximum radiation dosage specified in the filed Outline of                                    |
| at least              | regimens prescribed, lacteal secretions may be treated with at least 2.5 megarads of ionizing radiation, with a maximum                        |
| maximum               | least 2.5 megarads of ionizing radiation, with a maximum radiation dosage specified in the Outline of Production                               |
| at least              | 58.0-59.0 &#176;C for 30 minutes, or treated with at least 2.5 megarads of ionizing radiation, with a maximum                                  |
| maximum               | least 2.5 megarads of ionizing radiation, with a maximum radiation dosage specified in the filed Outline of                                    |
| after                 | at the time of heat treatment, and immediately after heat treatment shall be cooled to 7 &#176;C                                               |
| at least              | frozen state until time of use, shall contain at least one preservative from the following list, within the                                    |
| within                | at least one preservative from the following list, within the range of concentration set forth: (1) Phenol                                     |
| maximum               | (2) The  maximum allowable passage level of the hyperimmunizing antigen shall                                                                  |
| exceed                | product shown to be efficacious and shall not exceed  10 passages from the Master Seed.                                                        |
| within                | plates, or if a retest is not initiated within 21 days of the completion of the original                                                       |
| within                | plates, or if a retest is not initiated within 21 days of the completion of the original                                                       |
| within                | plates, or if a retest is not initiated within 21 days of the completion of the original                                                       |
| exceeds               | the 10 plates containing samples of the serial exceeds that specified in the filed Outline of Production                                       |
| exceeds               | number of bacterial colonies on the retest plates exceeds that specified in the filed Outline of Production                                    |
| within                | product, or if a retest is not initiated within 21 days of the completion of the original                                                      |
| less than             | final containers of Tetanus Antitoxin shall yield not less than the labeled unitage of antitoxin throughout the dating                         |
| minimum               | The  minimum package size permitted for marketing in the United                                                                                |
| more than             | expiration date of Tetanus Antitoxin shall be not more than 3 years after the date of a potency                                                |
| after                 | Antitoxin shall be not more than 3 years after the date of a potency test which demonstrates                                                   |
| at least              | the recoverable antitoxin from the final container provides at least 20 percent excess over the number of units                                |
| more than             | expiration date of Tetanus Antitoxin shall be not more than 3 years after the date of a potency                                                |
| after                 | Antitoxin shall be not more than 3 years after the date of a potency test which demonstrates                                                   |
| before                | ml of the Standard Antitoxin shall be diluted before use so the final volume contains 0.1 unit                                                 |
| prior to              | at 20&#176; to 25 &#176;C for 30 minutes prior to  combination with a test does of toxin.                                                      |
| within                | pig, results in death of that guinea pig within 60 to 120 hours with clinical signs of                                                         |
| before                | at 20&#176; to 25 &#176;C for 1 hour before  injections of guinea pigs are made.                                                               |
| within                | (5) Normal guinea pigs weighing  within a range of 340 to 380 grams shall                                                                      |
| within                | reach this point with clinical signs of tetanus within  24 hours of each other and                                                             |
| within                | reach this point with clinical signs of tetanus within  24 hours of each other and                                                             |
| greater               | not present, whereas those living longer indicate a greater  unit value.                                                                       |
| less than             | (2) If  less than eight of the 10 controls die from erysipelas                                                                                 |
| within                | eight of the 10 controls die from erysipelas within  7 days post-challenge, the test is invalid.                                               |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| less than             | (ii) If  less than 80 percent of the mice inoculated with the                                                                                  |
| less than             | Toxin die, the antitoxin is considered to contain less than 500 International Unit per ml and the serial                                       |
| at least              | unit of Standard Antitoxin and cause death in at least  80 percent of injected mice.                                                           |
| less than             | (ii) If  less than 80 percent of the mice inoculated with mixture                                                                              |
| less than             | Toxin die, the antitoxin is considered to contain less than 34 International Units per ml and the serial                                       |
| minimum               | of passive transfer (FPT) shall contain a specified minimum quantity of IgG per dose and shall be                                              |
| more than             | shall not be recommended for use in animals more than 24 hours of age, while one for parenteral                                                |
| at least              | the product is recommended shall be randomly selected. at least                                                                                |
| maximum               | the study shall be at or near the maximum  weight for neonates of the species.                                                                 |
| after                 | blood samples shall be taken from each animal. after                                                                                           |
| at least              | must remain free of unfavorable product-related reactions and at least 90 percent of the paired serum samples must                             |
| equal to              | increase in IgG concentration (posttreatment minus pretreatment concentration) equal to or greater than the IgG concentration of the           |
| greater than          | concentration (posttreatment minus pretreatment concentration) equal to or greater than  the IgG concentration of the IgG Species Standard.    |
| prior to              | to APHIS, to demonstrate functionality of product antibody. prior to                                                                           |
| exceed                | of the test serial does not meet or exceed that of the reference, one complete retest, involving                                               |
| exceed                | of the test serial does not meet or exceed that of the reference, or if a retest                                                               |


## Duration

| Duration    | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 6.0 month   | (4) Be held in a special compartment set aside by the licensee or permittee for holding these samples under refrigeration at the storage temperature recommended on the labels for 6 months after the expiration date stated on the labels.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 2.0 year    | Firms currently using immunoassays which do not satisfy this requirement shall have 2 years from the effective date of the final rule to update their filed Outlines of Production to be in compliance with this requirement unless granted an extension by the Administrator based on a showing by the firm seeking the extension that they have made a good faith effort with due diligence to achieve compliance.                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 5.0 year    | The lot of reference used to determine antigenic content shall have an initial dating period equal to the dating of the product or as supported by data acceptable to APHIS, except that frozen references may have an initial dating of up to 5 years, Provided, That the request for dating of the frozen references beyond the dating of the product is supported by preliminary data acceptable to APHIS and includes provisions for monitoring the stability of the reference to determine when the potency starts to decline and for taking the appropriate steps to requalify a reference with declining potency either by testing a Qualifying Serial in host animals or by providing other evidence of immunogenicity, e.g., antibody titers or laboratory animal test data previously correlated to host animal protection in a manner acceptable to APHIS. |
| 5.0 year    | If a new Master Reference is established, it shall be allowed an initial dating period equal to the dating of the product or as supported by data acceptable to APHIS, except that frozen references may have an initial dating period of 5 years, or as supported by data acceptable to APHIS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 90.0 day    | If any portion of a lot of commercial dehydrated medium is held for 90 days or longer after being so tested, it shall be retested before use.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | (3) Incubation shall be for an observation period of 14 days at 30 &#176;to 35 &#176;C. to test for bacteria and 14 days at 20 &#176;to 25 &#176;C. to test for fungi.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | (3) Incubation shall be for an observation period of 14 days at 30 &#176;to 35 &#176;C. to test for bacteria and 14 days at 20 &#176;to 25 &#176;C. to test for fungi.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 11 day      | (4) If the inoculum renders the medium turbid so that the absence of growth cannot be determined by visual examination, subcultures shall be made on the seventh to eleventh day from biological products prepared from clostridial toxoids, bacterins, and bacterin-toxoids and the third to seventh day for other biological products.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 7 day       | (4) If the inoculum renders the medium turbid so that the absence of growth cannot be determined by visual examination, subcultures shall be made on the seventh to eleventh day from biological products prepared from clostridial toxoids, bacterins, and bacterin-toxoids and the third to seventh day for other biological products.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14.0 day    | of fresh medium, and incubated the balance of the 14-day period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 14.0 day    | Incubation shall be at 30 &#176;to 35 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 30 &#176;to 35 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 30 &#176;to 35 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 30 &#176;to 35 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Incubation shall be at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 7.0 day     | One plate shall be incubated at 30 &#176;to 35 &#176;for 7 days and the other plate shall be incubated at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | One plate shall be incubated at 30 &#176;to 35 &#176;for 7 days and the other plate shall be incubated at 20 &#176;to 25 &#176;C for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 30.0 minute | (2) Inactivated horse serum&#8212;horse serum which has been inactivated at 56 &#176;C for 30 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 minute | (4) Cool the medium 30 minutes in a 56 &#176;C waterbath.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 14.0 day    | Incubate the flask at 33 to 37 &#176;C for 14 days during which time, one of four agar plates shall be streaked with 0.1 ml of material from the incubating flask of inoculated medium on the 3d day, one on the 7th day, one on the 10th day, and one on the 14th day post-inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14.0 day    | (5) All plates shall be incubated in a high humidity, 4-6 percent CO2 atmosphere at 33 &#176;to 37 &#176;C for 10-14 days and examined with a stereoscopic microscope at 35x to 100x or with a regular microscope at 100x.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 3.0 hour    | (4) After a minimum of 3 hours of drying time, turn off the vacuum pump and allow dry air to bleed into the oven until the pressure inside the oven is equalized with the prevailing atmospheric pressure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 2.0 hour    | (i) Allow a minimum of 2 hours for the weighing bottle to cool to room temperature or for its weight to reach equilibrium.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 24.0 hour   | The inoculated media shall be incubated 18-24 hours at 35-37 &#176;C.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 24.0 hour   | (c) Transfers shall be made to either MacConkey agar or Salmonella-Shigella agar, incubated for 18-24 hours and examined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 24.0 hour   | (d) If no growth typical of Salmonella is noted, the plates shall be incubated an additional 18-24 hours and again examined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 21.0 day    | (1) Each vaccine virus, cytopathic to chick embryo fibroblast cells, shall be effectively neutralized, inactivated, or separated so that minimal amounts of lymphoid leukosis virus can be propagated on cell culture during the 21-day growth period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 21.0 day    | (4) The cell cultures shall be propagated at 35-37 &#176;C for at least 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 7.0 day     | (a) One ml of the minced tissue used as the source of cells or 1 ml of the extract of the tissue prior to the addition of antibiotics, diluent and stabilizer, shall be inoculated onto each of three tryptose agar plates and incubated in a 10 percent CO2 atmosphere at a temperature of 35-37 &#176;C for at least 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | (1) Vaccine prepared for use as recommended on the label shall be tested by inoculating eight mice intraperitoneally or subcutaneously with 0.5 mL (the inoculation volume may be divided among more than one injection site), and the animals observed for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7.0 day     | (1) Unless otherwise prescribed in the Standard Requirement or approved in a filed Outline of Production for the product, a 0.5 ml dose shall be injected intraperitoneally or subcutaneously into eight mice and the animals observed for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 10.0 day    | (b) Each of ten 9- to 10-day-old embryonating eggs from Newcastle disease susceptible flocks shall be inoculated into the allantoic cavity with 0.2 ml of the undiluted inoculum.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5 day       | (c) Three to five days post-inoculation, a sample of allantoic fluid from each egg shall be tested separately by a rapid plate test for hemagglutinating activity using a 0.5 percent suspension of fresh chicken red blood cells.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 2.0 hour    | (4) Hold the two pools of vaccine at room temperature (20 &#176;to 25 &#176;C) for 2 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | (b) At least 25 healthy susceptible young chickens, properly identified and obtained from the same source and hatch, shall be immunized at least 14 days prior to being put on test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 21.0 day    | (e) All birds shall be observed for 21 days for signs of septicemic diseases, respiratory diseases, or other pathologic conditions.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 11.0 day    | (1) Twenty embryos, 9 to 11 days old, shall be inoculated on the chorio-allantoic membrane (CAM) with 0.1 ml, and in the allantoic sac with 0.1 ml.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7.0 day     | (2) Eggs shall be candled daily for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 24.0 hour   | Deaths occurring during the first 24 hours shall be disregarded but at least 18 viable embryos shall survive 24 hours post-inoculation for a valid test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 24.0 hour   | Deaths occurring during the first 24 hours shall be disregarded but at least 18 viable embryos shall survive 24 hours post-inoculation for a valid test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 1 day       | Examine all embryos and CAM's from embryos which die after the first day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 7 day       | The test shall be concluded on the seventh day post-inoculation and the surviving embryos (including CAM's) examined.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 7.0 day     | (a) Unless otherwise specified in the Standard Requirement or approved Outline of Production for the product, a 2 ml dose shall be injected either intramuscularly or subcutaneously into each of two guinea pigs and the animals observed for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | (2) Each of at least 10 susceptible cats shall be administered a sample of the Master Seed Virus equivalent to the amount of virus to be used in one cat dose of the vaccine, by the method to be recommended on the label, and the cats observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | (1) Each of two healthy cats shall be administered 10 cat doses by the method recommended on the label and the cats observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (2) Each of at least 10 susceptible dogs shall be administered a sample of the Master Seed Virus equivalent to the amount of virus to be used in one dog dose of the vaccine, by the method recommended on the label, and the dog shall be observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 14.0 day    | (1) Each of two healthy dogs shall be administered 10 dog doses by the method recommended on the label and the dogs shall be observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 21.0 day    | Each of two calves shall be injected with the equivalent of 10 doses of vaccine administered in the manner recommended on the label and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 21.0 day    | (a) Each of at least 10 mice obtained from a source free of LCM shall be injected in the footpad of a hindfoot with 0.02 ml of the material being tested and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 6.0 day     | (a) The yolk sac of 6-day-old chicken embryos shall be injected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 48.0 hour   | (3) For each of the three passages, embryo deaths occurring within 48 hours of injection shall be disregarded, except that if more than three such deaths occur at any passage, that passage shall be repeated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 48.0 hour   | (b) If one or more embryo deaths occur at any passage after 48 hours postinjection, the yolk sacs from each of the dead embryos shall be subcultured into 10 additional embryos.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | (3) Observe swine each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 21.0 day    | (3) Observe sheep each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 7.0 day     | One or more monolayers that are at least 6 cm&#8201;2 and at least 7 days from the last subculture shall be tested as provided in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 7.0 day     | One or more monolayers that are at least 6 cm&#8201;2 and at least 7 days from the last subculture shall be tested as provided in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 30.0 minute | (3) Incubate the monolayer at 4 &#176;C for 30 minutes, wash with phosphate buffered saline, and examine for hemadsorption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 30.0 minute | (4) If no hemadsorption is apparent, repeat step (b)(2) of this section and incubate the monolayers at 20-25 &#176;C for 30 minutes, wash with phosphate buffered saline, and examine again for hemadsorption.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | (a) Monolayer cultures of cells (monolayers), at least 7 days after the last subculturing, shall be processed and stained with the appropriate antiviral fluorochrome-conjugated antibody as specified in paragraph (b) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 7.0 day     | (3) Positive control monolayers may be fixed (processed so as to arrest growth and assure attachment of the monolayer to the surface of the vessel in which they are grown) before 7 days after subculturing if fluorescence is enhanced by doing so, Provided, That a monolayer of the material under test is also fixed at the same time as the positive control and a monolayer of the material under test is also fixed at least seven days after subculturing.                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7 day       | (3) Positive control monolayers may be fixed (processed so as to arrest growth and assure attachment of the monolayer to the surface of the vessel in which they are grown) before 7 days after subculturing if fluorescence is enhanced by doing so, Provided, That a monolayer of the material under test is also fixed at the same time as the positive control and a monolayer of the material under test is also fixed at least seven days after subculturing.                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7.0 day     | Monolayers that are fixed before 7 days after subculturing shall be stained at the same time as the test monolayers and negative controls fixed at least 7 days after subculturing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7.0 day     | Monolayers that are fixed before 7 days after subculturing shall be stained at the same time as the test monolayers and negative controls fixed at least 7 days after subculturing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 14.0 day    | (i) Monolayers of avian origin shall be maintained for at least 14 days and shall be subcultured at least once during the maintenance period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 28.0 day    | (ii) Monolayers not of avian origin shall be maintained for at least 28 days and shall be subcultured at least twice during the maintenance period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 21.0 day    | (1) The test monolayer shall be maintained for at least 21 days using the medium (with additives) intended for growth and maintenance and under conditions similar to those used to prepare biological products.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | (3) Monolayers shall be examined regularly throughout the 21-day maintenance period for evidence of the presence of cytopathogenic agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | (4) At the conclusion of the 21-day maintenance period, monolayers shall be tested for:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|             |               (i) Cytopathogenic and/or hemadsorbing agents as prescribed in &#167;&#8201;113.46; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |               (ii) Extraneous agents by the fluorescent antibody technique as prescribed in &#167;&#8201;113.47.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | (f) At the conclusion of the 21-day maintenance period provided in paragraph (e) of this section, at least one monolayer of at least 75 cm&#8201;2 shall also be shown free of extraneous agents as prescribed in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 15.0 minute | Centrifuge the disrupted cells at no greater than 2,000 &#215; g for no more than 15 minutes to remove cellular debris.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | (2) The monolayers of cells specified in paragraphs (f)(1)(i), (ii), (iii), and (iv) of this section shall be maintained for at least 14 days after inoculation with the aliquot of disrupted MCS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (3) Monolayers shall be examined regularly throughout the 14-day maintenance period for evidence of the presence of cytopathogenic agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | (4) At the conclusion of the 14-day maintenance period, monolayers shall be tested for:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|             |               (i) Cytopathogenic and/or hemadsorbing agents as prescribed in &#167;&#8201;113.46; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |               (ii) Extraneous viruses by the fluorescent antibody technique as prescribed in &#167;&#8201;113.47.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 21.0 day    | (3) The test monolayers shall be maintained for at least 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 21.0 day    | (5) Monolayers shall be examined regularly throughout the 21-day maintenance period for evidence of cytopathogenic agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | (6) At the conclusion of the 21-day maintenance period, monolayers shall be tested for:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|             |               (i) Cytopathogenic and/or hemadsorbing agents as prescribed in &#167;&#8201;113.46; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |               (ii) Extraneous viruses by the fluorescent antibody technique as prescribed in &#167;&#8201;113.47.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 1.0 hour    | After centrifuging for 1 hour at 80,000 &#215; g, the pellet material shall be reconstituted in distilled water and inoculated into a flask containing 75 cm&#8201;2 of a 30 to 50 percent confluent monolayer culture of primary porcine cells or a porcine cell line of proven equal PPV susceptibility.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | (2) The test and control monolayers shall be maintained for at least 14 days and subcultured at least once during the maintenance period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 14.0 day    | (3) At the end of the 14-day maintenance period, and 4 to 7 days after the last subculturing, monolayers shall be tested for the presence of porcine parvovirus by the fluorescent antibody technique as prescribed in &#167;&#8201;113.47(c).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | (3) At the end of the 14-day maintenance period, and 4 to 7 days after the last subculturing, monolayers shall be tested for the presence of porcine parvovirus by the fluorescent antibody technique as prescribed in &#167;&#8201;113.47(c).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 14.0 day    | (c) Each monolayer shall be maintained at least 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14.0 day    | (e) Monolayers shall be examined regularly throughout the 14-day maintenance period for evidence of cytopathogenic agents.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | (f) At the conclusion of the 14-day maintenance period, monolayers shall be tested for:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 96.0 hour   | The inoculated media shall be incubated at 35 to 37 &#176;C for 96 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 96.0 hour   | The inoculated media shall be incubated at 35 to 37 &#176;C for 96 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 96.0 hour   | The inoculated media shall be incubated at 35 to 37 &#176;C for 96 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 15 day      | (3) Fourteen to fifteen days postvaccination the vaccinates and controls shall each be challenged with not less than 4,500 guinea pig LD50 of a virulent suspension of Bacillus anthracis furnished or approved by Animal and Plant Health Inspection Service and observed for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 10.0 day    | (3) Fourteen to fifteen days postvaccination the vaccinates and controls shall each be challenged with not less than 4,500 guinea pig LD50 of a virulent suspension of Bacillus anthracis furnished or approved by Animal and Plant Health Inspection Service and observed for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 10.0 day    | (4) If at least 10 of the 12 controls do not die from Bacillus anthracis within the 10-day postchallenge observation period the test is invalid and may be repeated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.0 day    | (5) If at least 27 of 30 of the vaccinates do not survive the 10-day postchallenge observation period, the Master Seed is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 24.0 hour   | Each dilution expected to yield 30 to 300 colonies per plate shall be plated in triplicate on tryptose agar, inverted, and incubated at 35 to 70 &#176;C for 24 hours to 28 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 28.0 hour   | Each dilution expected to yield 30 to 300 colonies per plate shall be plated in triplicate on tryptose agar, inverted, and incubated at 35 to 70 &#176;C for 24 hours to 28 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 21 day      | Fourteen to twenty-one days postvaccination, the vaccinates and controls shall be challenged with a virulent Erysipelothrix rhusiopathiae culture and observed for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 7.0 day     | Fourteen to twenty-one days postvaccination, the vaccinates and controls shall be challenged with a virulent Erysipelothrix rhusiopathiae culture and observed for 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21 day      | Fourteen to twenty-one days post vaccination, the vaccinates and controls shall each be challenged by the respiratory route with a (virulent) pneumonia producing Pasteurella haemolytica culture and observed for 4 to 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 7.0 day     | Fourteen to twenty-one days post vaccination, the vaccinates and controls shall each be challenged by the respiratory route with a (virulent) pneumonia producing Pasteurella haemolytica culture and observed for 4 to 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 21 day      | Fourteen to twenty-one days post vaccination, the vaccinates and controls shall each be challenged by the respiratory route with a (virulent) pneumonia producing Pasteurella multocida culture and observed for 4 to 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 10.0 day    | Fourteen to twenty-one days post vaccination, the vaccinates and controls shall each be challenged by the respiratory route with a (virulent) pneumonia producing Pasteurella multocida culture and observed for 4 to 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 14.0 day    | (3) Not less than 14 days after vaccination, each of 20 vaccinates and each of 10 unvaccinated controls shall be challenged intramuscularly or by other methods acceptable to the Animal and Plant Health Inspection Service with a virulent Pasteurella multocida strain, for which protection is claimed, and observed daily for a 14 day post-challenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (3) Not less than 14 days after vaccination, each of 20 vaccinates and each of 10 unvaccinated controls shall be challenged intramuscularly or by other methods acceptable to the Animal and Plant Health Inspection Service with a virulent Pasteurella multocida strain, for which protection is claimed, and observed daily for a 14 day post-challenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | If at least 16 of 20 of the vaccinates do not survive the 14-day postchallenge period, the Master Seed is unsatisfactory at the selected bacterial count.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.0 day    | (i) Ten birds of a species for which the vaccine is recommended shall be given the equivalent of 10 doses each of the vaccine and observed for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 28.0 day    | (3) Fourteen or more days after the final dose of vaccine, the vaccinates and controls shall each be challenged intranasally with a minimum of 10,000 yolk sac LD50 of virulent feline pneumonitis furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 28 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 18.0 day    | From 14 to 18 days postvaccination, challenge each of 10 vaccinates and each of 10 controls intraperitoneally with a suspension of virulent Leptospira pomona organisms, using a dose of 10-10,000 hamster LD50 as determined by titration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | Observe the vaccinates and controls for 14 days post-challenge and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 18.0 day    | From 14 to 18 days postvaccination, challenge each of 10 vaccinates and each of 10 controls intraperitoneally with a suspension of virulent Leptospira icterohaemorrhagiae organisms, using a dose of 10-10,000 hamster LD50 as determined by titration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14.0 day    | Observe the vaccinates and controls for 14 days post-challenge and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 18.0 day    | From 14 to 18 days postvaccination, challenge each of 10 vaccinates and each of 10 controls intraperitoneally with a suspension of virulent Leptospira canicola organisms, using a dose of 10-10,000 hamster LD50 as determined by titration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | Observe the vaccinates and controls for 14 days post-challenge and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 18.0 day    | From 14 to 18 days postvaccination, challenge each of 10 vaccinates and each of 10 controls intraperitoneally with a suspension of virulent Leptospira grippotyphosa organisms, using a dose of 10-10,000 hamster LD50 as determined by titration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | Observe the vaccinates and controls for 14 days post-challenge and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 23.0 day    | A second guinea pig dose shall be injected 21 to 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 15.0 day    | (2) Clostridium chauvoei challenge material, available upon request from Animal and Plant Health Inspection Service, shall be used for challenge 14 to 15 days following the last injection of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 3.0 day     | The vaccinates and controls shall be observed for 3 days postchallenge and all deaths recorded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 day     | (3) For a valid test, at least 80 percent of the controls shall die within the 3 day post-challenge observation period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 23.0 day    | A second guinea pig dose shall be injected 21 to 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 15.0 day    | (2) Clostridium haemolyticum challenge material, available upon request from Animal and Plant Health Inspection Service, shall be used for challenge 14 to 15 days following the last injection of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 day     | The vaccinates and controls shall be observed for 3 days postchallenge and all deaths recorded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 day     | (3) For a valid test, at least 80 percent of the controls shall die within the 3 day post-challenge observation period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 25.0 minute | Such solutions shall be made by dissolving 1 gram of peptone and 0.25 gram of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 121 &#176;C for 25 minutes; and storing at 4 &#176;C until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 20.0 day    | A second dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 23.0 day    | A second dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 17 day      | (3) Fourteen to seventeen days after the second dose, all surviving rabbits shall be bled, and the serum tested for antitoxin content.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 72.0 hour   | Conclude the test 72 hours post injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 25.0 minute | Such solutions shall be made by dissolving 1 gram of peptone and 0.25 gram of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 121 &#176;C for 25 minutes; and storing at 4 &#176;C until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 20.0 day    | A second dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 23.0 day    | A second dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 17 day      | (3) Fourteen to seventeen days after the second dose, all surviving rabbits shall be bled, and the serum tested for antitoxin content.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 72.0 hour   | Conclude the test 72 hours post injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 28 day      | Twenty-one to twenty-eight days post-injection, the vaccinates and the controls shall be challenged intraperitoneally with botulinum Type C toxin which has been titrated in mice to provide for a 10&#8201;4.0 mouse MLD dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 7.0 day     | (2) The vaccinates and controls shall be observed for 7 days post-challenge and signs of botulism and deaths noted.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 25.0 minute | Such solutions shall be made by dissolving 1 gram of peptone and 0.25 grams of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 250 &#176;F for 25 minutes; and storing at 4 &#176;C until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 20.0 day    | A second equivalent dose shall be given not less than 20 days nor more than 23 days after the first does.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 23.0 day    | A second equivalent dose shall be given not less than 20 days nor more than 23 days after the first does.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 17 day      | (3) Fourteen to seventeen days after the second dose, all surviving rabbits shall be bled and the serum tested for antitoxin content.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 hour   | Conclude the test 24 hours post-injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 25.0 minute | Such solutions shall be made by dissolving 1 gram of peptone and 0.25 gram of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 250 &#176;F for 25 minutes; and storing at 4 &#176;C until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 20.0 day    | A second equivalent dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 23.0 day    | A second equivalent dose shall be given not less than 20 days nor more than 23 days after the first dose.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 17 day      | (3) Fourteen to seventeen days after the second dose, all surviving rabbits shall be bled, and the serum tested for antitoxin content.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 hour   | Conclude the test 24 hours post-injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 15.0 month  | (4) Under normal circumstances, microorganism(s) used for the production of autogenous biologics may not be older than 15 months from the date of isolation, or 12 months from the date of harvest of the first serial of product produced from the microorganism(s), whichever comes first.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 12.0 month  | (4) Under normal circumstances, microorganism(s) used for the production of autogenous biologics may not be older than 15 months from the date of isolation, or 12 months from the date of harvest of the first serial of product produced from the microorganism(s), whichever comes first.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 18.0 month  | (2) The expiration date of the autogenous biologic shall not exceed 18 months from the date of harvest.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 3 day       | (ii) Serials which are satisfactory after the third day of observation of purity test cultures and of safety test animals may be released for shipment to the customer and the tests continued throughout the required period; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               (iii) Serials released on the basis of satisfactory results of third day observations shall be immediately recalled if evidence of contamination occurs in test cultures or if any of the test animals used to demonstrate product safety, sicken, or die during the observation period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 3 day       | (ii) Serials which are satisfactory after the third day of observation of purity test cultures and of safety test animals may be released for shipment to the customer and the tests continued throughout the required period; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               (iii) Serials released on the basis of satisfactory results of third day observations shall be immediately recalled if evidence of contamination occurs in test cultures or if any of the test animals used to demonstrate product safety, sicken, or die during the observation period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 15.0 month  | After 15 months from the date of isolation, or 12 months from the harvest date of the first serial of autogenous product produced from a microorganism, whichever comes first, characterization and identification shall be completed to strain and/or serotype before such microorganism may be used for production.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 12.0 month  | After 15 months from the date of isolation, or 12 months from the harvest date of the first serial of autogenous product produced from a microorganism, whichever comes first, characterization and identification shall be completed to strain and/or serotype before such microorganism may be used for production.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 24.0 month  | Persons seeking authorization to prepare additional serials of autogenous biologics from microorganisms that are older than 24 months from the date of isolation, shall be required to conduct the following additional tests:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 6 week      | (1) Six weeks after injection, all surviving guinea pigs shall be bled and equal portions of serum, but not less than 0.5 ml from each, shall be pooled.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 7.0 day     | (1) Each rabbit shall be given a series of not more than three intramuscular injections at 7 day intervals (1.0 ml, 2.0 ml, 3.0 ml) and observed from 7-14 days following the third injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 14.0 day    | (1) Each rabbit shall be given a series of not more than three intramuscular injections at 7 day intervals (1.0 ml, 2.0 ml, 3.0 ml) and observed from 7-14 days following the third injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 30.0 minute | (3) Inactivate rabbit serum 56 &#176;C for 30 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 minute | (6) Incubate toxin-antitoxin mixture at room temperature for 30 minutes and add 1 ml of a 1.5 percent suspension of washed freshly drawn rabbit red blood cells suspended in normal saline to each tube.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 1.0 hour    | Mix and incubate the combined product in a 37 &#176;C water bath for 1 hour.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 6.0 week    | Turkeys at least 6 weeks old obtained from the same source and hatch shall be properly identified and used as provided in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.0 week    | A second dose shall be given after 3 weeks and the turkeys observed for an additional 2-week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 2.0 week    | A second dose shall be given after 3 weeks and the turkeys observed for an additional 2-week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 14.0 day    | Not less than 14 days after the second dose, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with virulent Pasteurella multocida, Strain P-1662, Type 4 (Little and Lyons classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 14.0 day    | Not less than 14 days after the second dose, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with virulent Pasteurella multocida, Strain P-1662, Type 4 (Little and Lyons classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 12.0 week   | Chickens, at least 12 weeks of age, obtained from the same source and hatch, shall be properly identified and used as provided in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 3.0 week    | A second dose shall be injected after 3 weeks and the chickens observed for an additional 2 week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 2.0 week    | A second dose shall be injected after 3 weeks and the chickens observed for an additional 2 week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 14.0 day    | Not less than 14 days after the second injection, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with a minimum of 250 colony-forming units of virulent Pasteurella multocida, Strain X-73, Type 1 (Little and Lyons classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | Not less than 14 days after the second injection, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with a minimum of 250 colony-forming units of virulent Pasteurella multocida, Strain X-73, Type 1 (Little and Lyons classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 6.0 week    | Turkeys, at least 6 weeks of age, obtained from the same source and hatch, shall be properly identified and used as provided in this paragraph.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 3.0 week    | A second dose shall be injected after 3 weeks and the turkeys observed for an additional 2 week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 week    | A second dose shall be injected after 3 weeks and the turkeys observed for an additional 2 week prechallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 14.0 day    | Not less than 14 days after the second injection, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with a minimum of 150 colony-forming units of virulent Pasteurella multocida, Strain P-1059, Type 3 (Little and Lyons Classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | Not less than 14 days after the second injection, each of 20 vaccinates, and each of 10 unvaccinated controls shall be challenged intramuscularly with a minimum of 150 colony-forming units of virulent Pasteurella multocida, Strain P-1059, Type 3 (Little and Lyons Classification) and observed daily for a 14-day postchallenge period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | (4) Each of 20 injected mice from each group shall be challenged subcutaneously 14 to 21 days after being injected.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 10.0 day    | All survivors in each group of mice shall be recorded 10 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.0 day    | (4) Each of 20 vaccinated mice per group shall be challenged intraperitoneally 7-10 days after the second vaccination with a 0.25 ml dose containing 100-10,000 mouse LD50 as determined by titration, of a suitable culture of Salmonella typhimurium.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | All survivors in each group of mice shall be recorded 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 12.0 day    | (4) Each of 20 injected mice per group shall be challenged intraperitoneally 10-12 days after the second vaccination with a 0.2 ml dose containing 100-10,000 mouse LD50, as determined by titration, of a suitable culture of Pasteurella multocida.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 10.0 day    | All survivors in each group of mice shall be recorded 10 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.0 day    | (4) Each of 20 vaccinated mice per group shall be challenged intraperitoneally 7 to 10 days after the second vaccination with a 0.25 ml dose containing 10-1,000 mouse LD50 as determined by titration of a suitable culture of Salmonella choleraesuis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14.0 day    | All survivors in each group of mice shall be recorded 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.0 day    | (4) Each of 20 vaccinated mice per group shall be challenged intraperitoneally 7 to 10 days after the second vaccination with a 0.25 ml dose containing 1,000-100,000 mouse LD50 as determined by titration of a suitable culture of Salmonella dublin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | All survivors in each group of mice shall be recorded 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | Each of the five vaccinates shall be injected with one dose of vaccine as recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 2.0 week    | At least 2 weeks after the last inoculation, the five vaccinates and the five controls shall be challenged with virulent mink enteritis virus and observed each day for 12 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 12.0 day    | At least 2 weeks after the last inoculation, the five vaccinates and the five controls shall be challenged with virulent mink enteritis virus and observed each day for 12 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 1 day       | Fecal material shall be collected on one day between days 4-8 (inclusive) postchallenge from each test animal that remains free of enteric signs and tested for the presence of mink enteritis virus by cell culture with fluorescent antibody examination.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 6.0 week    | A vaccination-challenge test shall be conducted using susceptible chickens 2 to 6 weeks of age at time of vaccination, properly identified and obtained from the same source and hatch.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | (1) Ten or more chickens shall be vaccinated as recommended on the label and kept isolated under observation for at least 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (2) After at least 14 days post-vaccination, the vaccinates and at least 10 unvaccinated chickens that have been kept isolated as controls shall be challenged with a virulent strain of Newcastle disease virus supplied by or approved by Veterinary Services and the vaccinates observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 14.0 day    | (2) After at least 14 days post-vaccination, the vaccinates and at least 10 unvaccinated chickens that have been kept isolated as controls shall be challenged with a virulent strain of Newcastle disease virus supplied by or approved by Veterinary Services and the vaccinates observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 12.0 hour   | (1) Each of at least ten 6 to 12 hour old chickens shall be injected subcutaneously with 0.5 ml of the product and the chickens observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 10.0 day    | (1) Each of at least ten 6 to 12 hour old chickens shall be injected subcutaneously with 0.5 ml of the product and the chickens observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | Each of 10 healthy guinea pigs (vaccinates) shall be injected with two guinea pig doses with an interval of 14 to 21 days between doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 21.0 day    | (2) Fourteen to 21 days after the second injection, serum samples from each vaccinate and each control shall be tested by a plaque reduction, serum neutralization test using Vero 76 cells.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 6.0 day     | Each of 15 or more AE susceptible 5 or 6 day old embryos shall be injected in the yolk sac with 0.2 ml of the vaccine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 48.0 hour   | For a valid test, at least 80 percent of the embryos shall survive for 48 hours post-inoculation (PI).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 13.0 day    | Eleven to 13 days PI, all embryos surviving the 48 hour PI period shall be examined for gross lesions of AE; all these embryos shall be normal or the serial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 48.0 hour   | Eleven to 13 days PI, all embryos surviving the 48 hour PI period shall be examined for gross lesions of AE; all these embryos shall be normal or the serial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 13.0 day    | At least 4 of the 5 embryos shall show evidence of AE virus infection during the 11 to 13 day PI period or the test shall be considered a No Test and repeated: Provided, That, if the test is not repeated, the serial shall be declared unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 7.0 day     | Each of 10 or more AE susceptible 7 day old chickens shall be injected intracerebrally with 0.1 ml vaccine each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 28.0 day    | The chickens shall be observed each day for 28 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 4.0 week    | Ten or more AE-susceptible chickens (vaccinates), 4 weeks or older, properly identified and obtained from the same source and hatch, shall be injected as recommended on the label.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 28.0 day    | (1) At least 28 days post-injection, the vaccinates and the controls shall be challenged intramuscularly with a virulent AE virus and the chickens observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 21.0 day    | (1) At least 28 days post-injection, the vaccinates and the controls shall be challenged intramuscularly with a virulent AE virus and the chickens observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 365.0 day   | (iii) On or about 30, 90, 180, 270, and 365 days postvaccination, all test animals shall be bled and individual serum samples tested for neutralizing antibodies to rabies virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 1.0 year    | (iv) All surviving test animals shall be challenged intramuscularly with virulent rabies virus furnished or approved by Animal and Plant Health Inspection Service 1 year after vaccinations, except as provided in (b)(4) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 90.0 day    | The challenged animals shall be observed each day for 90 days as prescribed in &#167;&#8201;113.5(b).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 90.0 day    | (v) Requirements for acceptance in challenge tests shall be death due to rabies in at least 80 percent of the controls while at least 22 of 25 or 26 of 30 or a statistically equivalent number of the vaccinates remain well for a period of 90 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 1.0 year    | Vaccinates shall be challenged at 1 year postvaccination.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 90.0 day    | All of the challenged vaccinates must remain well for a period of 90 days, and at least 80 percent of the controls must die of rabies for a satisfactory test without further challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 1.0 year    | (c) If more than 1 year duration of immunity is to be claimed, a duration of immunity test for the additional time shall be conducted and interpreted as prescribed in paragraph (b) of this section for the 1 year test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1.0 year    | (c) If more than 1 year duration of immunity is to be claimed, a duration of immunity test for the additional time shall be conducted and interpreted as prescribed in paragraph (b) of this section for the 1 year test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 180.0 day   | The test animals shall be monitored serologically at least every 180 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | Bulk samples from each serial shall be tested for virus inactivation and safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|             |               (i) At the end of the inactivation period, each of 20 12 to 16 gram mice shall be injected intracerebrally with 0.03 ml and two rabbits shall be injected into each cerebral hemisphere with 0.25 ml and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 14.0 day    | Material from each brain recovered shall be injected into each of five mice and the mice observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 28.0 day    | If unfavorable reactions attributable to the product occur during a 28 day observation period, the serial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | (iii) Fourteen or more days after the final dose of vaccine, the vaccinates and controls shall each be challenged intranasally with virulent feline calicivirus furnished or approved by Animal and Plant Health Inspection Service and observed each day for 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 28.0 day    | Inject each of 21 susceptible chickens 14 to 28 days of age, properly identified and obtained from the same source and hatch, with one dose of vaccine by the route recommended on the label and observe for at least 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | Inject each of 21 susceptible chickens 14 to 28 days of age, properly identified and obtained from the same source and hatch, with one dose of vaccine by the route recommended on the label and observe for at least 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 28.0 day    | Twenty-one to 28 days postvaccination, challenge 20 vaccinates and 10 controls by eyedrop with a virulent infectious bursal disease virus furnished or approved by Animal and Plant Health Inspection Service.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 4 day       | Four days postchallenge, necropsy all chickens and examine each for gross lesions of bursal disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 14 day      | (iv) Fourteen days or more after the last vaccination, blood samples shall be drawn and the individual serum samples inactivated and tested for bovine virus diarrhea virus neutralizing antibody by the same method used to determine susceptibility.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 14.0 day    | The animals shall be observed for 14 days post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 14.0 day    | The animals shall be observed each day for 14 days post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (1) Each of two lambs (vaccinates) shall be vaccinated by application of the vaccine to a scarified area on the medial surface of the thigh and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 2.0 week    | (3) If typical signs of ovine ecthyma, such as hyperemia, vesicles, and pustules do not develop on the controls during the first 2 weeks following challenge and persist for approximately 30 days, the test is a No Test and may be repeated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 30.0 day    | (3) If typical signs of ovine ecthyma, such as hyperemia, vesicles, and pustules do not develop on the controls during the first 2 weeks following challenge and persist for approximately 30 days, the test is a No Test and may be repeated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 2.0 week    | (4) If the vaccinates do not show a typical immune reaction, the serial is unsatisfactory: Provided, That, an initial active reaction with hyperemia which resolves progressively and disappears within 2 weeks, may be characterized as a typical immune reaction.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 21.0 day    | (b) The lot of Master Seed Virus shall be tested for extraneous viruses as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               (1) To detect virulent canine distemper virus, each of two distemper susceptible mink or ferrets shall be inoculated with 1 ml of the Master Seed Virus and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 21 day      | (3) At least twenty-one days post-injection, the immunity of each of the vaccinates and the controls shall be challenged with the same size dose of virulent distemper virus and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 21.0 day    | (3) At least twenty-one days post-injection, the immunity of each of the vaccinates and the controls shall be challenged with the same size dose of virulent distemper virus and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 21.0 day    | The mink shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 18.0 day    | (3) At least once during the period of 14 to 18 days postvaccination, individual serum samples shall be collected from each of the vaccinates and tested for virus neutralizing antibody using the 60 to 300 TCID50 of bluetongue virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 28 day      | (4) Twenty-one to twenty-eight days postvaccination the vaccinates and the controls shall each be challenged with virulent bluetongue virus and observed for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 14.0 day    | (4) Twenty-one to twenty-eight days postvaccination the vaccinates and the controls shall each be challenged with virulent bluetongue virus and observed for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 3.0 day     | The rectal temperature of each animal shall be taken and recorded for 17 consecutive days beginning 3 days prechallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 21.0 day    | (b) The lot of Master Seed Virus shall be tested for other agents as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|             |               (1) To detect virulent feline panleukopenia virus or virulent mink enteritis virus, each of two feline panleukopenia susceptible cats, as determined by the criteria prescribed in paragraph (c)(1) of this section, shall be injected subcutaneously with the equivalent of one cat dose each and the cats observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14 day      | (3) Fourteen days post-injection, the vaccinates and the controls shall be challenged with virulent feline panleukopenia virus furnished by Animal and Plant Health Inspection Service and the cats observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (3) Fourteen days post-injection, the vaccinates and the controls shall be challenged with virulent feline panleukopenia virus furnished by Animal and Plant Health Inspection Service and the cats observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 14.0 day    | (i) Each of two healthy cats shall be injected with 10 cat doses by the method recommended on the label and the cats observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 14.0 day    | (ii) Not less than 14 days postinjection, the vaccinates and the controls shall each be challenged intravenously with virulent infectious canine hepatitis virus furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | (ii) Not less than 14 days postinjection, the vaccinates and the controls shall each be challenged intravenously with virulent infectious canine hepatitis virus furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | (ii) Not less than 14 days postinjection, the vaccinates and the controls shall be challenged by exposure to a nebulized aerosol of virulent canine adenovirus type 2 furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 14.0 day    | (ii) Not less than 14 days postinjection, the vaccinates and the controls shall be challenged by exposure to a nebulized aerosol of virulent canine adenovirus type 2 furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | (1) To detect ferret virulent canine distemper virus, each of five canine distemper susceptible ferrets shall be injected with a sample of the Master Seed Virus equivalent to the amount of virus to be used in one dog dose and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 14.0 day    | (3) At least 14 days post-injection, the vaccinates and the controls shall each be challenged intracerebrally with virulent canine distemper virus furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | (3) At least 14 days post-injection, the vaccinates and the controls shall each be challenged intracerebrally with virulent canine distemper virus furnished or approved by the Animal and Plant Health Inspection Service and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 28 day      | (4) Twenty-one to twenty-eight days postvaccination, blood samples shall be drawn from all test animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 2.0 day     | The vaccinates shall be bled on day 6 &#177;2 days post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 4 week      | (4) Three to four weeks post-vaccination, all calves shall be bled for serum antibodies and nasal specimens shall be collected for PI3 virus isolation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | On the same day, all vaccinates and controls shall be given acceptable challenge PI3 virus titrating at least 10&#8201;7.0 TCID50 per ml and the animals observed for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 10.0 day    | Each day for at least the first 10 days post-challenge, nasal specimens for virus isolation attempts shall be taken.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 day     | All animals shall be bled on day 6 &#177;2 days post-challenge, and all animals shall be bled at least once 14 to 28 days post-challenge for serum antibody studies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 28.0 day    | All animals shall be bled on day 6 &#177;2 days post-challenge, and all animals shall be bled at least once 14 to 28 days post-challenge for serum antibody studies.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 14.0 day    | (i) All virus isolations attempts shall be by culture and at least one subculture in PI3 susceptible cells for a total of at least 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 4 week      | (ii) Two to four weeks post-vaccination, at least 19 of the 20 vaccinates shall have PI3 neutralizing antibody titers of at least 1:4 and all five controls shall be negative at 1:2 dilution.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 2.0 day     | None of the post-vaccination serums collected from the vaccinates on day 6 &#177;2 days shall reveal serum neutralization antibody titers of 1:32 or greater based upon final dilution.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 2.0 day     | (iii) Antibody values from alternate animals may be used only to replace values from up to and including five vaccinates which develop antibody of 1:32 or greater by day 6 &#177;2 days post-vaccination or up to and including two controls which develop antibody titers of 1:32 or greater by day 6 &#177;2 days post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 2.0 day     | (iii) Antibody values from alternate animals may be used only to replace values from up to and including five vaccinates which develop antibody of 1:32 or greater by day 6 &#177;2 days post-vaccination or up to and including two controls which develop antibody titers of 1:32 or greater by day 6 &#177;2 days post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 28.0 day    | (3) At least once during a period of 14 to 28 days post-vaccination, individual serum samples shall be collected for virus-neutralization tests from each of the vaccinates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | (4) The vaccinates and the controls shall each be challenged with virulent infectious bovine rhinotracheitis virus and observed for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 28.0 day    | (3) At least once during a period 14 to 28 days post-vaccination, individual serum samples shall be collected for virus-neutralization tests from each of the vaccinates.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 3.0 day     | The white cell count for all vaccinates and controls shall be established at least 3 days just before challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 8 day       | The white cell count shall be determined daily on each animal from the second through the eighth day post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 7.0 day     | If animals show definite symptoms, sacrifice and check regional lymph nodes, brain, salivary glands, and kidney for rabies virus by injection of suckling mice (not more than 7 days of age).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | Observe mice each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 90.0 day    | (iii) Observe all animals each day for 90 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 1.0 year    | (iv) All surviving test animals of each species shall be challenged intramuscularly with virulent rabies virus furnished or approved by Animal and Plant Health Inspection Service 1 year after vaccination, except as provided in paragraphs (b)(4), (b)(5), and (b)(6) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 90.0 day    | The challenged animals shall be observed each day for 90 days as prescribed in &#167;&#8201;113.5(b).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 90.0 day    | (v) Requirements for acceptance in challenge tests shall be death due to rabies in at least 80 percent of controls while at least 22 of 25 or 26 of 30 or a statistically equivalent number of the vaccinates remain well for a period of 90 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 1.0 year    | Vaccinates shall be challenged at 1 year postvaccination.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 90.0 day    | All of the challenged vaccinates must remain well for a period of 90 days, and at least 80 percent of the controls must die of rabies for a satisfactory test without further challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 1.0 year    | (c) If more than 1 year duration of immunity is to be claimed, a duration of immunity test for the additional time shall be conducted and interpreted as prescribed in paragraph (b) of this section for the 1 year test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 1.0 year    | (c) If more than 1 year duration of immunity is to be claimed, a duration of immunity test for the additional time shall be conducted and interpreted as prescribed in paragraph (b) of this section for the 1 year test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 180.0 day   | The test animals shall be monitored serologically at least every 180 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 28.0 day    | If unfavorable reactions attributable to the product occur during a 28 day observation period, the serial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | (ii) The injected young adult mice shall be observed each day for 14 days except when testing vaccines made with HCP SAD strain of rabies virus, in which case, the mice shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | (ii) The injected young adult mice shall be observed each day for 14 days except when testing vaccines made with HCP SAD strain of rabies virus, in which case, the mice shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 4 day       | Deaths and paralysis occurring subsequent to the fourth day post-injection shall be noted and the LD50 titer calculated by the Reed and Muench Method.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 6.0 day     | (4) Suckling mice, 6 days of age or younger, shall be used as test animals when virus in vaccine prepared with a high egg passage Flury Strain of rabies virus is titrated.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 21.0 day    | (ii) The injected suckling mice shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 4 day       | Deaths and paralysis occurring subsequent to the fourth day post-injection shall be noted and the LD50 titer calculated by the Reed and Muench Method; and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | (b) To detect virulent canine distemper virus, each of two canine distemper susceptible ferrets shall be injected with a sample of the Master Seed Virus equivalent to the amount of virus to be used in one dog dose and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 12.0 week   | (1) Twenty-five dogs, less than 12 weeks of age and free of measles antibody, shall be used as test animals (20 vaccinates and five controls).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | (4) At least 21 days postinoculation, the immunity of the vaccinates and controls shall be challenged by exposure to a uniform dose of aerosolized virulent canine distemper virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 21.0 day    | All test dogs shall be observed daily for 21 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 14.0 day    | (3) Twenty-one or more days after the final dose of vaccine, the vaccinates and controls shall each be challenged intranasally with a minimum of 100,000 TCID50 or plaque forming units of virulent feline calicivirus furnished or approved by Animal and Plant Health Inspection Service and observed each day for 14 days postchallenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 14.0 day    | (3) Twenty-one or more days after the final dose of vaccine, the vaccinates and controls shall each be challenged intranasally with a minimum of 100,000 TCID50 or plaque forming units of virulent feline rhinotracheitis virus furnished or approved by Animal and Plant Health Inspection Service and observed each day for 14 days post-challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 4.0 week    | (3) Three to 4 weeks after the final dose of vaccine, all dogs shall be bled for serum antibodies and nasal swabs shall be collected for canine parainfluenza virus isolation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 7.0 day     | Individual swabs shall be tested for virus isolation by culture in canine parainfluenza virus susceptible cells for at least 7 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 14 day      | (3) Fourteen days or more after the final dose of vaccine the vaccinates and the controls shall be challenged with virulent canine parvovirus furnished or approved by Animal and Plant Health Inspection Service and the dogs observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14.0 day    | (3) Fourteen days or more after the final dose of vaccine the vaccinates and the controls shall be challenged with virulent canine parvovirus furnished or approved by Animal and Plant Health Inspection Service and the dogs observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 10.0 day    | Rectal temperature, blood lymphocyte count, and feces for viral detection shall be taken from each dog each day for at least 10 days postchallenge and the presence or absence of clinical signs noted and recorded each day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 28.0 day    | (3) Fourteen to 28 days postvaccination, the vaccinates and controls shall be challenged with virulent pseudorabies virus furnished or approved by Animal and Plant Health Inspection Service and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 14.0 day    | (3) Fourteen to 28 days postvaccination, the vaccinates and controls shall be challenged with virulent pseudorabies virus furnished or approved by Animal and Plant Health Inspection Service and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 8 week      | (c) Each lot of Master Seed Virus shall be tested for immunogenicity and the selected virus dose to be used shall be established as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |               (1) Avian encephalomyelitis susceptible chickens, all of the same age (eight weeks or older) and from the same source, shall be used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 6.0 day     | At least three appropriate (not to exceed tenfold) dilutions shall be used and the test conducted as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|             |               (i) For each dilution, inoculate at least 10 embryos, 5 or 6 days old, in the yolk sac with 0.2 ml each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 48.0 hour   | Disregard all deaths during the first 48 hours post-inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 3 day       | (iii) On the third day after normal hatching time, count all unhatched eggs and all dead, paralyzed and ataxic chickens as positive evidence of viral infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 21.0 day    | (3) At least 21 days post-vaccination, the vaccinates and the controls shall be challenged intracerebrally with a virulent avian encephalomyelitis virus and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 21.0 day    | (3) At least 21 days post-vaccination, the vaccinates and the controls shall be challenged intracerebrally with a virulent avian encephalomyelitis virus and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 10.0 week   | Final container samples of completed product shall be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               (i) At least 25 AE susceptible birds (6 to 10 weeks of age) shall be vaccinated with the equivalent of 10 doses by each of all routes recommended on the label and be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 21.0 day    | Final container samples of completed product shall be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|             |               (i) At least 25 AE susceptible birds (6 to 10 weeks of age) shall be vaccinated with the equivalent of 10 doses by each of all routes recommended on the label and be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 11.0 day    | At least three appropriate (not to exceed tenfold) dilutions shall be used and the test conducted as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|             |               (i) For each dilution, inoculate at least five embryos, 9 to 11 days old, on the chorioallantoic membrane with at least 0.2 ml each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 24.0 hour   | Disregard all deaths during the first 24 hours post-inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | To be a valid test, at least four embryos in each dilution shall remain viable beyond 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 7.0 day     | (ii) Examine the surviving embryos for evidence of infection 5 to 7 days post-inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21 day      | (3) Fourteen to twenty-one days post-vaccination, all vaccinates and controls shall be challenged by the wing web method and observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 10.0 day    | (3) Fourteen to twenty-one days post-vaccination, all vaccinates and controls shall be challenged by the wing web method and observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 10.0 day    | Vaccines recommended for use in birds 10 days of age or younger shall be tested in accordance with paragraphs (d)(1)(i), (ii), and (iii) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 5.0 day     | (i) Each of 25 susceptible birds 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | (i) Each of 25 susceptible birds 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 10.0 day    | (iv) Vaccines not recommended for use in birds 10 days of age or younger shall be tested for safety as follows: Each of twenty-five 3- to 5-week-old, fowl-pox susceptible birds shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 week    | (iv) Vaccines not recommended for use in birds 10 days of age or younger shall be tested for safety as follows: Each of twenty-five 3- to 5-week-old, fowl-pox susceptible birds shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 14.0 day    | (iv) Vaccines not recommended for use in birds 10 days of age or younger shall be tested for safety as follows: Each of twenty-five 3- to 5-week-old, fowl-pox susceptible birds shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 11.0 day    | (i) For each dilution, inject at least five embryos, 9 to 11 days old, in the allantoic cavity with 0.1 ml each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | Deaths occurring during the first 24 hours shall be disregarded, but at least four viable embyros in each dilution shall survive beyond 24 hours of a valid test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 24.0 hour   | Deaths occurring during the first 24 hours shall be disregarded, but at least four viable embyros in each dilution shall survive beyond 24 hours of a valid test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 8.0 day     | After 5 to 8 days incubation, examine the surviving embryos for evidence of infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 28 day      | (3) Twenty-one to twenty-eight days post-vaccination, all vaccinates and controls shall be challenged by eye-drop with virulent bronchitis virus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 5.0 day     | (i) Tracheal swabs shall be taken once, 5 days post-challenge, from each control and vaccinate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 11.0 day    | For each chicken swab, at least five chicken embryos 9 to 11 days old shall be inoculated in the allantoic cavity with 0.2 ml each of broth from each tube.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 3 day       | (ii) All embryos surviving the third day post-inoculation shall be used in the evaluation, except that, if a swab is not represented by at least four embryos, the test of that swab is invalid and the results a No Test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 7.0 day     | A tracheal swab shall be positive for virus recovery when any of the embryos in a valid test show typical infectious bronchitis virus lesions, such as but not limited to, stunting, curling, kidney urates, clubbed down, or death during the 4 to 7 day post-inoculation period.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 3 day       | If less than 20 percent of the embryos which survive the third day post-inoculation die during the 4 to 7 day post-inoculation period and show no gross lesions typical of infectious bronchitis, they may be disregarded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 7.0 day     | If less than 20 percent of the embryos which survive the third day post-inoculation die during the 4 to 7 day post-inoculation period and show no gross lesions typical of infectious bronchitis, they may be disregarded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 5.0 day     | (i) Twenty-five susceptible chickens, 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated by the eye-drop method with the equivalent of 10 doses of vaccine and observed each day for 21 days post-vaccination.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 21.0 day    | (i) Twenty-five susceptible chickens, 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated by the eye-drop method with the equivalent of 10 doses of vaccine and observed each day for 21 days post-vaccination.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 4.0 week    | Each lot shall also be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|             |               (1) Each of at least ten 3 to 4 week old susceptible chickens obtained from the same source and hatch as those used in the immunogenicity test prescribed in paragraph (c) of this section shall be injected intratracheally with 0.2 ml of the virus as used in the vaccine and the chickens observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | Each lot shall also be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|             |               (1) Each of at least ten 3 to 4 week old susceptible chickens obtained from the same source and hatch as those used in the immunogenicity test prescribed in paragraph (c) of this section shall be injected intratracheally with 0.2 ml of the virus as used in the vaccine and the chickens observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 11.0 day    | At least three appropriate (not to exceed tenfold) dilutions shall be used for vaccine of chicken embryo origin and the test conducted as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               (i) For each dilution, inject at least five embryos, 9 to 11 days old, on the chorioallantoic membrane with 0.2 ml each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 hour   | Disregard all deaths during the first 24 hours post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 24.0 hour   | To be a valid test, at least four embryos in each dilution shall remain viable beyond 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 8.0 day     | (ii) Examine the surviving embryos for evidence of infection 5 to 8 days post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 14 day      | (4) Ten to fourteen days post-vaccination, all vaccinates and controls shall be challenged intratracheally or in the orbital sinus with infectious fowl laryngotracheitis virus and observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 10.0 day    | (4) Ten to fourteen days post-vaccination, all vaccinates and controls shall be challenged intratracheally or in the orbital sinus with infectious fowl laryngotracheitis virus and observed each day for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 4.0 week    | (i) Twenty-five 3 to 4 week old laryngotracheitis susceptible chickens shall be injected intratracheally with 0.2 ml of vaccine rehydrated at the rate of 30 ml for 1,000 doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 14.0 day    | Chickens shall be observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 11.0 day    | At least three appropriate (not to exceed tenfold) dilutions shall be used and the test conducted as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|             |               (i) For each dilution, inject at least five embryos, 9 to 11 days old, in the allantoic cavity with at least 0.1 ml each.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 24.0 hour   | Disregard all deaths during the first 24 hours post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 24.0 hour   | To be a valid test, at least four embryos in each dilution shall remain viable beyond 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 7.0 day     | (ii) Examine the surviving embryos for evidence of infection 5 to 7 days post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 28 day      | (3) Twenty to twenty-eight days postvaccination, all vaccinates and controls shall be challenged intramuscularly with at least 10&#8201;4.0 EID50 of virus per chicken and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 14.0 day    | (3) Twenty to twenty-eight days postvaccination, all vaccinates and controls shall be challenged intramuscularly with at least 10&#8201;4.0 EID50 of virus per chicken and observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.0 day    | Vaccines recommended for use in chickens 10 days of age or younger shall be tested in accordance with paragraphs (d)(2)(i), (ii), and (iii) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 5.0 day     | (i) Twenty-five susceptible chickens, 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated by the eye drop method with the equivalent of 10 doses of vaccine and the chickens observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 21.0 day    | (i) Twenty-five susceptible chickens, 5 days of age or younger, properly identified and obtained from the same source and hatch, shall be vaccinated by the eye drop method with the equivalent of 10 doses of vaccine and the chickens observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 10.0 day    | (iv) Vaccines not recommended for use in chickens 10 days of age or younger shall be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               Each of twenty-five 3 to 5 week old Newcastle disease susceptible chickens shall be vaccinated as recommended on the label with the equivalent of ten doses and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 5.0 week    | (iv) Vaccines not recommended for use in chickens 10 days of age or younger shall be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               Each of twenty-five 3 to 5 week old Newcastle disease susceptible chickens shall be vaccinated as recommended on the label with the equivalent of ten doses and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 21.0 day    | (iv) Vaccines not recommended for use in chickens 10 days of age or younger shall be tested for safety as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|             |               Each of twenty-five 3 to 5 week old Newcastle disease susceptible chickens shall be vaccinated as recommended on the label with the equivalent of ten doses and observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 50.0 day    | At least 50 test subjects shall be injected with a very virulent Marek's disease virus provided or approved by APHIS, at a dosage level that will cause gross lesions of Marek's disease in at least 80 per cent of the chickens within 50 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 5.0 day     | (2) At least 40 chickens in each group shall survive to 5 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 50.0 day    | The test shall be judged according to the following criteria:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|             |               (i) At 50 days of age, the remaining chickens in group 2 shall be killed and examined for gross lesions of Marek's disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 120.0 day   | (ii) At 120 days of age, the remaining chickens in groups 1, 3, and 4 shall be weighed, killed, and necropsied.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 120.0 day   | If less than 30 of the chickens in group 3 survive the 120 day period, or if any of the chickens in group 3 have gross lesions of Marek's disease at necropsy, the test is declared a No Test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 120.0 day   | If less than 30 chickens in groups 1 and 4 survive the 120 day period; or if any of the chickens in groups 1 and 4 have gross lesions of Marek's disease at necropsy; or if the average body weight of the chickens in groups 1 or 4 is significantly (statistically) different from the average in group 3 at the end of the 120 days, the lot of Master Seed Virus is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 120.0 day   | If less than 30 chickens in groups 1 and 4 survive the 120 day period; or if any of the chickens in groups 1 and 4 have gross lesions of Marek's disease at necropsy; or if the average body weight of the chickens in groups 1 or 4 is significantly (statistically) different from the average in group 3 at the end of the 120 days, the lot of Master Seed Virus is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 1.0 day     | A minimum of 35 test subjects shall be inoculated with the vaccine, using the recommended route, at 1 day of age for chicks or 18 days of embryonation for embryos.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 18.0 day    | A minimum of 35 test subjects shall be inoculated with the vaccine, using the recommended route, at 1 day of age for chicks or 18 days of embryonation for embryos.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 1.0 day     | Except for studies evaluating vaccines which contain only a Serotype 3 virus as the Marek's disease fraction, a minimum of 35 chicks shall be vaccinated at 1 day of age with a licensed Serotype 3 vaccine, in order to document the severity of the very virulent challenge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 5.0 day     | (2) At least 30 chickens in groups 1, 2, and 4, and at least 20 chickens in group 3, shall survive to 5 days of age.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 5.0 day     | All chickens in groups 1, 2, and 4 shall be challenged at 5 days of age in the following manner:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|             |               (i) For studies evaluating vaccines which contain only a Serotype 3 virus as the Marek's disease fraction, groups 1 and 2 shall be inoculated with a standard virulent challenge virus provided or approved by APHIS.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 7.0 week    | (3) All chickens shall be observed until 7 weeks of age, necropsied, and examined for grossly observable lesions consistent with Marek's disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 7.0 week    | All chickens dying before the end of the 7 week observation period shall be necropsied and evaluated for gross lesions of Marek's disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 26.0 day    | At least 25 one-day-old, specific pathogen free chickens shall be injected, by the subcutaneous route, with the equivalent of 10 chicken doses of virus (vaccine concentrated 10X).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 21.0 day    | The chickens shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 3.0 day     | (i) Samples of desiccated vaccine shall be incubated at 37 &#176;C for 3 days before preparation for use in the potency test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 2.0 hour    | Samples of desiccated or frozen vaccine shall be reconstituted in diluent according to the label recommendations, and held in an ice bath at 0 &#176;C to 4 &#176;C for 2 hours prior to use in the potency test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 1.0 day     | Each lot of Master Seed Virus used in the preparation of modified live virus vaccines shall also be nonpathogenic to chickens as determined by the following procedures:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|             |               (1) Each of twenty-five 1-day-old bursal disease susceptible chickens (vaccinates) shall be injected subcutaneously with 10 times the recommended dose of vaccine virus and observed for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 21.0 day    | Each lot of Master Seed Virus used in the preparation of modified live virus vaccines shall also be nonpathogenic to chickens as determined by the following procedures:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|             |               (1) Each of twenty-five 1-day-old bursal disease susceptible chickens (vaccinates) shall be injected subcutaneously with 10 times the recommended dose of vaccine virus and observed for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 17 day      | (i) Seventeen days postvaccination, each of five controls shall be administered at least 10&#8201;2.0 EID50 of a virulent bursal disease virus by eye-drop, isolated, and used as positive controls.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 21 day      | (iii) Twenty-one days postvaccination, the vaccinates and the controls shall be necropsied and examined for gross lesions of bursal disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.0 week    | (2) Each of thirty-five 3- to 4-week-old bursal disease susceptible chickens (vaccinates) shall be vaccinated with approximately one minimum protective dose of vaccine virus as determined in paragraph (c) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 4 day       | (i) Three or four days postvaccination, 10 of the vaccinates, the 10 positive controls, and 10 of the negative controls shall be necropsied and examined for gross lesions of bursal disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 14 day      | (ii) Fourteen days post-vaccination, the remaining vaccinates and negative controls shall be necropsied and examined for obvious bursal atrophy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 3.0 week    | (c) Each lot of Master Seed Virus shall be tested for immunogenicity and the selected virus dose to be used shall be established as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |               (1) Bursal Disease susceptible chickens, all of the same age (3 weeks or younger) and from the same source, shall be used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 35.0 day    | (3) When the test chickens are 28 to 35 days of age but not less than 14 days postvaccination, each vaccinate and each control shall be challenged by eye-drop with a virulent bursal disease virus provided or approved by Animal and Plant Health Inspection Service.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 14.0 day    | (3) When the test chickens are 28 to 35 days of age but not less than 14 days postvaccination, each vaccinate and each control shall be challenged by eye-drop with a virulent bursal disease virus provided or approved by Animal and Plant Health Inspection Service.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 5 day       | (i) Three to five days postchallenge, all vaccinates and controls shall be necropsied and examined for gross lesions of bursal disease as described in paragraph (b)(2)(i) of this section.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 1.0 day     | (i) Final container samples of completed product from each serial shall be tested to determine whether the vaccine is safe as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|             |               (A) For vaccines intended for parenteral administration, each of twenty-five 1-day-old bursal disease susceptible chickens shall be vaccinated with the equivalent of 10 doses by subcutaneous injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 5.0 week    | (B) For vaccines intended for drinking water administration, each of twenty-five 4- to 5-week-old bursal disease susceptible chickens shall be vaccinated orally with the equivalent of 10 doses.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 21.0 day    | The vaccinates and controls shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 3.0 week    | (2) Lymphoid leukosis virus contamination as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|             |               (i) Each of at least 10 3-week-old or older lymphoid leukosis free chickens from the same source and hatch shall be injected intra-muscularly with an amount of Master Seed equal to 100 label doses of vaccine.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 28.0 day    | (ii) Twenty-one to 28 days postinoculation, blood samples shall be taken from each chicken and the serum separated using a technique conducive to virus preservation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 14.0 day    | (4) Safety using the following chicken test:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |               (i) For vaccines intended for use in chickens less than 14 days of age, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 1-day-old tenosynovitis susceptible chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1.0 day     | (4) Safety using the following chicken test:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|             |               (i) For vaccines intended for use in chickens less than 14 days of age, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 1-day-old tenosynovitis susceptible chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 14.0 day    | (ii) For vaccines intended for use only in chickens 14 days of age or older, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 4-week-old or older tenosynovitis susceptible chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 4.0 week    | (ii) For vaccines intended for use only in chickens 14 days of age or older, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 4-week-old or older tenosynovitis susceptible chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 21.0 day    | (iii) The vaccinates shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 4.0 week    | Vaccines intended for use in older chickens shall be administered to 4-week-old or older chickens.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 28.0 day    | (3) Twenty-one to 28 days postvaccination, each vaccinate and control shall be challenged by injecting virulent virus furnished or approved by Animal and Plant Health Inspection Service into one foot pad.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 14.0 day    | The vaccinates and controls shall be observed each day for 14 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 5.0 day     | If at least 19 of 20, 27 of 30, or 36 of 40 vaccinates do not remain free from these signs, disregarding transient swelling which subsides within 5 days postchallenge, the Master Seed is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1.0 day     | (i) Final container samples of completed product from each serial shall be safety tested as follows:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|             |               (A) For vaccines intended for use in very young chickens, each of 25 1-day-old tenosynovitis susceptible chickens shall be vaccinated with the equivalent of 10 doses by one method recommended on the label.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 4.0 week    | (B) For vaccines intended for use in older chickens, each of 25 4-week-old or older tenosynovitis susceptible chickens shall be vaccinated with the equivalent of 10 doses by one method recommended on the label.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 21.0 day    | (ii) The vaccinates shall be observed each day for 21 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 10.0 day    | Two mature guinea pigs shall be injected subcutaneously with 1 ml and observed for 10 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 30.0 day    | The guinea pigs shall be considered sensitized for testing not less than 30 days nor more than 120 days post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 120.0 day   | The guinea pigs shall be considered sensitized for testing not less than 30 days nor more than 120 days post-injection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 4.0 hour    | (2) The guinea pigs shall be prepared for sensitivity testing at least 4 hours prior to the injection of tuberculin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 10.0 minute | The entire abdominal and flank areas shall be clipped, a depilatory agent applied for 5-10 minutes, the area rinsed with warm water, and dried.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 24.0 hour   | (4) The sensitivity of the tuberculins shall be determined 24 hours after injected by measuring the area of erythema.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 90.0 minute | A 2.5 ml sample of completed antigen shall be diluted with 2.5 ml of buffer solution formulated in the same manner as the vehicle of the antigen being tested in a modified Hopkins tube and then sedimented at 1,000 &#215; g in a refrigerated centrifuge at 20 &#176;C for 90 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 35 day      | (3) Thirty-five days post-injection, the guinea pigs shall be used for tuberculin testing.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 4.0 hour    | (4) The sensitized animals and controls shall be prepared at least 4 hours prior to injection of PPD tuberculin by clipping the hair from the entire abdominal and flank areas, applying a depilatory agent for 5 to 10 minutes, then rinsing with warm water and drying.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 10.0 minute | (4) The sensitized animals and controls shall be prepared at least 4 hours prior to injection of PPD tuberculin by clipping the hair from the entire abdominal and flank areas, applying a depilatory agent for 5 to 10 minutes, then rinsing with warm water and drying.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 24.0 hour   | Measure the area of erythema produced at each site on each guinea pig 24 hours following injection of PPD tuberculin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 11.0 second | When a bioassay is valid and reactions are not observed in unsensitized guinea pigs, the following interpretation of the specificity index will be used for classifying each serial of PPD tuberculin:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|             |               (11) Second stage test.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 30.0 day    | Nonreactors to the supplemental tests shall be retested after 30 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 30.0 day    | Nonreactors to the supplemental tests shall be retested after 30 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 28.0 day    | Production shall not be renewed until a negative herd test is obtained not less than 28 days following removal of the positive animal(s).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 60.0 minute | (1) Blood derivatives of equine origin shall be heated at 58.0-59.0 &#176;C for 60 minutes, and blood derivatives of bovine, porcine, or other origin shall be heated at 58.0-59.0 &#176;C for 30 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 30.0 minute | (1) Blood derivatives of equine origin shall be heated at 58.0-59.0 &#176;C for 60 minutes, and blood derivatives of bovine, porcine, or other origin shall be heated at 58.0-59.0 &#176;C for 30 minutes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 15.0 second | (2) Lacteal secretions shall be heated as described in paragraph (e)(1) of this section, or shall be pasteurized at either 72 &#176;C for 15 seconds or 89 &#176;C for 1 second using appropriate equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 1.0 second  | (2) Lacteal secretions shall be heated as described in paragraph (e)(1) of this section, or shall be pasteurized at either 72 &#176;C for 15 seconds or 89 &#176;C for 1 second using appropriate equipment.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 30.0 minute | (3) Egg material shall be heated at 58.0-59.0 &#176;C for 30 minutes, or treated with at least 2.5 megarads of ionizing radiation, with a maximum radiation dosage specified in the filed Outline of Production for the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | The plate shall then be incubated at 35 &#176;C for 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | If characteristic growth is observed on any of the retest plates, or if a retest is not initiated within 21 days of the completion of the original test, the serial or subserial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 24.0 hour   | The plate shall then be incubated at 35 &#176;C for 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | If characteristic growth is observed on any of the retest plates, or if a retest is not initiated within 21 days of the completion of the original test, the serial or subserial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 5.0 day     | The plate shall then be incubated at 20-25 &#176;C for 5 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 21.0 day    | If growth is observed on any of the retest plates, or if a retest is not initiated within 21 days of the completion of the original test, the serial or subserial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 48.0 hour   | The plate shall then be incubated at 35 &#176;C for 48 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 21.0 day    | If the average number of bacterial colonies on the retest plates exceeds that specified in the filed Outline of Production for the product, or if a retest is not initiated within 21 days of the completion of the original test, the serial or subserial is unsatisfactory.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 3.0 year    | (2) The expiration date of Tetanus Antitoxin shall be not more than 3 years after the date of a potency test which demonstrates that the recoverable antitoxin from the final container provides at least 20 percent excess over the number of units claimed on the label or not more than 1 year after the date of a potency test which demonstrates that the recoverable antitoxin from the final container provides 10 to 19 percent excess over the number of units claimed on the label.                                                                                                                                                                                                                                                                                                                                                                         |
| 1.0 year    | (2) The expiration date of Tetanus Antitoxin shall be not more than 3 years after the date of a potency test which demonstrates that the recoverable antitoxin from the final container provides at least 20 percent excess over the number of units claimed on the label or not more than 1 year after the date of a potency test which demonstrates that the recoverable antitoxin from the final container provides 10 to 19 percent excess over the number of units claimed on the label.                                                                                                                                                                                                                                                                                                                                                                         |
| 30.0 minute | The dilution shall be held at 20&#176; to 25 &#176;C for 30 minutes prior to combination with a test does of toxin.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 1.0 hour    | (2) The Standard Toxin test dose is that amount which when mixed with 0.1 unit of Standard Antitoxin, incubated at 20&#176; to 25 &#176;C for 1 hour, and injected subcutaneously into a 340 to 380 gram guinea pig, results in death of that guinea pig within 60 to 120 hours with clinical signs of tetanus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 120.0 hour  | (2) The Standard Toxin test dose is that amount which when mixed with 0.1 unit of Standard Antitoxin, incubated at 20&#176; to 25 &#176;C for 1 hour, and injected subcutaneously into a 340 to 380 gram guinea pig, results in death of that guinea pig within 60 to 120 hours with clinical signs of tetanus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 1.0 hour    | This Standard Toxin-Antitoxin mixture shall be held at 20&#176; to 25 &#176;C for 1 hour before injections of guinea pigs are made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 1.0 year    | When testing is done on bulk material, the final container fill shall reflect the endpoint value plus 10 percent overage for 1 year dating and 20 percent overage for 3 year dating.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 3.0 year    | When testing is done on bulk material, the final container fill shall reflect the endpoint value plus 10 percent overage for 1 year dating and 20 percent overage for 3 year dating.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 24.0 hour   | For a satisfactory test, the controls must reach this point with clinical signs of tetanus within 24 hours of each other and within an overall time of 60 to 120 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 120.0 hour  | For a satisfactory test, the controls must reach this point with clinical signs of tetanus within 24 hours of each other and within an overall time of 60 to 120 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 24 hour     | Twenty-four hours postinjection, the injected mice and 10 additional mice designated controls shall be challenged subcutaneously with the same culture of Erysipelothrix rhusiopathiae.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 7.0 day     | (2) If less than eight of the 10 controls die from erysipelas within 7 days post-challenge, the test is invalid.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 10.0 day    | (3) The mice injected with product shall be observed for 10 days postchallenge and all deaths recorded.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 25.0 minute | Such solution shall be made by dissolving 1 gram of peptone and 0.25 gram of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 250 &#176;F. for 25 minutes; and storing at 4 &#176;C. until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 24.0 hour   | Conclude the test 24 hours post-injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 25.0 minute | Such solution shall be made by dissolving 1 gram of peptone and 0.25 gram of sodium chloride in each 100 ml of distilled water; adjusting the pH to 7.2; autoclaving at 250 &#176;F. for 25 minutes; and storing at 4 &#176;C. until used.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 1.0 hour    | (v) Neutralize all toxin-antitoxin mixtures at room temperature for 1 hour, and hold in ice water until injections of mice can be made.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 24.0 hour   | Conclude the test 24 hours post-injection and record all deaths.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 24.0 hour   | A product for oral administration shall not be recommended for use in animals more than 24 hours of age, while one for parenteral administration shall only be recommended for use in neonatal animals.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 24.0 hour   | (3) Each animal shall be administered one dose of reference by the recommended route and shall be observed for 24 hours.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 24.0 hour   | (4) After 24 hours, blood samples shall be taken from each animal.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |


## Condition

| Condition     | Context                                                                                                                               |
|:--------------|:--------------------------------------------------------------------------------------------------------------------------------------|
| when          | To better ensure consistent and reproducible test results  when Standard Requirement tests prescribed in the regulations are          |
| when          | To better ensure consistent and reproducible test results  when Standard Requirement tests prescribed in the regulations are          |
| where         | Requirements and in each filed Outline of Production where such test is conducted to support a request                                |
| if            | Each sample shall be marked for ident if ication by the person making the selection after                                             |
| when          | Bulk containers of completed product may be sampled  when  authorized by the Administrator.                                           |
| if            | in final containers and shall be randomly selected if  desiccated in the final container.                                             |
| when          | be stated in the filed Outline of Production. when                                                                                    |
| unless        | each serial and subserial shall be: (1) Vaccines: unless                                                                              |
| if            | sample of product, other than Marek's Disease Vaccine, if such diluent is required to rehydrate or dilute                             |
| unless        | all applicable Standard Requirements shall be complied with unless otherwise exempted by the Administrator and provided that          |
| provided that | with unless otherwise exempted by the Administrator and provided that such exemption is noted in the filed Outline                    |
| when          | A critical period shall be the time  when certain specified reactions must occur in required tests                                    |
| when          | as final, and the test may be repeated. when                                                                                          |
| when          | methods, and if not found to be satisfactory when  so tested shall not be released.                                                   |
| if not        | thereafter shall be evaluated by such methods, and if not found to be satisfactory when so tested shall                               |
| when          | methods, and if not found to be satisfactory when  so tested shall not be released.                                                   |
| when          | shall with reasonable certainty yield the results intended when used as recommended or suggested in its labeling                      |
| until         | permittee shall withhold such product from the market until  a determination has been made.                                           |
| when          | be evaluated by tests applicable to each fraction. when                                                                               |
| when          | must be used to evaluate each fraction except when written Standard Requirements or outlines of production make                       |
| when          | must be used to evaluate each fraction except when written Standard Requirements or outlines of production make                       |
| when          | results from one test of the completed product. when                                                                                  |
| when          | test requirements prescribed in &#167;&#8201;113.100 are complied with. when                                                          |
| when          | from a required animal potency test for release when an evaluation can, with reasonable certainty, be made                            |
| if            | serial or subserial is satisfactory without additional testing. if                                                                    |
| if            | be retested, using double the number of samples. if                                                                                   |
| if            | the following shall apply to live virus vaccines: if                                                                                  |
| if            | (i) If the d if ference between the average titer obtained in the                                                                     |
| if            | (ii) If the d if ference between the average titer obtained in the                                                                    |
| if            | serial or subserial considered satisfactory for bacterial count. if                                                                   |
| if            | serial or subserial considered satisfactory for bacterial count. if                                                                   |
| if            | determined using the counts obtained in all tests. if                                                                                 |
| unless        | Production to be in compliance with this requirement unless granted an extension by the Administrator based on                        |
| if            | potency, the serial is satisfactory without additional testing. if                                                                    |
| if            | and 4) with disposition to be as spec if ied in paragraphs (c)(4)(i) and (ii) of this                                                 |
| if            | and 4) with disposition to be as spec if ied in paragraphs (c)(4)(i) and (ii) of this                                                 |
| if            | and 3 (tests 3 and 4) as follows: if either retest (test 3 or 4) shows that                                                           |
| if            | and 3 (tests 3 and 4) as follows: if either retest (test 3 or 4) shows that                                                           |
| subject to    | potency test may be repeated by the firm, subject to the provisions specified in paragraphs (i) and (ii)                              |
| if            | 2, 3, and 4) with disposition as spec if ied in paragraphs (c)(5) (i) and (ii) of                                                     |
| if            | 2, 3, and 4) with disposition as spec if ied in paragraphs (c)(5) (i) and (ii) of                                                     |
| if            | the required minimum potency, the serial is satisfactory. if                                                                          |
| if            | a third retest (test 4) may be performed. if                                                                                          |
| if            | If both retests (tests 2 and 3) or  if the third retest (test 4) is an equivocal                                                      |
| subject to    | potency test may be repeated by the firm, subject to the provisions specified in paragraphs (c)(4) (i) and                            |
| when          | monitoring the stability of the reference to determine when the potency starts to decline and for taking                              |
| if            | may be extended by data acceptable to APHIS if the minimum potency of the Master Reference is                                         |
| if            | percent of the controls do not show spec if ic responses to challenge, the test is inconclusive                                       |
| when          | Health Inspection Service or the licensee or both. when                                                                               |
| if            | product is made and the problem is resolved. if                                                                                       |
| until         | information by Animal and Plant Health Inspection Service until at least two additional product licenses are issued                   |
| unless        | product licenses are issued for the product or unless use of the test is authorized by the                                            |
| until         | of Production and the test shall be conducted. until                                                                                  |
| when          | product is specifically exempted as provided in &#167;&#8201;113.4. when                                                              |
| unless        | the Standard Requirement, such test shall be conducted unless the product is specifically exempted as provided in                     |
| when          | they may be made from dehydrated mixtures which, when rehydrated with purified water, have the same or                                |
| unless        | shall be tested as prescribed in this section unless  otherwise specified by the Administrator.                                       |
| when          | Thioglycollate Medium without beef extract shall be substituted when  testing biological products containing mercurial preservatives. |
| when          | each serial and each subserial shall be tested. when                                                                                  |
| if            | individual test vessel of culture medium: Provided, That, if each final container sample contains less than 2                         |
| when          | test sample from each lot shall be tested. when                                                                                       |
| if            | third to seventh day for other biological products. if                                                                                |
| if            | or subserial meets the requirements of the test. if                                                                                   |
| if            | be conducted using 20 unopened final container samples. if                                                                            |
| if            | product, as the case may be, is unsatisfactory. if                                                                                    |
| if            | Additional medium shall be used  if the determination required in &#167;&#8201;113.25(d) indicates the need                           |
| if            | Additional medium shall be used  if the determination required in &#167;&#8201;113.25(d) indicates the need                           |
| if            | be conducted using 20 unopened final container samples. if                                                                            |
| if            | or subserial meets the requirements of the test. if                                                                                   |
| if            | a retest, the serial or subserial is unsatisfactory. if                                                                               |
| if            | Additional medium shall be used  if the determination required in &#167;&#8201;113.25(d) indicates the need                           |
| if            | Additional medium shall be used  if the determination required in &#167;&#8201;113.25(d) indicates the need                           |
| if            | be conducted using 20 unopened final container samples. if                                                                            |
| if            | or subserial meets the requirements of the test. if                                                                                   |
| if            | a retest, the serial or subserial is unsatisfactory. if                                                                               |
| if            | using a new sample of Master Seed Virus. if                                                                                           |
| if            | the lot of Master Seed Virus is unsatisfactory. if                                                                                    |
| if            | using a new sample of Master Seed Bacteria. if                                                                                        |
| if            | the lot of Master Seed Bacteria is unsatisfactory. if                                                                                 |
| if            | be inoculated with vaccine equal to 10 doses if the vaccine is recommended for poultry or 1                                           |
| if            | be inoculated with vaccine equal to 10 doses if the vaccine is recommended for poultry or 1                                           |
| if            | may be conducted using 20 unopened final containers. if                                                                               |
| if            | other animals, the serial or subserial is unsatisfactory. if                                                                          |
| when          | agar, provided in this section shall be conducted when a test for mycoplasma contamination is prescribed in                           |
| until         | ml aliquots into 125 ml flasks and store until  needed.                                                                               |
| when          | procedure provided in this paragraph shall be followed when  conducting the mycoplasma detection test.                                |
| if            | the negative control test, the test is valid. if                                                                                      |
| if            | tested, the results are positive for mycoplasma contamination. if                                                                     |
| when          | Methods provided in this section must be used  when a determination of moisture content in desiccated biological                      |
| until         | the moisture content in desiccated biological products have until November 5, 2004 to update their Outlines of                        |
| until         | at room temperature in their original airtight containers until  use.                                                                 |
| until         | allow dry air to bleed into the oven until the pressure inside the oven is equalized with                                             |
| if            | (7) The results are considered satisfactory  if the percentage of residual moisture is less than                                      |
| when          | contamination provided in this section shall be conducted when such a test is prescribed in an applicable                             |
| if            | incubated an additional 18-24 hours and again examined. if                                                                            |
| if            | suitable media shall be made for positive ident if ication.                                                                           |
| if            | viral product shall be exempt from this requirement if the licensee can demonstrate to Animal and Plant                               |
| if            | (a) Propagation of contaminating lymphoid leukosis viruses,  if present, shall be done in chick embryo cell                           |
| when          | production cell cultures shall be used as inoculum. when                                                                              |
| when          | They shall be passed  when necessary to maintain viability and samples harvested from                                                 |
| until         | shall be stored at &#8722;60 &#176;C or colder until  used in the test.                                                               |
| unless        | anticomplementary activity, shall be considered a positive test unless the activity can definitely be established to be               |
| when          | contamination provided in this section shall be conducted when such a test is prescribed in an applicable                             |
| if            | (b) If colonies are ident if ied as Brucella, the biological product is unsatisfactory.                                               |
| if            | of Brucella are observed but cannot be ident if ied as a Brucella species, either (1) The                                             |
| until         | subculture or other procedures shall be carried out until  a positive identification can be made.                                     |
| when          | tests provided in this section shall be conducted when such test is prescribed in a Standard Requirement                              |
| if            | recommended for animals other than poultry: Provided, That if the inherent nature of one or more ingredients                          |
| if            | observation period, the serial or subserial is unsatisfactory. if                                                                     |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial or                                               |
| unless        | mice and the animals observed for 7 days. unless                                                                                      |
| if            | observation period, the serial or subserial is unsatisfactory. if                                                                     |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial or                                               |
| when          | viruses provided in this section shall be conducted when such a test is prescribed in an applicable                                   |
| if            | fluids from each of the original test eggs. if                                                                                        |
| if            | the product is observed, the serial is unsatisfactory. if                                                                             |
| when          | activity provided in this section shall be conducted when such a test is prescribed in an applicable                                  |
| if            | (3) Neutralize to remove other fractions,  if  necessary.                                                                             |
| when          | The holding period shall begin  when  rehydration is completed.                                                                       |
| if            | of the vaccine virus(es) rehydrated with sterile pur if ied water, the product is unsatisfactory for use                              |
| if            | judged by the results of the second test. if                                                                                          |
| if            | not prohibited from release as separate licensed products if  labeled as prescribed in &#167;&#8201;112.7(g).                         |
| when          | pathogens provided in this section shall be conducted when such a test is prescribed in an applicable                                 |
| if            | vaccinates, the serial or subserial tested is unsatisfactory. if                                                                      |
| if            | If the controls do not remain healthy or  if unfavorable reactions not attributable to the product occur                              |
| if            | If the controls do not remain healthy or  if unfavorable reactions not attributable to the product occur                              |
| when          | pathogens provided in this section shall be conducted when such a test is prescribed in an applicable                                 |
| if            | inoculum occur, the serial is unsatisfactory: Provided, That, if there is a vaccine virus override, the test                          |
| if            | inoculum occur, the serial is unsatisfactory: Provided, That, if there is a vaccine virus override, the test                          |
| when          | test provided in this section shall be conducted when prescribed in a Standard Requirement or approved Outline                        |
| unless        | pigs and the animals observed for 7 days. unless                                                                                      |
| if            | observation period, the serial or subserial is unsatisfactory. if                                                                     |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial or                                               |
| when          | tests provided in this section shall be conducted when prescribed in a standard requirement or in the                                 |
| when          | test provided in this paragraph shall be used when  the Master Seed Virus is tested for safety.                                       |
| if            | (ii) The cats shall be considered susceptible  if swabs are negative for virus isolation and the                                      |
| when          | and Plant Health Inspection Service shall be used. when                                                                               |
| if            | observation period, the Master Seed Virus is unsatisfactory. if                                                                       |
| if not        | declared a No Test and repeated: Provided, That, if not  repeated, the Master Seed Virus shall be unsatisfactory.                     |
| when          | test provided in this paragraph shall be used when a serial of vaccine is tested for safety                                           |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if not        | declared a No Test and repeated: Provided, That, if not  repeated, the serial shall be unsatisfactory.                                |
| when          | tests provided in this section shall be conducted when prescribed in a Standard Requirement or in the                                 |
| when          | Serials which are not found to be satisfactory  when tested pursuant to the procedures in this section                                |
| when          | test provided in this paragraph shall be used when  the Master Seed Virus is tested for safety.                                       |
| if            | observation period, the Master Seed Virus is unsatisfactory. if                                                                       |
| if            | No Test and may be repeated: Provided: That, if the test is not repeated, the Master Seed                                             |
| when          | test provided in this paragraph shall be used when a serial of vaccine is tested for safety                                           |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial shall                                            |
| when          | test provided in this section shall be conducted when prescribed in a Standard Requirement or in the                                  |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial or                                               |
| when          | virus provided in this section shall be conducted when such a test is prescribed in an applicable                                     |
| when          | Vaccine virus may be neutralized with specific antiserum  when  necessary.                                                            |
| if            | mice show swelling in the injected footpad or if more than one becomes systemically abnormal, the material                            |
| if            | mice show swelling in the injected footpad or if more than one becomes systemically abnormal, the material                            |
| when          | agents provided in this section shall be conducted when such a test is prescribed in an applicable                                    |
| if            | hours of injection shall be disregarded, except that if more than three such deaths occur at any                                      |
| if            | embryos shall be subcultured into 10 additional embryos. if                                                                           |
| when          | test provided in this section shall be conducted when prescribed in a Standard Requirement or in the                                  |
| if            | No Test and may be repeated; Provided, That, if the test is not repeated, the serial or                                               |
| when          | test provided in this section shall be conducted when prescribed in a Standard Requirement or in the                                  |
| if            | No Test and may be repeated; Provided, That, if the test is not repeated, the serial or                                               |
| when          | agents provided in this section shall be conducted when prescribed in an applicable Standard Requirement or in                        |
| if            | phosphate buffered saline, and examine again for hemadsorption. if                                                                    |
| if            | (c) If spec if ic cytopathology or hemadsorption attributable to an extraneous                                                        |
| when          | technique provided in this section shall be conducted when prescribed in an applicable Standard Requirement or in                     |
| if            | they are grown) before 7 days after subculturing if fluorescence is enhanced by doing so, Provided, That                              |
| if            | material under test shows any evidence of spec if ic viral fluorescence, it is unsatisfactory and may                                 |
| if            | material under test shows any evidence of spec if ic viral fluorescence, it is unsatisfactory and may                                 |
| if            | fluorescence of the monolayers inoculated with the spec if ic virus as positive controls is equivocal, or                             |
| if            | fluorescence of the monolayers inoculated with the spec if ic virus as positive controls is equivocal, or                             |
| if            | fluorescence of the monolayers inoculated with the spec if ic virus as positive controls is equivocal, or                             |
| when          | the minimum acceptable potency within the dating period when  stored at the recommended temperature.                                  |
| if            | serial of biological product shall not be released if produced from primary cells that are found unsatisfactory                       |
| if            | serial of biological product shall not be released if produced from a cell line that is found                                         |
| if            | (3) If spec if ic fluorescence is not found in the monolayers                                                                         |
| if            | (4) If nonspec if ic fluorescence is found in the monolayers stained                                                                  |
| until         | test results equivocal, the procedure shall be repeated until either specific fluorescence is found only in the                       |
| if            | of origin of the MCS may be used if  approved by APHIS.                                                                               |
| if            | the same species of origin as the MCS if  d                                                                                           |
| if            | the same species of origin as the MCS if  d                                                                                           |
| if not        | cells, or a cell line of bovine origin if not specified in paragraphs (f)(1)(ii), and (iii) of this                                   |
| if            | for tumorigenicity/oncogenicity by a method acceptable to APHIS. if                                                                   |
| if            | serial of biological product shall not be released if produced using an ingredient that is found unsatisfactory                       |
| when          | Cell lines used shall have been found satisfactory  when tested as prescribed in &#167;&#8201;113.52 and primary cells                |
| when          | Cell lines used shall have been found satisfactory  when tested as prescribed in &#167;&#8201;113.52 and primary cells                |
| when          | shall also be used in the growth medium when  monolayers are subcultured.                                                             |
| when          | If the ingredient being tested is cytotoxic  when tested in this manner, other procedures may be                                      |
| if            | in this manner, other procedures may be used if  approved by APHIS.                                                                   |
| when          | supplied in a final container by the licensee when such diluent is required for rehydration or dilution                               |
| if            | serial of biological product shall not be released if produced from a MSV that is found unsatisfactory                                |
| if            | in which the MSV is presently being propagated if  d                                                                                  |
| when          | Cell lines used shall have been found satisfactory  when tested as prescribed in &#167;&#8201;113.52 and primary cells                |
| when          | Cell lines used shall have been found satisfactory  when tested as prescribed in &#167;&#8201;113.52 and primary cells                |
| if            | undesirable colonies, the serial or subserial is unsatisfactory. if                                                                   |
| if            | using double the number of samples: Provided, That, if the test is not repeated, the serial or                                        |
| if            | per dose, the serial or subserial is unsatisfactory. if                                                                               |
| if            | one time using four additional final container vials. if                                                                              |
| if            | error and the serial or subserial is satisfactory. if                                                                                 |
| if            | determined from the counts of all six vials. if                                                                                       |
| if            | at least 3.0 billion viable organisms per dose. if                                                                                    |
| if            | per milliliter, the serial or subserial is unsatisfactory. if                                                                         |
| if            | may be retested one time using four samples. if                                                                                       |
| if            | per milliliter, the serial or subserial is unsatisfactory. if                                                                         |
| if            | the test is invalid and may be repeated. if                                                                                           |
| if            | postchallenge observation period, the Master Seed is unsatisfactory. if                                                               |
| when          | used in the immunogenicity test to assure that when tested at any time within the expiration period,                                  |
| if            | for high body temperature shall be considered susceptible if  sacr                                                                    |
| if            | for high body temperature shall be considered susceptible if  sacr                                                                    |
| when          | used in the immunogenicity test to assure that, when tested at any time within the expiration period,                                 |
| when          | used in the immunogenicity test to assure that, when tested at any time within the expiration period,                                 |
| when          | test count per dose established to assure that, when tested at any time within the expiration period,                                 |
| if            | of the test birds, the serial is unsatisfactory. if                                                                                   |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | of the next test are not satisfactory, or if the test is not repeated, the serial shall                                               |
| when          | test count per dose established to assure that, when tested at any time within the expiration period,                                 |
| if            | The cats shall be considered suitable for use  if all serums are negative for pneumonitis antibody in                                 |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | (ii) If a sign if icant d                                                                                                             |
| when          | paragraph (b) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | Production to be in compliance with this requirement. if                                                                              |
| until         | content other than the ferric chloride test have until July 14, 2004 to update their Outline of                                       |
| if            | in a manner identical to the first stage. if                                                                                          |
| if            | according to the second part of the table. if                                                                                         |
| if            | first stage, the second stage shall be used. if                                                                                       |
| if            | according to the second part of the table. if                                                                                         |
| if            | first stage, the second stage shall be used. if                                                                                       |
| if            | according to the second part of the table. if                                                                                         |
| if            | in a manner identical to the first stage. if                                                                                          |
| if            | according to the second part of the table. if                                                                                         |
| when          | test, the following words and terms shall mean: when                                                                                  |
| until         | for 25 minutes; and storing at 4 &#176;C until  used.                                                                                 |
| if            | Provided, That,  if the product is recommended only for sheep, half                                                                   |
| if            | is invalid and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                       |
| if            | is invalid and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                       |
| until         | for 1 hour and hold in ice water until  injections of mice can be made.                                                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | contain less than 0.50 International Units per ml. if                                                                                 |
| if            | International Unit per ml, the serial is unsatisfactory. if                                                                           |
| when          | and terms shall mean: (i) International antitoxin unit. when                                                                          |
| until         | for 25 minutes; and storing at 4 &#176;C until  used.                                                                                 |
| if            | half of the recommended cattle dose: Provided, That, if the product is recommended only for sheep, half                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| until         | for 1 hour and hold in ice water until  injections of mice can be made.                                                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | contain less than 1.0 International Units per ml. if                                                                                  |
| if            | International Unit per ml, the serial is unsatisfactory. if                                                                           |
| when          | and terms shall mean: (i) International antitoxin unit. when                                                                          |
| until         | for 25 minutes; and storing at 4 &#176;C until  used.                                                                                 |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| until         | for 1 hour and hold in ice water until  injections of mice can be made.                                                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | contain less than 10 International Units per ml. if                                                                                   |
| when          | and terms shall mean: (i) International antitoxin unit. when                                                                          |
| until         | for 25 minutes; and storing at 4 &#176;C until  used.                                                                                 |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| until         | for 1 hour and hold in ice water until  injections of mice can be made.                                                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | Units per ml, and the serial is unsatisfactory. if                                                                                    |
| if            | appropriate expertise in specialized situations such as aquaculture, if  approved by the Administrator.                               |
| if            | shall meet the requirements in this section, and if found unsatisfactory by any prescribed test shall not                             |
| when          | in herds adjacent to the herd of origin, when  adjacent herds are considered to be at risk.                                           |
| when          | the recipient herd involved may not be known when autogenous biologics are to be used in other                                        |
| subject to    | each serial of an autogenous biologic shall be subject to the following restrictions: (1) Microorganisms used to prepare              |
| when          | vessels of each of the test media required. when                                                                                      |
| if            | of third day observations shall be immediately recalled if  evidence of contamination occurs in test cultures or                      |
| if            | of third day observations shall be immediately recalled if  evidence of contamination occurs in test cultures or                      |
| if            | in accordance with paragraph (c)(2)(iv)(A) of this section. if                                                                        |
| if            | the serum pool is at least 2.0 A.U. if                                                                                                |
| if            | be retested by the following procedure: Provided, That, if the serial is not retested, it shall be                                    |
| if            | (2) The sample of serum from each rabbit,  if the five rabbit individual test is conducted or                                         |
| if            | (2) The sample of serum from each rabbit,  if the five rabbit individual test is conducted or                                         |
| when          | &#8220;Lh&#8221; dose is the amount of toxin which when mixed with one unit of standard antitoxin produces                            |
| if            | antitoxin units per ml, the serial is unsatisfactory. if                                                                              |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if the validity requirement is not met, but the                                                      |
| if            | is a No Test and may be repeated if the validity requirement is not met, but the                                                      |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if the validity requirements are not met, but the                                                    |
| if            | is a No Test and may be repeated if the validity requirements are not met, but the                                                    |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if unfavorable reactions that are not attributable to the                                            |
| if            | is a No Test and may be repeated if the validity requirements are not met, but the                                                    |
| if            | is a No Test and may be repeated if the validity requirements are not met, but the                                                    |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | However, the second stage may be conducted  if seven or eight vaccinates die in stage one,                                            |
| if            | than 0.6, the serial being tested is unsatisfactory. if                                                                               |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | protection, the Unknown is satisfactory without additional testing. if                                                                |
| if            | in a manner identical to the initial test. if                                                                                         |
| if            | error and the serial is satisfactory for potency. if                                                                                  |
| if            | using the RP values obtained in all tests. if                                                                                         |
| if            | than 0.30, the serial being tested is unsatisfactory. if                                                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | protection, the Unknown is satisfactory without additional testing. if                                                                |
| if            | in a manner identical to the initial test. if                                                                                         |
| if            | test system error and the serial is satisfactory. if                                                                                  |
| if            | using the RP values obtained in all tests. if                                                                                         |
| if            | than 0.50, the serial being tested is unsatisfactory. if                                                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test: Provided, That, if  the Unknown is not retested or                                              |
| if            | protection, the Unknown is satisfactory without additional testing. if                                                                |
| if            | in a manner identical to the initial test. if                                                                                         |
| if            | test system error and the serial is satisfactory. if                                                                                  |
| if            | using the RP values obtained in all tests. if                                                                                         |
| if            | than 0.50, the serial being tested is unsatisfactory. if                                                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | protection, the Unknown is satisfactory without additional testing. if                                                                |
| if            | in a manner identical to the initial test. if                                                                                         |
| if            | test system error and the serial is satisfactory. if                                                                                  |
| if            | using the RP values obtained in all tests. if                                                                                         |
| if            | than 0.30, the serial being tested is unsatisfactory. if                                                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | manner identical to the initial test; Provided, That, if  the Unknown is not retested or                                              |
| if            | protection, the Unknown is satisfactory without additional testing. if                                                                |
| if            | in a manner identical to the initial test. if                                                                                         |
| if            | test system error and the serial is satisfactory. if                                                                                  |
| if            | using the RP values obtained in all tests. if                                                                                         |
| until         | content other than the ferric chloride test have until July 14, 2004 to update their Outline of                                       |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial is                                               |
| if            | A serial is satisfactory  if at least 80 percent of the vaccinates remain                                                             |
| if            | No Test and may be repeated: Provided, That, if at least 80 percent of the vaccinates do                                              |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial shall                                            |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial is                                               |
| if            | that fraction and may be repeated: Provided, That, if four or more of the vaccinate serum samples                                     |
| if            | that fraction and may be repeated: Provided, That, if four or more of the vaccinate serum samples                                     |
| if            | be used for the relevant fraction(s): Provided, That, if a fraction is found acceptable by the first                                  |
| if            | be used for the relevant fraction(s): Provided, That, if a fraction is found acceptable by the first                                  |
| if            | type fraction, the serial or subserial is unsatisfactory. if                                                                          |
| if            | be conducted using susceptible chicken embryos: Provided, That, if a non-embryo adapted virus is used for vaccine                     |
| if            | considered a No Test and repeated: Provided, That, if the test is not repeated, the serial shall                                      |
| if            | No Test and may be repeated: Provided, That, if the test is not repeated, the serial shall                                            |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | do not remain normal, the serial is unsatisfactory. if                                                                                |
| as soon as    | (1) The preinactivation virus titer must be established  as soon as possible after harvest by at least five separate                  |
| when          | paragraph (b)(3)(iv) of this section may be used when the test animals are of species other than                                      |
| if            | of this section for the 1 year test. if                                                                                               |
| unless        | rabies virus is confirmed, the serial is unsatisfactory unless  reprocessed in accordance with &#167;&#8201;114.18.                   |
| if            | The cats shall be considered suitable for use  if all swabs are negative for virus isolation and                                      |
| if            | the test is inconclusive and may be repeated. if                                                                                      |
| if            | (v) If a sign if icant d                                                                                                              |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| when          | The test shall establish that the vaccine,  when used as recommended on the label, is capable                                         |
| if            | in a manner identical to the first stage. if                                                                                          |
| if            | the table on the basis of cumulative results. if                                                                                      |
| if            | of the second test are not satisfactory, or if the test is not repeated, the serial is                                                |
| if            | Calves shall be considered susceptible  if there is no neutralization at 1:2 final serum                                              |
| if            | of the second test are not satisfactory, or if the test is not repeated, the serial is                                                |
| if            | Calves shall be considered susceptible  if there is no neutralization at 1:2 final serum                                              |
| if            | 104.0 &#176;F for 2 or more days or if more than one of the vaccinates develops respiratory                                           |
| unless        | test prescribed in &#167;&#8201;113.33(a) shall also be conducted unless the virus or agent in the vaccine is                         |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | may be characterized as a typical immune reaction. if                                                                                 |
| if            | The mink shall be considered susceptible  if the results are negative at a 1:2 final                                                  |
| if            | Other means of insuring susceptibility may be used  if prior approval from Animal and Plant Health Inspection                         |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | observation period, the Master Seed Virus is unsatisfactory. if                                                                       |
| if            | No Test and may be repeated: Provided, That if the test is not repeated, the serial or                                                |
| when          | paragraph (c) of this section to assure that, when tested at any time within the expiration period,                                   |
| when          | paragraph (c) of this section to assure that, when tested at any time within the expiration period,                                   |
| if            | A lamb shall be considered susceptible  if there is no neutralization at a 1:2 final                                                  |
| if            | considered a No Test and may be repeated. if                                                                                          |
| if            | of 1:4 final serum dilution or higher, or if more than one of the vaccinates shows a                                                  |
| if            | of 1:4 final serum dilution or higher, or if more than one of the vaccinates shows a                                                  |
| if            | of 1:4 final serum dilution or higher, or if more than one of the vaccinates shows a                                                  |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | (ii) Cats shall be considered susceptible  if there is no neutralization at a 1:2 final                                               |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | this section, the Master Seed Virus is unsatisfactory. if                                                                             |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if not        | declared a No Test and repeated: Provided, That, if not  repeated, the serial shall be unsatisfactory.                                |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | The dogs shall be considered susceptible  if the results are negative at a 1:2 final                                                  |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | observation period, the Master Seed Virus is unsatisfactory. if                                                                       |
| if            | The dogs shall be considered susceptible  if the results are negative at a 1:2 final                                                  |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | (B) If a sign if icant d                                                                                                              |
| when          | paragraph (b) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | The dogs shall be considered susceptible  if the results are negative at a 1:2 final                                                  |
| if            | five controls do not die and the survivor, if any, does not show clinical signs of canine                                             |
| if            | five controls do not die and the survivor, if any, does not show clinical signs of canine                                             |
| if            | observation period, the Master Seed Virus is unsatisfactory. if                                                                       |
| when          | paragraph (b) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | Horses shall be considered susceptible  if there is no neutralization at a 1:2 final                                                  |
| if            | In a valid test,  if at least 19 of 20 vaccinates do not                                                                              |
| when          | paragraph (b) of this section to assure that, when tested at any time within the expiration period,                                   |
| subject to    | (ii) Alternates shall be  subject to all requirements outlined for the animals for which                                              |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | The calves shall be considered susceptible  if the results are negative at a 1:2 final                                                |
| if            | considered a No Test and may be repeated. if                                                                                          |
| if            | tubes of the 1:2 final serum dilution, or if more than one of the vaccinates show a                                                   |
| if            | tubes of the 1:2 final serum dilution, or if more than one of the vaccinates show a                                                   |
| if            | tubes of the 1:2 final serum dilution, or if more than one of the vaccinates show a                                                   |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | considered susceptible to bovine virus diarrhea virus infection if the results are negative at a 1:2 final                            |
| if            | in all tubes of the 1:8 dilution; or if more than one of the vaccinates exhibits respiratory                                          |
| if            | in all tubes of the 1:8 dilution; or if more than one of the vaccinates exhibits respiratory                                          |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| until         | (iii) Observe all animals for signs of rabies  until  scheduled time to sacrifice.                                                    |
| until         | Tissues may be held frozen at &#8722;70 &#176;C.  until  suckling mice are available.                                                 |
| if            | If any mice die, determine  if the deaths were due to rabies virus in                                                                 |
| if            | any animals show clinical signs of rabies, sacr if ice the animal and check appropriate brain tissue                                  |
| if            | the lot of Master Seed Virus is unsatisfactory. if                                                                                    |
| when          | paragraph (b)(3)(iv) of this section may be used when the test animals are of species other than                                      |
| if            | of this section for the 1 year test. if                                                                                               |
| if            | tested for LCM virus as prescribed in &#167;&#8201;113.42. if                                                                         |
| when          | paragraph (b) of this section to assure that, when tested at any time within the expiration period,                                   |
| when          | 16 grams, shall be used as test animals when the virus in vaccine prepared with a low                                                 |
| when          | be observed each day for 14 days except when testing vaccines made with HCP SAD strain of                                             |
| when          | That, the lowest titer permitted at expiration date when determined by this test shall be 10&#8201;3.0 LD50                           |
| when          | or younger, shall be used as test animals when virus in vaccine prepared with a high egg                                              |
| when          | That, the lowest titer permitted at expiration date when determined by this test shall be 10&#8201;3.0 LD50                           |
| if            | The dogs shall be considered susceptible  if the results are negative at a 1:2 final                                                  |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | 8 postchallenge, the Master Seed Virus is unsatisfactory. if                                                                          |
| when          | used in lieu of the 20 dog requirement. when                                                                                          |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | The cats shall be considered suitable for use  if  all swabs are negative for virus isolation and                                     |
| if            | The cats shall be considered suitable for use  if  all swabs are negative for virus isolation and                                     |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | (ii) If a sign if icant d                                                                                                             |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | The cats shall be considered suitable for use  if  all swabs are negative for virus isolation and                                     |
| if            | The cats shall be considered suitable for use  if  all swabs are negative for virus isolation and                                     |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | (ii) If a sign if icant d                                                                                                             |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | Dogs shall be considered susceptible  if  all swabs are negative for virus isolation and                                              |
| if            | Dogs shall be considered susceptible  if  all swabs are negative for virus isolation and                                              |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | clinical signs of canine parainfluenza virus infection; or, if less than 19 of 20 vaccinates show serum                               |
| if            | clinical signs of canine parainfluenza virus infection; or, if less than 19 of 20 vaccinates show serum                               |
| if            | clinical signs of canine parainfluenza virus infection; or, if less than 19 of 20 vaccinates show serum                               |
| when          | significant reduction in virus isolation rate in vaccinates when  compared with controls, the Master Seed is unsatisfactory.          |
| when          | paragraph (b) of this section to assure that, when tested at any time within the expiration period,                                   |
| if            | Dogs shall be considered susceptible  if there is no neutralization at a 1:2 final                                                    |
| if            | of this section, the Master Seed is unsatisfactory. if                                                                                |
| when          | paragraph (c) of this section to assure that, when tested at any time within the expiration period,                                   |
| if            | Pigs shall be considered susceptible  if there is no neutralization at a 1:2 final                                                    |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | signs of pseudorabies, the Master Seed is unsatisfactory. if                                                                          |
| when          | paragraph (b) of this section to assure that, when tested at any time within the expiration period,                                   |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if            | declared a No Test and repeated, except that, if the test is not repeated, the serial shall                                           |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | Two-stage sequential testing may be conducted  if the first test (which then becomes stage one)                                       |
| if            | or, in lieu thereof, the serial declared unsatisfactory. if                                                                           |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | tube and swab shall be swirled thoroughly and if they are to be stored, be immediately frozen                                         |
| if            | shall be used in the evaluation, except that, if a swab is not represented by at least                                                |
| when          | tracheal swab shall be positive for virus recovery when any of the embryos in a valid test                                            |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | virus recovery, the Master Seed Virus is unsatisfactory. if                                                                           |
| if            | the requirements prescribed in this paragraph, except that, if the vaccine contains more than one virus type,                         |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | Two-stage sequential testing may be conducted  if the first test (which then becomes stage one)                                       |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | during the observation period, the virus is unsatisfactory. if                                                                        |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | Two-stage sequential testing may be conducted  if the first test (which then becomes stage one)                                       |
| if            | or in lieu thereof, the serial declared unsatisfactory. if                                                                            |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | is a No Test and may be repeated. if                                                                                                  |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | Two-stage sequential testing may be conducted  if the first test (which then becomes stage one)                                       |
| if            | declared a No Test and may be repeated. if                                                                                            |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | group 3 survive the 120 day period, or if any of the chickens in group 3 have                                                         |
| if            | and 4 survive the 120 day period; or if any of the chickens in groups 1 and                                                           |
| if            | and 4 survive the 120 day period; or if any of the chickens in groups 1 and                                                           |
| until         | (3) All chickens shall be observed  until 7 weeks of age, necropsied, and examined for                                                |
| if            | prescribed in &#167;&#8201;113.37 shall be conducted, except that, if the test is a No Test because of                                |
| if            | observation period, the test is a No Test. if                                                                                         |
| if            | attributable to the vaccine, the serial is unsatisfactory. if                                                                         |
| if            | test may be repeated one time, Provided, that if the test is not repeated, the serial shall                                           |
| if            | test may be repeated one time, Provided, that if the test is not repeated, the serial shall                                           |
| when          | but not less than 750 pfu per dose. when                                                                                              |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | bursal disease, the Master Seed Virus is unsatisfactory. if                                                                           |
| if            | the Master Seed Virus is unsatisfactory, except that, if any of the negative controls or less than                                    |
| if            | the Master Seed Virus is unsatisfactory, except that, if any of the negative controls or less than                                    |
| if            | the Master Seed Virus is unsatisfactory, except that, if any of the negative controls have such atrophy,                              |
| when          | approved by Animal and Plant Health Inspection Service. when                                                                          |
| if            | the Master Seed Virus is unsatisfactory, except that, if less than 90 percent of the controls have                                    |
| if            | the Master Seed Virus is unsatisfactory, except that, if less than 90 percent of the controls have                                    |
| if            | embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of                           |
| if            | during the observation period, the serial is unsatisfactory. if                                                                       |
| if            | in more than one of the controls or if unfavorable reactions which are not attributable to the                                        |
| if            | in more than one of the controls or if unfavorable reactions which are not attributable to the                                        |
| when          | paragraph (c) of this section to assure that when tested at any time within the expiration period,                                    |
| when          | paragraph (c) of this section to assure that, when tested at any time within the expiration period,                                   |
| if            | declared a No Test and repeated: Provided, That if the test is not repeated, the serial shall                                         |
| if            | of the Reference Tuberculin, the serial is unsatisfactory. if                                                                         |
| if            | of large visible particles (strands or clumps) or if  it autoagglutinates, the serial is unsatisfactory.                              |
| when          | (2) Stereo-microscopic examination shall be used  when  necessary to evaluate a granular appearing antigen.                           |
| if            | concurrently in a single test series are valid if  the spec                                                                           |
| if            | serial is satisfactory after the second stage test, if  its spec                                                                      |
| if            | serial is satisfactory after the second stage test, if  its spec                                                                      |
| if            | The true name of a bacterium-spec if ic product shall: include the term &#8220;antibody&#8221;                                        |
| if            | The true name of a bacterium-spec if ic product shall: include the term &#8220;antibody&#8221;                                        |
| if            | Horses shall be retested annually for EIA and, if housed or pastured with any other species, shall                                    |
| if            | secretions need not be tested individually for brucellosis if a portion of their secretions contribute to the                         |
| if            | secretions need not be tested individually for brucellosis if a portion of their secretions contribute to the                         |
| if            | from the herd and the remaining animals retested. if                                                                                  |
| until         | Production shall not be renewed  until a negative herd test is obtained not less                                                      |
| if            | be one of those described below and spec if ied in the filed Outline of Production for                                                |
| until         | following preparation and maintained in a frozen state until time of use, shall contain at least one                                  |
| until         | with the agar-sample mixture and allowed to stand until  the mixture solidifies.                                                      |
| if            | observed on any of the retest plates, or if a retest is not initiated within 21 days                                                  |
| until         | with the agar-sample mixture and allowed to stand until  the mixture solidifies.                                                      |
| if            | observed on any of the retest plates, or if a retest is not initiated within 21 days                                                  |
| until         | with the agar-sample mixture and allowed to stand until  the mixture solidifies.                                                      |
| if            | observed on any of the retest plates, or if a retest is not initiated within 21 days                                                  |
| until         | with the agar-sample mixture and allowed to stand until  the mixture solidifies.                                                      |
| if            | colonies on the retest plates exceeds that spec if ied in the filed Outline of Production for                                         |
| when          | the amount which is delivered from such container when  opened and inverted until the flow stops.                                     |
| until         | delivered from such container when opened and inverted until  the flow stops.                                                         |
| when          | Standard Toxin test dose is that amount which when mixed with 0.1 unit of Standard Antitoxin, incubated                               |
| until         | (6) Controls shall be observed  until they are down and are unable to rise                                                            |
| when          | of the spine, asymmetry of the body outline when the resting animal is viewed from above, generalized                                 |
| when          | of the spine, asymmetry of the body outline when the resting animal is viewed from above, generalized                                 |
| if            | within 7 days post-challenge, the test is invalid. if                                                                                 |
| if            | All dead mice shall be examined to determine  if  the cause of death was Erysipelothrix rhusiopathiae infection.                      |
| when          | The second stage shall be required  when 7-10 of the mice injected with product die                                                   |
| when          | and terms shall mean: (i) International antitoxin unit. when                                                                          |
| until         | for 25 minutes; and storing at 4 &#176;C. until  used.                                                                                |
| until         | for 1 hour and hold in ice water until  injections of mice can be made.                                                               |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | Unit per ml and the serial is unsatisfactory. if                                                                                      |
| when          | and terms shall mean: (i) International antitoxin unit. when                                                                          |
| until         | for 25 minutes; and storing at 4 &#176;C. until  used.                                                                                |
| until         | for 1 hour, and hold in ice water until  injections of mice can be made.                                                              |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | No Test and shall be repeated: Provided, That, if the test is not repeated, the serial shall                                          |
| if            | Units per ml and the serial is unsatisfactory. if                                                                                     |
| if            | meet or exceed that of the reference, or if a retest is not conducted, the serial is                                                  |


## Entities

| Entities                         | Context                                                                                                                                             |
|:---------------------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------|
| Compliance                       | Compliance .                                                                                                                                        |
| U.S. Department                  | the regulations are conducted, National Veterinary Services Laboratories, U.S. Department of Agriculture, may provide testing aids, when available, |
| Agriculture                      | conducted, National Veterinary Services Laboratories, U.S. Department of Agriculture , may provide testing aids, when available, to                 |
| United States                    | subserial of a biological product manufactured in the United States  or imported into the                                                           |
| United States                    | subserial of a biological product manufactured in the United States  or imported into the                                                           |
| Agriculture                      | (a) Either an employee of the Department of  Agriculture , of the licensee, or of the permittee,                                                    |
| Biological                       | Biological product in final container shall be selected to                                                                                          |
| Bulk                             | Bulk containers of completed product may be sampled when                                                                                            |
| Biological                       | Biological products desiccated in bulk shall be sampled at                                                                                          |
| Production                       | reagents as prescribed in a filed Outline of Production ; (2) Be adequate in quantity for appropriate                                               |
| Animal                           | Requirements for the product shall be submitted to Animal  and Plant Health Inspection Service.                                                     |
| Blank                            | Blank forms shall be furnished upon request to Animal                                                                                               |
| Animal                           | Blank forms shall be furnished upon request to  Animal  and Plant Health Inspection Service.                                                        |
| Animal                           | Animal  and Plant Health Inspection Service testing.                                                                                                |
| United States                    | to cause a biological product, manufactured in the United States  or imported into the                                                              |
| United States                    | to cause a biological product, manufactured in the United States  or imported into the                                                              |
| Virus                            | (e)  Virus titrations for a multivirus product shall be conducted                                                                                   |
| Release                          | Release of the serial may not be based on                                                                                                           |
| That                             | paragraphs (c)(4)(i) and (ii) of this section; Provided, That , if the serial is not retested or                                                    |
| That                             | (c)(5) (i) and (ii) of this section; Provided, That , if the serial is not retested or                                                              |
| Serial                           | with declining potency either by testing a Qualifying Serial in host animals or by providing other evidence                                         |
| Provided                         | reference may be granted an extension of dating, Provided , That its immunogenicity has been confirmed using                                        |
| New                              | New  potency test.                                                                                                                                  |
| Culture                          | Culture  media for detection of bacteria and fungi.                                                                                                 |
| United States Pharmacopeia       | Ingredients for which standards are prescribed in the United States Pharmacopeia , or elsewhere in this part, shall conform                         |
| United States Pharmacopeia       | &#167;&#167;&#8201;113.26 and 113.27 are set forth in the United States Pharmacopeia , 19th Edition.                                                |
| Additional                       | Additional control may be used by incubation of representative                                                                                      |
| Incubation                       | Incubation shall be at 30 &#176;to 35 &#176;C for                                                                                                   |
| Incubation                       | Incubation shall be at 20 &#176;to 25 &#176;C for                                                                                                   |
| Product                          | Product recommended for mass vaccination shall be rehydrated at                                                                                     |
| Incubation                       | Incubation shall be at 30 &#176;to 35 &#176;C for                                                                                                   |
| Incubation                       | Incubation shall be at 20 &#176;to 25 &#176;C for                                                                                                   |
| Frozen                           | Frozen liquid Master Seed Virus shall be thawed, and                                                                                                |
| Incubation                       | Incubation shall be at 30 &#176;to 35 &#176;C for                                                                                                   |
| Incubation                       | Incubation shall be at 20 &#176;to 25 &#176;C for                                                                                                   |
| Frozen                           | Frozen liquid Master Seed Bacteria shall be thawed, and                                                                                             |
| Incubation                       | Incubation shall be at 30 &#176;to 35 &#176;C for                                                                                                   |
| Incubation                       | Incubation shall be at 20 &#176;to 25 &#176;C for                                                                                                   |
| Kinetic                          | Heart Infusion Agar shall be used with 500 Kinetic (Kersey) units of penicillinase per ml of medium                                                 |
| Kersey                           | Agar shall be used with 500 Kinetic ( Kersey ) units of penicillinase per ml of medium                                                              |
| Product                          | Product recommended for mass vaccination shall be rehydrated at                                                                                     |
| Twenty                           | Twenty ml of medium shall be added to each                                                                                                          |
| Media                            | (a)  Media additives provided in this paragraph shall be prepared                                                                                   |
| Filter                           | Filter sterilize, dispense in appropriate amounts and store frozen                                                                                  |
| Balance                          | (3)  Balance , accurate to 0.1 mg (rated precision &#177;0.01mg).                                                                                   |
| Sample                           | Sample and control should be kept at room temperature                                                                                               |
| Salmonella                       | Detection of  Salmonella  contamination.                                                                                                            |
| Salmonella                       | The test for detection of  Salmonella contamination provided in this section shall be conducted                                                     |
| Salmonella                       | (d) If no growth typical of  Salmonella is noted, the plates shall be incubated an                                                                  |
| Animal                           | this requirement if the licensee can demonstrate to Animal and Plant Health Inspection Service that the agent                                       |
| Animal                           | source flock (or other sampling procedure acceptable to Animal and Plant Health Inspection Service) used for the                                    |
| Newcastle                        | are tested, the equivalent of 200 doses of Newcastle disease vaccine or 500 doses of other vaccines                                                 |
| Source                           | Source flocks from which contaminated material was obtained are                                                                                     |
| Brucella                         | Detection of  Brucella  contamination.                                                                                                              |
| Brucella                         | The test for detection of  Brucella contamination provided in this section shall be conducted                                                       |
| Brucella                         | (b) If colonies are identified as  Brucella , the biological product is unsatisfactory.                                                             |
| Brucella                         | (c) If colonies suspicious of  Brucella  are observed but cannot be identified as a                                                                 |
| Brucella                         | (c) If colonies suspicious of  Brucella  are observed but cannot be identified as a                                                                 |
| Mouse                            | Mouse  safety tests.                                                                                                                                |
| Newcastle                        | of ten 9- to 10-day-old embryonating eggs from Newcastle disease susceptible flocks shall be inoculated into the                                    |
| Newcastle                        | (2) Test an allantoic fluid sample of  Newcastle  disease virus as a positive control.                                                              |
| Test                             | (c)  Test procedure: (1) Rehydrate at least two vials of                                                                                            |
| Twenty                           | Twenty birds may be used for each route or                                                                                                          |
| Examine                          | Examine all embryos and CAM's from embryos which die                                                                                                |
| Guinea                           | Guinea  pig safety test.                                                                                                                            |
| Cat                              | Cat  safety tests.                                                                                                                                  |
| Blood                            | Blood samples shall also be drawn and individual serum                                                                                              |
| Animal                           | (ii) of this section, a method acceptable to Animal  and Plant Health Inspection Service shall be used.                                             |
| Dog                              | Dog  safety tests.                                                                                                                                  |
| Calf                             | Calf  safety test.                                                                                                                                  |
| Test                             | (a)  Test  procedure.                                                                                                                               |
| Vaccine                          | Vaccine virus may be neutralized with specific antiserum when                                                                                       |
| Swine                            | Swine  safety test.                                                                                                                                 |
| Test                             | (a)  Test  procedure.                                                                                                                               |
| That                             | a No Test and may be repeated; Provided, That , if the test is not repeated, the                                                                    |
| Sheep                            | Sheep  safety test.                                                                                                                                 |
| Test                             | (a)  Test  procedure.                                                                                                                               |
| That                             | a No Test and may be repeated; Provided, That , if the test is not repeated, the                                                                    |
| Provided                         | subculturing if fluorescence is enhanced by doing so, Provided , That a monolayer of the material under                                             |
| Reovirus                         | tested for: (i) Bovine virus diarrhea virus; (ii) Reovirus ; and                                                                                    |
|                                  |               (iii) Rabies virus.                                                                                                                   |
| Canine                           | (3)  Canine  cells shall, in addition, be tested for:                                                                                               |
|                                  |               (i)                                                                                                                                   |
| Canine                           | (3)  Canine  cells shall, in addition, be tested for:                                                                                               |
|                                  |               (i)                                                                                                                                   |
| Canine                           | (3)  Canine  cells shall, in addition, be tested for:                                                                                               |
|                                  |               (i)                                                                                                                                   |
| Porcine                          | (6)  Porcine  cells shall, in addition, be tested for:                                                                                              |
|                                  |               (i)                                                                                                                                   |
| Porcine                          | (6)  Porcine  cells shall, in addition, be tested for:                                                                                              |
|                                  |               (i)                                                                                                                                   |
| Porcine                          | (6)  Porcine  cells shall, in addition, be tested for:                                                                                              |
|                                  |               (i)                                                                                                                                   |
| Porcine                          | (6)  Porcine  cells shall, in addition, be tested for:                                                                                              |
|                                  |               (i)                                                                                                                                   |
| Fixed                            | Fixed positive rabies virus control monolayers will be provided                                                                                     |
| That                             | is unsatisfactory and may not be used; Provided, That , if specific fluorescence attributable to the virus                                          |
| That                             | a No Test, and may be repeated; Provided, That , if the test is not repeated, the                                                                   |
| Animal                           | in a frozen state, and made available to Animal and Plant Health Inspection Service (APHIS) upon request                                            |
| Vero                             | one monolayer (at least 75 cm&#8201;2) of: (i) Vero (African green monkey kidney) cell line; (ii) Embryonic                                         |
| Animal                           | heat sterilization or other sterilization methods acceptable to Animal and Plant Health Inspection Service (APHIS), such as,                        |
| Vero                             | paragraph; (1) Monolayers at least 75 cm&#8201;2 of Vero (African green monkey kidney) cell line and of                                             |
| Cell                             | Cell lines used shall have been found satisfactory when                                                                                             |
| Sterile                          | Sterile  diluent.                                                                                                                                   |
| Vero                             | (at least 75 cm&#8201;2 in area) of: (1) Vero (African green monkey kidney) cell line; (2) Embryonic                                                |
| Cell                             | Cell lines used shall have been found satisfactory when                                                                                             |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Fluorescence                     | Fluorescence  typical for the bacteria concerned shall be demonstrated.                                                                             |
| Fluorescence                     | Fluorescence shall not occur in control smears treated with                                                                                         |
| Agglutination                    | Agglutination shall not occur with negative serum used as                                                                                           |
| Agglutination                    | Agglutination shall not occur with negative serum used as                                                                                           |
| Data                             | Data shall be obtained by determining the percent moisture                                                                                          |
| Strain                           | forms of the Brucella abortus organism, identified as Strain  19.                                                                                   |
| Brucella                         | If organisms not typical of  Brucella abortus organisms are evident, the serial or subserial                                                        |
| Brucella                         | If growth not typical of  Brucella abortus organisms is evident, the serial or subserial                                                            |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Smooth                           | Smooth  colonies are the desired form.                                                                                                              |
| Brucella                         | If organisms or growth not characteristic of  Brucella abortus are found, the serial or subserial is                                                |
| Bacillus                         | live spore suspension prepared from nonencapsulated variants of Bacillus  anthracis.                                                                |
| Bacillus                         | guinea pig LD50 of a virulent suspension of Bacillus anthracis furnished or approved by Animal and Plant                                            |
| Bacillus                         | of the 12 controls do not die from Bacillus anthracis within the 10-day postchallenge observation period the                                        |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Erysipelothrix                   | Erysipelothrix Rhusiopathiae Vaccine shall be prepared as a desiccated                                                                              |
| Animal                           | for preparation and use shall be obtained from Animal  and Plant Health Inspection Service.                                                         |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Pasteurella                      | Pasteurella  Haemolytica Vaccine, Bovine.                                                                                                           |
| Bovine                           | Pasteurella Haemolytica Vaccine,  Bovine .                                                                                                          |
| Pasteurella                      | Pasteurella Haemolytica Vaccine, Bovine, shall be prepared as a                                                                                     |
| Bovine                           | Pasteurella Haemolytica Vaccine,  Bovine , shall be prepared as a desiccated live                                                                   |
| Pasteurella                      | Pasteurella Haemolytica Vaccine, Bovine, shall be prepared as a                                                                                     |
| Pasteurella                      | the respiratory route with a (virulent) pneumonia producing Pasteurella haemolytica culture and observed for 4 to 7                                 |
| Lung                             | Lung lesions will be assessed at necropsy in calves                                                                                                 |
| Lung                             | Lung lesion scores will be used in the assessment                                                                                                   |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Pasteurella                      | Pasteurella  Multocida Vaccine, Bovine.                                                                                                             |
| Bovine                           | Pasteurella Multocida Vaccine,  Bovine .                                                                                                            |
| Pasteurella                      | Pasteurella Multocida Vaccine, Bovine, shall be prepared as a                                                                                       |
| Bovine                           | Pasteurella Multocida Vaccine,  Bovine , shall be prepared as a desiccated live                                                                     |
| Pasteurella                      | the respiratory route with a (virulent) pneumonia producing Pasteurella multocida culture and observed for 4 to 10                                  |
| Lung                             | Lung lesions will be assessed at necropsy in calves                                                                                                 |
| Lung                             | Lung lesion scores will be used in the assessment                                                                                                   |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Pasteurella                      | Pasteurella  Multocida Vaccine, Avian Isolate.                                                                                                      |
| Pasteurella                      | Pasteurella Multocida Vaccine, Avian Isolate, shall be prepared as                                                                                  |
| Pasteurella                      | Pasteurella Multocida Vaccine, Avian Isolate, shall be prepared as                                                                                  |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Chlamydia                        | Chlamydia  Psittaci Vaccine (Feline Pneumonitis), Live                                                                                              |
| Chlamydia                        | Chlamydia  Psittaci Vaccine (Feline Pneumonitis), Live                                                                                              |
| Blood                            | Blood samples shall be drawn and individual serum samples                                                                                           |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Chlamydia                        | (2)  Chlamydia  titer requirements.                                                                                                                 |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Inject                           | Inject each of at least 10 but not more                                                                                                             |
| Retain                           | Retain at least 10 but not more than 12                                                                                                             |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Inject                           | Inject each of at least 10 but not more                                                                                                             |
| Retain                           | Retain at least 10 but not more than 12                                                                                                             |
| Serials                          | Serials found unsatisfactory by any prescribed test shall not                                                                                       |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Inject                           | Inject each of at least 10 but not more                                                                                                             |
| Retain                           | Retain at least 10 but not more than 12                                                                                                             |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Inject                           | Inject each of at least 10 but not more                                                                                                             |
| Retain                           | Retain at least 10 but not more than 12                                                                                                             |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Clostridium                      | Clostridium  Chauvoei Bacterin.                                                                                                                     |
| Clostridium                      | Clostridium Chauvoei Bacterin shall be produced from a culture                                                                                      |
| Clostridium                      | Clostridium Chauvoei Bacterin shall be produced from a culture                                                                                      |
| Clostridium                      | Each serial of biological product containing  Clostridium chauvoei fraction shall meet the applicable requirements in                               |
| Serials                          | Serials found unsatisfactory by any prescribed test shall not                                                                                       |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | Clostridium chauvoei challenge material, available upon request from Animal and Plant Health Inspection Service, shall be used                      |
| Clostridium                      | Clostridium Haemolyticum Bacterin shall be produced from a culture                                                                                  |
| Clostridium                      | Clostridium Haemolyticum Bacterin shall be produced from a culture                                                                                  |
| Clostridium                      | Each serial of biological product containing  Clostridium haemolyticum fraction shall meet the applicable requirements in                           |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | Clostridium haemolyticum challenge material, available upon request from Animal and Plant Health Inspection Service, shall be used                  |
| Clostridium                      | Clostridium Novyi Bacterin-Toxoid shall be produced from a culture                                                                                  |
| Clostridium                      | Clostridium Novyi Bacterin-Toxoid shall be produced from a culture                                                                                  |
| Clostridium                      | Each serial of biological product containing  Clostridium novyi fraction shall meet the applicable requirements in                                  |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Clostridium                      | Clostridium  Sordellii Bacterin-Toxoid.                                                                                                             |
| Clostridium                      | Clostridium Sordellii Bacterin-Toxoid shall be produced from a culture                                                                              |
| Clostridium                      | Clostridium Sordellii Bacterin-Toxoid shall be produced from a culture                                                                              |
| Clostridium                      | Each serial of biological product containing  Clostridium sordellii fraction shall meet the applicable requirements in                              |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Clostridium                      | Clostridium  Botulinum Type C Bacterin-Toxoid.                                                                                                      |
| Clostridium                      | Clostridium Botulinum Type C Bacterin-Toxoid shall be produced from                                                                                 |
| Clostridium                      | Clostridium Botulinum Type C Bacterin-Toxoid shall be produced from                                                                                 |
| Clostridium                      | Each serial of biological product containing  Clostridium botulinum Type C fraction shall meet the applicable                                       |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Clostridium                      | Clostridium  Perfringens Type C Toxoid and Bacterin-Toxoid.                                                                                         |
| Clostridium                      | Clostridium  Perfringens Type C Toxoid and                                                                                                          |
| Clostridium                      | Clostridium  Perfringens Type C Toxoid and                                                                                                          |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Animal                           | which is supplied by or is acceptable to Animal  and Plant Health Inspection Service.                                                               |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Clostridium                      | Clostridium  Perfringens Type D Toxoid and                                                                                                          |
| Clostridium                      | Clostridium  Perfringens Type D Toxoid and                                                                                                          |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Animal                           | which is supplied by or is acceptable to Animal  and Plant Health Inspection Service.                                                               |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Provided, That                   | direction of a veterinarian under a veterinarian-client-patient relationship, Provided, That , such products may be prepared for use                |
| Ames, IA                         | and Compliance, 1920 Dayton Avenue, P.O. Box 844, Ames, IA  50010) the following information.                                                       |
| Ames, IA                         | and Compliance, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010) for authorization to prepare a product for                                        |
| Provided, That                   | microorganism(s) older than the above stated time periods, Provided, That , the person requesting such authorization submits the                    |
| Ames, IA                         | and Compliance, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010) on a quarterly basis by the 21st                                                  |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bacteria                         | of autogenous biologics shall be identified as follows: Bacteria , fungi, and mycoplasma shall be identified at                                     |
| Policy                           | submitted to the Director, Center for Veterinary Biologics, Policy , Evaluation, and Licensing, 1920 Dayton Avenue, P.O.                            |
| Ames, IA                         | and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA  50010 for review.                                                                        |
| Clostridium                      | Toxoid shall be produced from a culture of Clostridium  tetani which has been inactivated and is nontoxic.                                          |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Appropriate                      | Appropriate  controls should be included for accurate interpretations.                                                                              |
| Mix                              | Mix and incubate the combined product in a 37                                                                                                       |
| Pasteurella                      | Pasteurella  Multocida Bacterin, Avian Isolate, Type 4.                                                                                             |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 4 shall be                                                                                      |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 4 shall be                                                                                      |
| Lyons                            | Pasteurella multocida, avian isolate, Type 4 (Little and Lyons  classification), which have been inactivated, and are nontoxic.                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Turkeys                          | Turkeys at least 6 weeks old obtained from the                                                                                                      |
| Lyons                            | Pasteurella multocida, Strain P-1662, Type 4 (Little and Lyons classification) and observed daily for a 14-day postchallenge                        |
| Pasteurella                      | Pasteurella  Multocida Bacterin, Avian Isolate, Type 1.                                                                                             |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 1, shall be                                                                                     |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 1, shall be                                                                                     |
| Lyons                            | Pasteurella multocida, avian isolate, Type 1 (Little and Lyons  classification), which have been inactivated and are nontoxic.                      |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Chickens                         | Chickens , at least 12 weeks of age, obtained                                                                                                       |
| Lyons                            | Pasteurella multocida, Strain X-73, Type 1 (Little and Lyons classification) and observed daily for a 14-day postchallenge                          |
| Pasteurella                      | Pasteurella  Multocida Bacterin, Avian Isolate, Type 3.                                                                                             |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 3, shall be                                                                                     |
| Pasteurella                      | Pasteurella Multocida Bacterin, Avian Isolate, Type 3, shall be                                                                                     |
| Lyons                            | Pasteurella multocida, avian isolate, Type 3 (Little and Lyons  classification), which have been inactivated and are nontoxic.                      |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Turkeys                          | Turkeys , at least 6 weeks of age, obtained                                                                                                         |
| Erysipelothrix                   | Erysipelothrix Rhusiopathiae Bacterin shall be produced from a culture                                                                              |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Such                             | Such swine dose shall not be less than 1                                                                                                            |
| Unknown                          | The ability of the bacterin being tested ( Unknown ) to protect mice shall be compared with                                                         |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Unknown                          | of the Standard and each dilution of an Unknown , a group of at least 20 mice,                                                                      |
| Salmonella                       | Salmonella Typhimurium Bacterin shall be prepared from a culture                                                                                    |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Unknown                          | The ability of the bacterin being tested ( Unknown ) to protect mice shall be compared with                                                         |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Unknown                          | of the Standard and each dilution of an Unknown , a group of at least 20 mice,                                                                      |
| Salmonella                       | determined by titration, of a suitable culture of Salmonella  typhimurium.                                                                          |
| That                             | a manner identical to the initial test; Provided, That , if the Unknown is not retested or                                                          |
| Pasteurella                      | Pasteurella  Multocida Bacterin.                                                                                                                    |
| Pasteurella                      | Pasteurella Multocida Bacterin shall be prepared from a culture                                                                                     |
| Pasteurella                      | Pasteurella Multocida Bacterin shall be prepared from a culture                                                                                     |
| Pasteurella                      | Each serial of biological product containing  Pasteurella multocida fraction shall meet the applicable requirements in                              |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Unknown                          | The ability of the bacterin being tested ( Unknown ) to protect mice shall be compared with                                                         |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Pasteurella                      | determined by titration, of a suitable culture of Pasteurella  multocida.                                                                           |
| Salmonella                       | Salmonella Choleraesuis Bacterin shall be prepared from a culture                                                                                   |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Unknown                          | The ability of the bacterin being tested ( Unknown ) to protect mice shall be compared with                                                         |
| Unknown                          | of the Standard and each dilution of an Unknown , a group of at least 20 mice,                                                                      |
| Salmonella                       | determined by titration of a suitable culture of Salmonella  choleraesuis.                                                                          |
| That                             | a manner identical to the initial test; Provided, That , if the Unknown is not retested or                                                          |
| Salmonella                       | Salmonella Dublin Bacterin shall be prepared from a culture                                                                                         |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Unknown                          | The ability of the bacterin being tested ( Unknown ) to protect mice shall be compared with                                                         |
| Unknown                          | of the Standard and each dilution of an Unknown , a group of at least 20 mice,                                                                      |
| Salmonella                       | determined by titration of a suitable culture of Salmonella  dublin.                                                                                |
| That                             | a manner identical to the initial test; Provided, That , if the Unknown is not retested or                                                          |
| Suitable                         | Suitable tests to assure complete inactivation shall be written                                                                                     |
| Bacteria                         | (c) Purity tests&#8212;(1)  Bacteria  and fungi.                                                                                                    |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Avian                            | (2)  Avian  origin vaccine.                                                                                                                         |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Fecal                            | Fecal material shall be collected on one day between                                                                                                |
| Newcastle                        | Newcastle  Disease Vaccine, Killed Virus.                                                                                                           |
| Newcastle                        | Newcastle Disease Vaccine (Killed Virus) shall be prepared from                                                                                     |
| Newcastle                        | shall be challenged with a virulent strain of Newcastle disease virus supplied by or approved by Veterinary                                         |
| Newcastle                        | the controls do not show typical signs of Newcastle disease or die, the test is a No                                                                |
| Final                            | Final container samples of completed product shall meet the                                                                                         |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Eastern, Western, and Venezuelan | Encephalomyelitis Vaccine,  Eastern, Western, and Venezuelan , Killed Virus.                                                                        |
| Eastern, Western, and Venezuelan | Encephalomyelitis Vaccine,  Eastern, Western, and Venezuelan , Killed Virus, shall be prepared from virus-bearing                                   |
| Bulk                             | Bulk samples of completed product from each serial shall                                                                                            |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Eastern                          | For each fraction contained in the product&#8212; Eastern type, Western type, or Venezuelan type&#8212;the serological interpretations              |
| Western                          | For each fraction contained in the product&#8212;Eastern type,  Western type, or Venezuelan type&#8212;the serological interpretations required in  |
| Eastern                          | a titer of less than 1:40 for the Eastern type fraction, less than 1:40 for the Western                                                             |
| Eastern                          | a titer of less than 1:40 for the Eastern type fraction, less than 1:40 for the Western                                                             |
| Eastern                          | a titer of less than 1:40 for the Eastern type fraction or the Western type fraction, or                                                            |
| Avian                            | Avian Encephalomyelitis Vaccine (Killed Virus) shall be prepared from                                                                               |
| Chicken                          | (ii)  Chicken  test.                                                                                                                                |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Vaccine                          | Rabies  Vaccine (Killed Virus) shall be prepared from virus-bearing cell                                                                            |
| Rabies                           | potency in chapter 37 of &#8220;Laboratory Techniques in Rabies ,&#8221; Fourth Edition (1996), edited by F.X.                                      |
| Meslin, M.M                      | Meslin, M.M .                                                                                                                                       |
| Kaplan, and H. Koprowski         | Kaplan, and H. Koprowski , World Health Organization, Geneva, Switzerland (ISBN 92                                                                  |
| Geneva, Switzerland              | Kaplan, and H. Koprowski, World Health Organization,  Geneva, Switzerland  (ISBN 92 4 154479 1).                                                    |
| Rabies                           | provisions of chapter 37 of &#8220;Laboratory Techniques in Rabies ,&#8221; Fourth Edition (1996), are the minimum standards                        |
| United States                    | In the  United States , that authority is the Animal and Plant                                                                                      |
| Ames, IA                         | located at 1920 Dayton Avenue, P.O. Box 844, Ames, IA  50010; phone (515) 337-6100; fax (515) 337-6120.                                             |
| Policy                           | Plant Health Inspection Service, Center for Veterinary Biologics, Policy , Evaluation, and Licensing, 1920 Dayton Avenue, P.O.                      |
| Ames, IA                         | and Licensing, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010, or at the National Archives and Records                                            |
| Animal                           | fluorescent antibody test or other method acceptable to Animal  and Plant Health Inspection Service.                                                |
| Bulk                             | Bulk samples from each serial shall be tested for                                                                                                   |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Rabies                           | potency in Chapter 37 of &#8220;Laboratory Techniques in Rabies ,&#8221; Fourth Edition (1996), which is incorporated by                            |
| Animal                           | shall be established by a method acceptable to Animal  and Plant Health Inspection Service.                                                         |
| Vaccine                          | Vaccine used for this test shall be at the                                                                                                          |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Throat                           | Throat and nasal swabs shall be collected from each                                                                                                 |
| Blood                            | Blood samples shall be drawn and individual serum samples                                                                                           |
| Animal                           | shall be established by a method acceptable to Animal  and Plant Health Inspection Service.                                                         |
| Vaccine                          | Vaccine used for this test shall be at the                                                                                                          |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Inject                           | Inject each of 21 susceptible chickens 14 to 28                                                                                                     |
| Retain                           | Retain at least 10 additional chickens from the same                                                                                                |
| Vaccine                          | Vaccine used for this test shall be at the                                                                                                          |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Individual                       | Individual serum samples shall be collected, inactivated, and individually                                                                          |
| Calves                           | Calves shall be considered susceptible if there is no                                                                                               |
| Test                             | (v)  Test  interpretation.                                                                                                                          |
| Vaccine                          | Vaccine used for this test shall be at the                                                                                                          |
| Bulk                             | Bulk or final container samples of completed product shall                                                                                          |
| Individual                       | Individual serum samples shall be collected, inactivated, and individually                                                                          |
| Calves                           | Calves shall be considered susceptible if there is no                                                                                               |
| Test                             | (v)  Test  interpretation.                                                                                                                          |
| Bacteria                         | (a) Purity tests&#8212;(1)  Bacteria  and fungi.                                                                                                    |
| Final                            | Final container samples of completed product and comparable samples                                                                                 |
| Final                            | Final container samples of completed product and comparable samples                                                                                 |
| Virus                            | (c)  Virus  identity test.                                                                                                                          |
| Fluorescence                     | Fluorescence typical of the virus concerned shall be demonstrated                                                                                   |
| Serum                            | (2)  Serum  neutralization test.                                                                                                                    |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Animal                           | susceptibility may be used if prior approval from Animal  and Plant Health Inspection Service is received.                                          |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Animal                           | virulence in sheep using a method acceptable to Animal  and Plant Health Inspection Service.                                                        |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Animal                           | of bluetongue virus or another method acceptable to Animal  and Plant Health Inspection Service.                                                    |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Blood                            | Blood samples drawn from each cat shall be individually                                                                                             |
| Clinical                         | Clinical signs of feline panleukopenia shall include a pronounced                                                                                   |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Canine                           | Canine  Hepatitis and                                                                                                                               |
| Canine                           | Canine  Hepatitis Vaccine and                                                                                                                       |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Thirty                           | Thirty canine adenovirus type 2 susceptible dogs shall be                                                                                           |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (1)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Canine                           | Canine Distemper Vaccine shall be prepared from virus-bearing cell                                                                                  |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Venezuelan                       | Encephalomyelitis Vaccine,  Venezuelan .                                                                                                            |
| Venezuelan                       | Encephalomyelitis Vaccine,  Venezuelan , shall be prepared from virus-bearing cell culture                                                          |
| Venezuelan                       | horses (20 vaccinates and 2 controls), susceptible to Venezuelan  equine encephalomyelitis, shall be used as test animals.                          |
| Blood                            | Blood samples shall be taken from each horse and                                                                                                    |
| Venezuelan                       | neutralization test using 60 to 300 TCID50 of Venezuelan  equine encephalomyelitis virus.                                                           |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Brucella                         | The test for  Brucella contamination prescribed in &#167;&#8201;113.32 shall be conducted on                                                        |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Brucella                         | The test for  Brucella contamination prescribed in &#167;&#8201;113.32 shall be conducted on                                                        |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Brucella                         | The test for  Brucella contamination prescribed in &#167;&#8201;113.32 shall be conducted on                                                        |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Divide                           | Divide  each species into two groups of five animals.                                                                                               |
| Inject                           | Inject each mouse in one litter intracerebrally with 0.02                                                                                           |
| Observe                          | Observe  mice each day for 21 days.                                                                                                                 |
| Animal                           | fluorescent antibody test or other method acceptable to Animal  and Plant Health Inspection Service.                                                |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Virus                            | (2)  Virus  titrations.                                                                                                                             |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Virus                            | (iii)  Virus titer requirements for release and at expiration date                                                                                  |
| Virus                            | (iii)  Virus titer requirements for release and at expiration date                                                                                  |
| Blood                            | Blood samples shall be drawn from these animals and                                                                                                 |
| Twenty                           | Twenty dogs shall be vaccinated with a predetermined quantity                                                                                       |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Throat                           | Throat swabs shall be collected from each cat and                                                                                                   |
| Blood                            | Blood samples shall be drawn and individual serum samples                                                                                           |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Throat                           | Throat swabs shall be collected from each cat and                                                                                                   |
| Blood                            | Blood samples shall be drawn and individual serum samples                                                                                           |
| Final                            | Final  container samples of completed product shall be tested.                                                                                      |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Canine                           | Canine  Parainfluenza Vaccine.                                                                                                                      |
| Canine                           | Canine Parainfluenza Vaccine shall be prepared from virus-bearing cell                                                                              |
| Nasal                            | Nasal swabs shall be collected from each dog on                                                                                                     |
| Blood                            | Blood samples shall also be drawn and individual serum                                                                                              |
| Nasal                            | Nasal swabs shall be collected from each dog each                                                                                                   |
| Individual                       | Individual swabs shall be tested for virus isolation by                                                                                             |
| Virus                            | (1)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Canine                           | (2) [Reserved]                                                                                                                                      |
|                                  |               Parvovirus Vaccine ( Canine ).                                                                                                        |
| Parvovirus                       | Parvovirus Vaccine recommended for use in dogs shall be                                                                                             |
| Animal                           | virulence in dogs using a method acceptable to Animal  and Plant Health Inspection Service.                                                         |
| Blood                            | Blood samples drawn from each dog shall be individually                                                                                             |
| Rectal                           | Rectal temperature, blood lymphocyte count, and feces for viral                                                                                     |
| Virus                            | (1)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Blood                            | Blood samples shall be taken from each pig and                                                                                                      |
| Pigs                             | Pigs shall be considered susceptible if there is no                                                                                                 |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be titrated                                                                                      |
| Avian                            | Avian  Encephalomyelitis Vaccine.                                                                                                                   |
| Avian                            | Avian Encephalomyelitis Vaccine shall be prepared from virus-bearing tissues                                                                        |
| Avian                            | be used shall be established as follows: (1) Avian encephalomyelitis susceptible chickens, all of the same age                                      |
| Twenty                           | Twenty similar embryos obtained from the same source shall                                                                                          |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Avian                            | Avian  Pox Vaccine.                                                                                                                                 |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Severe                           | Severe clinical signs or death shall be counted as                                                                                                  |
| Virus                            | (2)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Severe                           | Severe respiratory signs or death shall be counted as                                                                                               |
| Virus                            | be evaluated according to the following table: (3) Virus  titer requirements.                                                                       |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Equal                            | Equal parts of heat-inactivated Newcastle disease antiserum shall be                                                                                |
| Productions                      | Service and written into the filed Outline of Productions .                                                                                         |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Live                             | Live virus vaccine not prepared with modified live virus                                                                                            |
| Chickens                         | Chickens  shall be observed each day for 14 days.                                                                                                   |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Newcastle                        | Newcastle  Disease Vaccine.                                                                                                                         |
| Newcastle                        | Newcastle Disease Vaccine shall be prepared from virus-bearing cell                                                                                 |
| Newcastle                        | the controls do not develop clinical signs of Newcastle disease during the observation period, the test is                                          |
| Newcastle                        | do not remain free from clinical signs of Newcastle disease during the observation period, the Master Seed                                          |
| Animal                           | (5) A strain identity test acceptable to  Animal  and Plant Health Inspection Service shall be conducted.                                           |
| Severe                           | Severe respiratory signs or death shall be counted as                                                                                               |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Fifty                            | Fifty  uninoculated controls.                                                                                                                       |
| Final                            | Final container samples of completed product shall also meet                                                                                        |
| Chickens                         | Chickens dying during the period shall be examined, cause                                                                                           |
| Provided                         | vaccine, the test may be repeated one time, Provided , that if the test is not repeated,                                                            |
| Fifteen                          | Fifteen chickens of the same source and hatch shall                                                                                                 |
| Animal                           | conduct the titrations by a method acceptable to Animal  and Plant Health Inspection Service.                                                       |
| Final                            | Final container samples from each serial shall be tested                                                                                            |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Tenosynovitis                    | Tenosynovitis Vaccine shall be prepared from virus-bearing cell culture                                                                             |
| Animal                           | shall be established using a method acceptable to Animal and Plant Health Inspection Service before the immunogenicity                              |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Virus                            | (3)  Virus  titer requirements.                                                                                                                     |
| Final                            | Final container samples of completed product shall be titrated                                                                                      |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Tuberculin                       | Tuberculin , Intradermic.                                                                                                                           |
| Tuberculin                       | Tuberculin , Intradermic, is a filtrate produced from cultures                                                                                      |
| Pn, C, and Dt                    | Intradermic, is a filtrate produced from cultures of Pn, C, and Dt strains of Mycobacterium tuberculosis (supplied by Animal and                    |
| Mycobacterium                    | cultures of Pn, C, and Dt strains of Mycobacterium tuberculosis (supplied by Animal and Plant Health Inspection                                     |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Test                             | Test animals shall be 10 sensitized white female guinea                                                                                             |
| Mycobacterium                    | amounts of strains Pn, C, and Dt of Mycobacterium  tuberculosis.                                                                                    |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Pullorum                         | Pullorum  antigen.                                                                                                                                  |
| Salmonella                       | produced from a culture of representative strains of Salmonella pullorum which are of known antigenic composition, high                             |
| Final                            | Final container samples of completed product shall be tested                                                                                        |
| Microscopic                      | Microscopic  examination shall be made in this determination.                                                                                       |
| Avian                            | Avian  mycoplasma antigen.                                                                                                                          |
| Mycoplasma                       | Mycoplasma antigens shall be prepared from organisms, grown in                                                                                      |
| Plate                            | Plate antigens shall be stained with a dye acceptable                                                                                               |
| Animal                           | shall be stained with a dye acceptable to Animal  and Plant Health Inspection Service (APHIS).                                                      |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Mycobacterium                    | a purified protein derivative produced from cultures of Mycobacterium bovis Strain AN-5 (supplied by Animal and Plant                               |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Allowance                        | Allowance should be made for deaths during the sensitization                                                                                        |
| Inject                           | Inject each animal intramuscularly with 0.5 ml of a                                                                                                 |
| Inject                           | Inject each animal intramuscularly with 0.5 ml of a                                                                                                 |
| Final                            | Final container samples of completed product from each serial                                                                                       |
| Phenol                           | Phenol content of the final product shall be 0.50                                                                                                   |
| Antibody                         | Antibody .                                                                                                                                          |
| IgG                              | IgG  (Immunoglobulin G).                                                                                                                            |
| Failure                          | Failure  of passive transfer.                                                                                                                       |
| Antibody                         | Antibody products shall be named as follows: (1) Virus-specific                                                                                     |
| Example                          | Example : &#8220;Duck Virus Hepatitis Antibody, Duck Origin.&#8221;                                                                                 |
| Example                          | Example : &#8220;Escherichia Coli Monoclonal Antibody, Murine Origin.&#8221; (3)                                                                    |
| Example                          | Example : &#8220;Bovine IgG.&#8221;                                                                                                                 |
|                                  |               (4) Combination products.                                                                                                             |
| Blood                            | Blood , lacteal secretions, and egg material shall be                                                                                               |
| Blood                            | Blood  derivatives (serum, plasma, etc.                                                                                                             |
| Liquid                           | Liquid antibody products, except those immediately frozen following preparation                                                                     |
| Final                            | Final container samples of each serial and each subserial                                                                                           |
| Bulk                             | Bulk or final container samples of each serial shall                                                                                                |
| Dried                            | Dried product shall be reconstituted as indicated on the                                                                                            |
| Clostridium                      | product containing antibodies directed against the toxin of Clostridium  tetani.                                                                    |
| United States                    | minimum package size permitted for marketing in the United States  shall be a 1,500 unit vial.                                                      |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Normal                           | (5)  Normal guinea pigs weighing within a range of 340                                                                                              |
| Test                             | Test animals dying sooner than the controls indicate the                                                                                            |
| Erysipelothrix                   | Erysipelothrix Rhusiopathiae Antibody is a specific antibody product containing                                                                     |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Swiss                            | (1) In the first stage, each of 40  Swiss mice, each weighing 16 to 20 grams, shall                                                                 |
| Erysipelothrix                   | be challenged subcutaneously with the same culture of Erysipelothrix  rhusiopathiae.                                                                |
| Clostridium                      | Clostridium Perfringens Type C Antitoxin is a specific antibody                                                                                     |
| Clostridium                      | Clostridium Perfringens Type C Antitoxin is a specific antibody                                                                                     |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Animal                           | which is supplied by or is acceptable to Animal  and Plant Health Inspection Service.                                                               |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Clostridium                      | Clostridium  Perfringens Type D Antitoxin.                                                                                                          |
| Clostridium                      | Clostridium Perfringens Type D Antitoxin is a specific antibody                                                                                     |
| Clostridium                      | Clostridium Perfringens Type D Antitoxin is a specific antibody                                                                                     |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |
| Animal                           | which is either supplied by or acceptable to Animal  and Plant Health Inspection Service.                                                           |
| Animal                           | which is supplied by or is acceptable to Animal  and Plant Health Inspection Service.                                                               |
| Swiss                            | (vi) Five  Swiss white mice, each weighing 16-20 grams, shall be                                                                                    |
| Label                            | Label directions may indicate a single dosage regardless of                                                                                         |
| Bulk                             | Bulk or final container samples of completed product from                                                                                           |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                     |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-10-14 | (5) All plates shall be incubated in a high humidity, 4-6 percent CO2 atmosphere at 33 &#176;to 37 &#176;C for 10-14 days and examined with a stereoscopic microscope at 35x to 100x or with a regular microscope at 100x.                                                                                                                                                                                                  |
| 2004-11-05 | Firms currently using methods other than those provided in this section for determining the moisture content in desiccated biological products have until November 5, 2004 to update their Outlines of Production to be in compliance with this requirement.                                                                                                                                                                |
| 2018-09-10 | (b) Each of ten 9- to 10-day-old embryonating eggs from Newcastle disease susceptible flocks shall be inoculated into the allantoic cavity with 0.2 ml of the undiluted inoculum.                                                                                                                                                                                                                                           |
| 2004-07-14 | (f) If formaldehyde is used as the inactivating agent, and the serial has not been found satisfactory by the viricidal activity test, bulk or final container samples of completed product from each serial must be tested for residual free formaldehyde content using the ferric chloride test.&#8201;1                                                                                                                   |
|            |                  Firms currently using tests for residual free formaldehyde content other than the ferric chloride test have until July 14, 2004 to update their Outline of Production to be in compliance with this requirement.                                                                                                                                                                                           |
| 800-01-01  | Bulk or final container samples of completed product shall be diluted with physiological saline so that each 0.25 ml contains not more than 1/800th of the dose recommended on the label and shall be tested for potency, using the two-stage test provided in this paragraph.                                                                                                                                              |
| 1980-01-01 | Bulk or final container samples of completed product shall be diluted with physiological saline so that each 0.25 ml contains not more than 1/80th of the dose recommended on the label and shall be tested for potency, using the two-stage test provided in this paragraph.                                                                                                                                               |
| 1980-01-01 | Bulk or final container samples of completed product shall be diluted with physiological saline so that each 0.25 ml contains not more than 1/80th of the dose recommended on the label and shall be tested for potency, using the two-stage test provided in this paragraph.                                                                                                                                               |
| 800-01-01  | Bulk or final container samples of completed product shall be diluted with physiological saline so that each 0.25 ml contains not more than 1/800th of the dose recommended on the label and shall be tested for potency, using the two-stage test provided in this paragraph.                                                                                                                                              |
| 2018-04-08 | (2) Each of at least eight rabbits of a strain acceptable to the Animal and Plant Health Inspection Service, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the recommended cattle dose.                                                                                                                                                                                             |
| 2018-04-08 | (2) Each of at least eight rabbits of a strain acceptable to the Animal and Plant Health Inspection Service, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the recommended cattle dose: Provided, That, if the product is recommended only for sheep, half of the recommended sheep dose shall be used.                                                                             |
| 2018-04-08 | (2) Each of at least eight rabbits of a strain acceptable to APHIS, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any species indicated on the product label.                                                                                                                                                                                      |
| 2018-04-08 | (2) Each of at least eight rabbits of a strain acceptable to APHIS, each weighing 4-8 pounds, shall be injected subcutaneously with not more than half of the largest recommended dose for any species indicated on the product label.                                                                                                                                                                                      |
| 2018-10-01 | (iv) Test summaries must be submitted to the Administrator (in c/o the Director, Center for Veterinary Biologics, Inspection and Compliance, 1920 Dayton Avenue, P.O. Box 844, Ames, IA 50010) on a quarterly basis by the 21st day of January, April, July, and October or more often as required by the Administrator.                                                                                                    |
| 2018-07-14 | (1) Each rabbit shall be given a series of not more than three intramuscular injections at 7 day intervals (1.0 ml, 2.0 ml, 3.0 ml) and observed from 7-14 days following the third injection.                                                                                                                                                                                                                              |
| 2018-01-10 | A mouse dose shall be 1/10 of the least dose recommended on the label for swine.                                                                                                                                                                                                                                                                                                                                            |
| 2018-01-20 | A mouse dose shall be 1/20 of the least dose recommended on the label for other animals which shall not be less than 2 ml.                                                                                                                                                                                                                                                                                                  |
| 2018-07-10 | (4) Each of 20 vaccinated mice per group shall be challenged intraperitoneally 7-10 days after the second vaccination with a 0.25 ml dose containing 100-10,000 mouse LD50 as determined by titration, of a suitable culture of Salmonella typhimurium.                                                                                                                                                                     |
| 2018-01-20 | A mouse dose shall be 1/20 of the least dose recommended on the label for other animals which shall not be less than 2 ml.                                                                                                                                                                                                                                                                                                  |
| 2018-10-12 | (4) Each of 20 injected mice per group shall be challenged intraperitoneally 10-12 days after the second vaccination with a 0.2 ml dose containing 100-10,000 mouse LD50, as determined by titration, of a suitable culture of Pasteurella multocida.                                                                                                                                                                       |
| 2018-01-20 | A mouse dose shall be 1/20 of the least dose recommended on the label for other animals which shall not be less than 2 ml.                                                                                                                                                                                                                                                                                                  |
| 2018-01-20 | A mouse dose shall be 1/20 of the least dose recommended on the label for other animals which shall not be less than 2 ml.                                                                                                                                                                                                                                                                                                  |
| 2004-07-14 | If formaldehyde is used as the killing agent, the residual free formaldehyde content must not exceed 0.74 grams per liter (g/L) as determined using the ferric chloride test.&#8201;2                                                                                                                                                                                                                                       |
|            |                  Firms currently using tests for residual free formaldehyde content other than the ferric chloride test have until July 14, 2004 to update their Outline of Production to be in compliance with this requirement.                                                                                                                                                                                           |
| 2018-04-08 | Fecal material shall be collected on one day between days 4-8 (inclusive) postchallenge from each test animal that remains free of enteric signs and tested for the presence of mink enteritis virus by cell culture with fluorescent antibody examination.                                                                                                                                                                 |
| 2036-05-01 | (b) Each lot of Master Seed shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.                                                                                            |
| 2036-05-01 | (b) Each lot of Master Seed Virus shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the test may be repeated and if the repeat test is inconclusive for the same reason, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly. |
| 2036-05-01 | (1) Final container samples from each serial shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the vaccine judged accordingly.                                                                         |
| 2018-03-05 | (iv) Vaccines not recommended for use in birds 10 days of age or younger shall be tested for safety as follows: Each of twenty-five 3- to 5-week-old, fowl-pox susceptible birds shall be vaccinated with the equivalent of 10 doses of vaccine by each of all routes recommended on the label and observed each day for 14 days.                                                                                           |
| 2036-05-01 | (b) Each lot of Master Seed Virus shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the test may be repeated and if the repeat test is a No Test for the same reason, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.    |
| 2036-05-01 | (1) Final container samples from each serial shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the vaccine judged accordingly.                                                                         |
| 2036-05-01 | (b) Each lot of Master Seed Virus shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of vaccine virus override, the test may be repeated and if the repeat test is a No Test for the same reason, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.      |
| 2036-05-01 | (1) Final container samples from each serial shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the vaccine judged accordingly.                                                                         |
| 2036-05-01 | (b) Each lot of Master Seed Virus shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the test may be repeated and if the repeat test is a No Test for the same reason, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.    |
| 2036-05-01 | (1) Final container samples from each serial shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the vaccine judged accordingly.                                                                         |
| 2036-05-01 | Each lot of Master Seed Virus shall also be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.                                                                                     |
| 2036-05-01 | The chicken embryo inoculation test prescribed in &#167;&#8201;113.37 shall be conducted, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.                                                                                                                                      |
| 2036-05-01 | (b) Each lot of Master Seed Virus shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the virus judged accordingly.                                                                                      |
| 2018-03-04 | (2) Each of thirty-five 3- to 4-week-old bursal disease susceptible chickens (vaccinates) shall be vaccinated with approximately one minimum protective dose of vaccine virus as determined in paragraph (c) of this section.                                                                                                                                                                                               |
| 2036-05-01 | Final container samples from each serial shall be tested for pathogens by the chicken embryo inoculation test prescribed in &#167;&#8201;113.37, except that, if the test is a No Test because of a vaccine virus override, the chicken inoculation test prescribed in &#167;&#8201;113.36 may be conducted and the serial judged accordingly.                                                                              |
| 2018-04-05 | (B) For vaccines intended for drinking water administration, each of twenty-five 4- to 5-week-old bursal disease susceptible chickens shall be vaccinated orally with the equivalent of 10 doses.                                                                                                                                                                                                                           |
| 2018-10-03 | (2) Lymphoid leukosis virus contamination as follows:                                                                                                                                                                                                                                                                                                                                                                       |
|            |               (i) Each of at least 10 3-week-old or older lymphoid leukosis free chickens from the same source and hatch shall be injected intra-muscularly with an amount of Master Seed equal to 100 label doses of vaccine.                                                                                                                                                                                              |
| 2018-01-25 | (4) Safety using the following chicken test:                                                                                                                                                                                                                                                                                                                                                                                |
|            |               (i) For vaccines intended for use in chickens less than 14 days of age, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 1-day-old tenosynovitis susceptible chickens.                                                                                                                                                                                                  |
| 2018-01-25 | (ii) For vaccines intended for use only in chickens 14 days of age or older, Master Seed equal to 10 label doses shall be administered subcutaneously to each of 25 4-week-old or older tenosynovitis susceptible chickens.                                                                                                                                                                                                 |
| 2018-01-25 | (i) Final container samples of completed product from each serial shall be safety tested as follows:                                                                                                                                                                                                                                                                                                                        |
|            |               (A) For vaccines intended for use in very young chickens, each of 25 1-day-old tenosynovitis susceptible chickens shall be vaccinated with the equivalent of 10 doses by one method recommended on the label.                                                                                                                                                                                                 |
| 2018-01-25 | (B) For vaccines intended for use in older chickens, each of 25 4-week-old or older tenosynovitis susceptible chickens shall be vaccinated with the equivalent of 10 doses by one method recommended on the label.                                                                                                                                                                                                          |
| 2018-05-10 | The entire abdominal and flank areas shall be clipped, a depilatory agent applied for 5-10 minutes, the area rinsed with warm water, and dried.                                                                                                                                                                                                                                                                             |
| 2018-05-01 | Horses with standard agglutination titers equal to or greater than 1:100 may be tested by the Rivanol or card tests.                                                                                                                                                                                                                                                                                                        |
| 2018-05-01 | Cattle with standard agglutination titers equal to or greater than 1:100 may be tested by the Rivanol or card tests.                                                                                                                                                                                                                                                                                                        |
| 2018-10-15 | One milliliter of each rehydrated sample shall be pipetted into a 100 &#215; 15 mm petri dish and 10-15 ml of violet red bile agar at 45-50 &#176;C added.                                                                                                                                                                                                                                                                  |
| 2018-10-15 | One milliliter of each rehydrated sample shall be pipetted into a 100 &#215; 15 mm petri dish and 10-15 ml of brilliant green agar at 45-50 &#176;C added.                                                                                                                                                                                                                                                                  |
| 2018-10-15 | One milliliter of each rehydrated sample shall be pipetted into a 100 &#215; 15 mm petri dish and 10-15 ml of appropriately acidified potato dextrose agar at 45-50 &#176;C added.                                                                                                                                                                                                                                          |
| 2018-10-15 | One milliliter of each rehydrated sample, undiluted or diluted as prescribed in the Outline of Production, shall be pipetted into a 100 &#215; 15 mm petri dish and 10-15 ml of tryptone glucose extract agar at 45-50 &#176;C added.                                                                                                                                                                                       |


